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Executive summary  
Context 
The Drug Policy Modelling Program at the National Drug and Alcohol Research Centre was 
commissioned by the NSW Ministry of Health to conduct this process evaluation of the New South 
Wales Involuntary Drug and Alcohol Treatment (IDAT) Program, reflecting the first four years of the 
program. A separate outcome evaluation and costing work are underway. This executive summary 
reflects the findings of the process evaluation at the time it was conducted (from September to 
December 2016). 
 
The NSW Drug and Alcohol Treatment Act 2007 (the Act) provides the legislative basis for the IDAT 
Program. The Act provides for the involuntary detention, treatment and stabilisation regime (for 28 
days) for persons with severe substance dependence, with the stated aim of protecting the health and 
safety of such persons, while also aiming to address all human rights aspects that were the subject of 
criticism of the previous legislation. 
 
The IDAT Program commenced in New South Wales in 2012 with two gazetted treatment units. One 
treatment unit has 4 IDAT beds, is located in Sydney as part of an existing voluntary detoxification unit 
at Herbert Street Clinic (HSC), Royal North Shore Hospital, Northern Sydney Local Health District. The 
other treatment unit has 8 IDAT beds, is located in Orange, as part of the Bloomfield (BF) hospital in 
Western NSW Local Health District. The choice of location aimed to ensure that both metropolitan and 
rural regions were covered.  
 
Aim of the process evaluation  
The process evaluation aimed to provide descriptive information about the program operations, its 
reach, strengths and weaknesses, patient progression though the model of care, and the feasibility and 
appropriateness of the model of care. In providing this description, it also aimed to evaluate whether 
the Act was being implemented according to how it was originally conceived, and the extent to which 
the implementation of the IDAT program was consistent with the Model of Care and the legislative basis 
for the program, at the time of the process evaluation.  
 
Methodology  
Data for this process evaluation were collected from the following sources: 1) the IDAT program 
database; 2) in-depth interviews with patients; 3) in-depth interviews with stakeholders; 4) observations 
of weekly staff meetings at the two IDAT Treatment Centres; and 5) documentary review (including 
legislative documents, and records by the Official Visitors), and review of a limited number of patient 
files.  
A complete copy of the IDAT database was made available to the evaluators, covering the period from 
program commencement (31 May 2012) to 24 June 2016 (4 years). Twelve in-depth interviews with 
patients were conducted, proportionately balanced across the two treatment units. A total of 37 
stakeholders were interviewed and written submissions were received from two stakeholders. 
Observation of four weekly staff meetings was conducted across two treatment units. Reviews were 
conducted of the Act, the Model of Care, and the Official Visitors’ Books. Complete patients files of five 
patients were reviewed. Across the five different types of data collected for the process evaluation, a 
number of quantitative and qualitative data analytic tools were deployed. For the quantitative data, 
descriptive statistics were used along with simple tests of associations to analyse the IDAT database. 
The qualitative data (in-depth interviews with stakeholders) were analysed according to standard 
qualitative data techniques. Analysis of the diversity or congruence of views was also undertaken.  
 





The NSW Drug and Alcohol Treatment Act 2007 
There are four eligibility criteria in order to determine a person’s suitability for involuntary detention 
under the Act: a) Severe substance dependence; b) Potential for harm to self or others; c) Benefit from 
treatment; d) No other appropriate options. All four must be met with each person. Stakeholders noted 
that the eligibility criteria were subject to individual interpretation – which was regarded as both a 
strength (capacity for individual tailoring) and a potential weakness (insufficient clarity).  
 
The Act provides fundamental safeguards to ensure patients’ civil and human rights are addressed. It 
contains provisions to ensure that: 1) involuntary detention is a last resort; 2) the interests of the 
person are paramount; 3) the person will receive the best possible treatment in the least restrictive 
environment; and 4) any interference with the rights, dignity and self-respect of the person is kept to a 
minimum. The Act also contains provisions to ensure that a person and their primary carer are provided 
with clear information about their legal rights and their rights of appeal. There are good checks and 
balances in the process of deprivation of liberty, and the clinical processes (procedural requirements for 
patient referral) and legal processes (all the Dependency Certificates must be reviewed by a Magistrate, 
and Independent Official Visitors acting as an advocate on behalf of patients) occur independently from 
any political oversight. 
 
A fundamental issue with the Act is the definition of ‘treatment’, and ‘likely to benefit’. There is an 
important distinction between protection, stabilisation and assessment, compared to treatment. The 
objectives of the Act appear more concerned with the former: protecting an individual, stabilisation of 
the physical and mental state, comprehensive assessment and voluntary treatment engagement post 
program, versus the implication in the eligibility criteria that alcohol and other drug treatment is 
provided. The evaluators noted a tension between the former assessment, stabilisation, protection 
function and the latter treatment function, which goes to the heart of a number of themes arising from 
the process evaluation. There is significant pressure on beds (see waiting times section), and the 
provision of treatment (as opposed to protection, stabilisation and assessment) potentially increases 
the length of stay. In addition, the very existence of a delay to admission suggests that the immediate 
protection function may be compromised (someone assessed as in need of protection may no longer be 
in such a situation at the point in time that a bed becomes available). There is also some natural 
inclination for AOD clinicians within IDAT to want to (and be skilled at) providing AOD treatment 
interventions.  
 
The conditions under which an extension to the Dependency Certificate can be granted under the Act 
are limited to those with acquired brain injury and impaired cognitive function (‘drug and/or alcohol 
related brain injury’). The evaluators were unable to assess whether everyone who received an 
extension met the criteria. On the surface, it appeared a potential limitation to the legislation, with drug 
or alcohol related brain injury being only one of a number of potential reasons for seeking an extension 
to the DC.  
 
The Model of Care 
The Model of Care (MOC) provides a resource for managers, clinicians and other key stakeholders 
involved in supporting and delivering the Program. The MOC describes the principles, objectives, aims 
and the underpinning approach for the Program. The MOC represents an ‘ideal’ view of how IDAT 
should operate. The evaluation noted that the actual operations of the program varied from what was 
documented in the MOC. One example of this was the community treatment component (where limited 
‘aftercare’ is the more apparent model in practice). 
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Numbers of referrals to the program 
For the period from program commencement (31 May 2012) to 24 June 2016 (4 years), a total of 640 
episodes of referral were recorded for IDAT. These 640 referrals reflected 529 unique patients, with 80 
patients (15.12%) having two records (referred twice) and 31 patients (6%) having three records 
(referred three times). In the first year, referral numbers were low, as would be expected with a new 
program establishment. By the second year however, the rate of referral seemed to have stabilised (at 
184 for year 2, 162 for year 3 and 181 for year 4). On average there was an almost equivalent referral 
rate between the two units – HSC received a total of 327 referrals over the period, and BF received a 
total of 313 referrals. 
 
Referral sources 
The majority of admitted patients were referred from a general health service (including general 
practitioners, hospital, and medical officer/specialist) at 59%; an alcohol and drug (AOD) treatment 
service (31%); and a mental health service (4.3%).  
 
Rate of admission 
Of the total of 640 episodes of referral, 342 resulted in admission to IDAT (following the issuance of a 
Dependency Certificate). The admission rates were slightly higher in year 1 (57% of all referrals), but 
since have stabilised to an average of 53%. This means that half of all referrals to IDAT did not result in 
an admission. Of those referrals that did not result in an admission, 202 referrals (31.5% of all referrals) 
were assessed as ineligible, and the remainder (96 referrals, representing 15% of all referrals) were 
assessed as eligible but not admitted (likely due to the bed availability and wait time – resulting in a 
second subsequent assessment at which time patients who were originally deemed eligible had 
received alternative treatment options).  
 
Waiting times 
The median waiting time for admitted patients was 15.5 days; with a mean of 27 days. The proportion 
of patients admitted on the day of referral was 9.8%. Almost 20% of patients attending IDAT waited 
more than 42 days before their admission. But 25% were admitted within 2 to 7 days after referral. The 
two IDAT units were extremely aware of the waiting time problem. The mere presence of waiting time 
seemed inconsistent with the intention of the Act, which is to provide protection and care for people at 
acute risk of harms.  
 
In the context of demand exceeding supply, both of the IDAT units must engage in an ongoing, active 
patient prioritisation process. Stakeholders reported that patients were prioritised based on the needs, 
the extent to which the admission was deemed urgent (that is, the patient was highly likely to be 
harmed if not admitted), the fit between the Unit and the patient (where patients with serious mental 
health conditions could potentially benefit more from treatment at a psychiatric ward), and certain 
population groups (gender mix with existing patients).  
 
Length of stay 
The mean length of stay (LOS) across both units was 35.24 days (SD=22.80). The median LOS across both 
units was: 27.00 days (interquartile range from 24 to 49 days with the range from 0 to 138 days) and the 
modal LOS across both units was 27.00 days. The most common period of program retention was 
between 22 and 42 days (52.3%). The next most common category was an extension to the DC, received 
by 28.1% of IDAT patients. A relatively small proportion (19.6%) was discharged in under 21 days.  
 
Completion rates 
Of the 342 referrals that resulted in a patient being admitted into treatment, 63% (217) completed a full 
treatment episode and were discharged at the end of the treatment period, 3% (12) were discharged 
after an initial extension period (i.e. Dependency Certificate was extended), 3% (9) were discharged 
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after a subsequent, second extension period, 19% (66) were discharged early by the Accredited Medical 
Practitioner, 5% (16) were discharged early because the Dependency Certificate was not upheld by the 
Magistrate, 1.5% (5) absconded, and the exit status of 5% (18) was unclear. 
 
Patient characteristics 
IDAT patients in this period were an average age of 44 years, with 56% male, and 6.7% of ATSI origin. 
The majority were on some form of government support/pension (65%), 60% had attained year 11 or 
above, and about half had been married or in a de facto relationship. Alcohol was the principal drug of 
concern for the vast majority (83%), but more than half also had poly substance use. Across the IDAT 
program, the primary substance of concern for most admitted patients was alcohol (83.40%), followed 
by meth/amphetamines (9.09%), benzodiazepines (2.77%), heroin (1.98%) and cannabis (1.58%).   
 
IDAT patients represented a complex group of alcohol and drug dependent patients. At admission, the 
majority of the patients (89% for HSC and 91.3% for BF) had a Severity of Dependence Scale (SDS) score 
of 3 and above, which meets the criteria for substance use dependence. At admission IDAT patients had 
a mean of 18.63 unit per day of alcohol consumption prior to admission. The majority of IDAT patients 
were presenting with physical health issue (73%), risk behaviour issue (66%) and psychiatric/mental 
health issue (42%).  
 
A series of analyses were undertaken to compare the unique eligible patients (n=341) with those unique 
patients assessed but found to be ineligible (n=188), notwithstanding significant missing data. Eligible 
patients tend to be slightly older, less likely to be of ATSI origin, more likely to live alone, more likely to 
have alcohol as their primary drug of concern, and more likely to use poly drugs.  
 
The treatment services provided 
Both the stakeholders and the patients reported that the in-patient treatment component of the IDAT 
program was excellent, especially with regard to medical treatment and comprehensive assessment and 
care. The program offers patients the opportunity to engage in a comprehensive treatment program 
which addresses multiple issues: medical, psychiatric, addictions, and social issues, with a multi-
disciplinary team and which includes aftercare planning.  
 
In the Model of Care, aftercare is called ‘community-based program’, but the IDAT teams call it 
‘aftercare’. There is a lack of clarity in terminology. For some, ‘aftercare’ is (usually minimal) post-
treatment support; for others aftercare implies the provision of the next stage of treatment1. For 
example, at BF, aftercare is more minimalist akin to assertive follow-up post-treatment and involves 
making a phone call to the patient. At HSC, the program is responsible for aftercare services for patients 
who live in Northern Sydney Local Health District because it is their local service. It is easier for this 
patient group because there are a lot more community-based treatment services in Northern Sydney, 
compared to rural areas. 
 
These definitional issues notwithstanding, the extent to which aftercare services are being taken up by 
IDAT patients (which also speaks to whether IDAT changes the course of the person’s addiction) was not 
able to be fully assessed in the process evaluation. Aftercare was the component identified by nearly all 
stakeholders as the most challenging part and also a weakness of the IDAT program. The challenges 
associated with provision of on-ongoing aftercare services for IDAT patients were reported to include: 
- Limited human resource capacity within the IDAT team to do community outreach (especially 
for BF) 
- Limited community-based service options for linking patients to community-care services 
- Most IDAT patients are cognitively impaired and could be eligible for ACAT (Aged Care 
Assessment Team) housing but they are under 65 years of age so the option is limited. 
 
1 This definition and terminology problem is not unique to IDAT 
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- Limited availability of community-based services 
- Limited housing and accommodation options.  
 
Readmission 
Of the total of 254 unique patients admitted to IDAT, 59 patients were admitted for a second (and a 
third episode of care) over the period under analysis. Comparing this group with those patients having a 
single admission to IDAT over the four year period under review, the analysis suggested that those 
admitted more than once were more likely to be younger, female, alcohol as the principle drug of 
concern, and with higher severity of dependence scores. At the same time, they were also less likely to 
be homeless, and had fewer physical health (and mental health) problems. Missing data prevented 
confident statistical analyses of these differences.  
 
Transportation issues and the brokerage fund  
Two categories of funds were provided for within IDAT: the Transport Fund was provided to each of the 
local health districts for coordination of transporting patients to IDAT units for admission. The 
Brokerage Fund was provided to each of the two hospitals where the two IDAT units are located.  The 
Brokerage Fund can be used for a range of services to support and/or facilitate a patient’s treatment, 
psychosocial welfare and recovery in the community.  
 
Accessibility of both funds was identified as challenging. For the Transport Fund, in a number of LHDs, it 
was reportedly used for other purposes and was not made available to the referring ITLOs. As such, 
other existing transport funds (such as Patient Transport) were used in lieu. In other LHDs, funds were 
not spent because of lack of personnel who were able to take patients to the treatment units. For the 
Brokerage Fund, administrative difficulties local to the hospital accounts arrangements represented a 
barrier for the funds to be expended in a timely manner and this reportedly had critical flow-on effects 
on the continuity of patient care. 
 
Families and primary carers 
The critical role of a primary carer (potentially a family member) is identified in the IDAT Act. The Act 
stipulates that the primary carer must be notified within 24 hours after a Dependency Certificate has 
been issued as the primary carer should be informed of the patient’s admission to the program, when 
they are on leave, if they do not return to the IDAT unit after leave, when their Dependency Certificate 
is extended, or when they are discharged and, where possible and appropriate, involved in the 
development of the care plan, particularly the community-based component of this plan.  
 
A combination of the review of the Official Visitor reports, review of the patients’ files, and the patient 
in-depth interviews suggested that nomination of primary carer was not attempted for a proportion of 
IDAT patients. It is likely that in many circumstances, the paperwork/formalities were completed when 
the patients were still physically and/or mentally unstable, rendering their ability to recall these events 
impaired. In other circumstances, the patients could not complete the primary carer nomination form 
for a range of practical reasons. 
 
The evaluators observed that the IDAT patient group appeared to have few connections with family. 
Visits from family and loved ones while in the IDAT unit did occur but infrequently, made more difficult 
for many BF patients by the distance from their home community. Of the 12 patients interviewed, five 
reported close connections with family members and/or loved ones, including children, partners and 
parents. The other seven did not readily identify family support.  
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Bed occupancy rate  
The bed occupancy rate (BOR) for IDAT (averaged over the four year period under review) was 86.2% 
for HSC and 60.1% for BF. Given that there was not a significant difference between the average LOS at 
BF compared to HSC, the much lower BOR for BF was likely due to two factors: 1) more limited staffing 




As we understood it, there were three separate decision-makers involved in the local LHD staffing 
profile for IDAT: for the allied health staff, the staffing profile (and availability) was determined by the 
hospital Allied Health Director; for the medical staff it was determined by the hospital Clinical Director, 
and for the nursing staff it was determined by the hospital Director of Nursing. The current staffing 
profile was somewhat difficult to determine for each of the IDAT treatment units. This was partly 
because of the complex local LHD processes that occurred to determine a daily staffing profile.  
 
The extent to which the hospital prioritises the staffing rosters for IDAT over and above all the other 
hospital wards was not known. Based on a number of assumptions and calculations, we calculated the 
current staffing profile to be 16.3 FTEs for BF and 16.2 FTEs for HSC. It is important to note that the low 
staffing profile for BF (in relation to the number of beds) was not due to lack of funding. It was 
reportedly due to decisions made by the hospital administration (likely based on the hospital policy on 
staff:patient ratio). 
 
It was difficult to make an assessment of the appropriateness of the current staffing level at each of the 
two treatment units because many factors needed to be considered: 1) the number of beds; 2) the 
patient profile of each treatment unit (more patients admitted to BF were homeless, had serious 
physical health conditions, and mental health issues); 3) challenges in connecting patients to 
community-based services upon discharge for rural areas compared to urban areas; 4) efficiencies of 
scale (for HSC with the combined voluntary detoxification unit with IDAT); and 5) HSC team had 
responsibility to provide aftercare services for patients returning to Northern Sydney LHD. 
 
In addition, the evaluators noted that there were many demands on staff time over and above the 
provision of central IDAT program functions. These included: 
• Responding to enquiries from other health professionals, families and others; 
• Much time spent on administrative work given the complexity of patients; 
• Guardianship applications (for patients with mental health issues). 
 
Human rights and coercion issues 
There are various human rights protections built into the NSW Drug and Alcohol Treatment Act 2007 
with a strong aim to address all human rights aspects that were the subject of criticism of the previous 
legislation (the Inebriates Act 1912). 
 
Overall, all stakeholders interviewed (particularly the Magistrates and the Official Visitors) confirmed 
that the safeguards that are set out in the Act are properly exercised in practice. The stakeholders 
interviewed also stated that interpretation of the legislation through the model of care and 
implementation was more consistent with contemporary values regarding human rights and dignities of 
severely substance dependent people. The majority of the interviewed patients were aware of their 
rights and strongly felt that their rights were protected. All patients expressed that coercion into IDAT 
was justified and worked in their best interests. With regard to experience with the Magistrate hearing 
process, all interviewed patients expressed positive opinions of the procedure in the sense that their 
concerns were properly addressed by the Magistrate. 
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Perceptions of strengths and weaknesses  
The balance between involuntary detention, human rights, and health care was identified by the 
majority of stakeholders as a significant strength of IDAT. As intended by the legislators, the program is 
not simply a short-term detention program focussed solely on protecting an individual from harm, but it 
also provides the opportunity to change harmful alcohol and other drug behaviours into the future. 
However, achieving this balance between protection and AOD treatment is challenging and gives rise to 
some contradictions within the program (e.g. eligibility criteria based on risk of immediate harm to self 
or others versus the likelihood of benefit from AOD treatment). Nonetheless, the achieved balance was 
a significant strength, as perceived by stakeholders and other jurisdictions who are seeking to emulate 
this model.  
 
While acknowledging that the fundamental purpose of the procedural requirements involved in the 
referral process is to ensure good checks and balances are in place in the process of deprivation of 
liberty, the majority of the ITLOs identified that the administratively cumbersome referral process was a 
weakness, along with the lack of aftercare provision and follow-up.  
 
From the clinical perspective, stakeholders identified that the program provides high standards of 
medical treatment accompanied by comprehensive assessment and care, which is another strength of 
the program. The program offers the patients the opportunity to engage in a comprehensive treatment 
program which addresses multiple issues. Ironically, such a comprehensive and high standard of care 
was reportedly identified as lacking in the community. 
 
While some stakeholders felt that the program was well-resourced (from a budget allocation point of 
view, and relative to other AOD treatment services), other stakeholders noted the lack of resources as 
one of the weaknesses. This lack of resources was reportedly due to the cumbersome administrative 
process within hospital administration rather than a lack of budget. The complexity of staffing in a unit 
that is part of a larger LHD system (with priorities other than IDAT) was noted. In a similar context, the 
required administrative processes (hospital bureaucracy) in order to spend the brokerage funds were 
identified as a weakness.  
 
In relation to the length of the program (28 days as specified in the Act), on the one hand this was 
perceived as a strength in terms of a relatively short time for the deprivation of liberty (with the option 
to cease earlier than 28 days) but it was regarded by some stakeholders as insufficient time to achieve 
the comprehensive assessment, stabilisation, treatment and aftercare planning for a substantial 
proportion of patients.  
 
The largest weakness, identified by almost every stakeholder, was access to beds. The significant 
waiting time for patient entry was perceived to be a substantial issue for the program, especially in the 
context where these waiting patients were highly vulnerable and had been assessed as being at risk to 
themselves or others, and requiring protection.  
 
Data issues 
For monitoring and accountability purpose, from the onset of the program a comprehensive data 
collection system was established to enable ongoing monitoring and evaluation of the program. The 
IDAT database was developed to capture both administrative data (including referral, admission and 
discharge, and Magistrate review) and a comprehensive suite of outcome data (at assessment, 
admission, at discharge, 1 month, 3 month and 6 month post discharge).  
A number of issues were identified in relation to data pertaining to the IDAT program. These were: 
• Data collection and the use of paper-based forms 
• Missing data and outcome data  
• Database 
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These various issues largely surround two key aspects: responsibility and resources. The responsibility 
for data collection and data entry was not clear, and relatedly, the resources for this task were 
reportedly insufficient. Only 29% of all admitted patients had data for the 1-month follow-up. This 
dropped to 21% at 3 months, and 18% at 6 months. For HSC 40% of the patients were contacted at 1 
and 3 months (with lower number at 6 months). For BF the percentage of patients who were contacted 
at 1, 3 and 6 months was very small (by 6 months, only 6% had been contacted). 
 
For this reason, the evaluators could only use the administrative data for the purpose of this report. It 
was not possible to analyse the outcome data because the sample was not representative (it is highly 
likely to over-represent the success of the program). 
 
Conclusions 
Involuntary detention for the purposes of drug and alcohol treatment is a complex matter, which 
requires balancing the risks to the individual against their human rights. Whilst recognising the 
infringement on human rights associated with involuntary detention and treatment, the majority of the 
stakeholders (including patients) interviewed for this process evaluation believed that the NSW IDAT 
program is an appropriate last resort option, which balances involuntary detention with human rights 
and health care. 
 
The key issue identified in this process evaluation was the extent to which the IDAT program should 
focus on the provision of comprehensive alcohol and other drug treatment versus providing immediate 
medical care (including detoxification) when people are at acute risk of harm to themselves. The 
provision of comprehensive alcohol and other drug treatment is associated with a program capacity 
problem – represented by the current waiting times, and reflecting the low acceptance rate 
(approximately 50% of referrals are admitted), which is then associated with disincentives to refer, 
alongside resource-intensive pre-program assessment and referral procedures. Furthermore, the 
community aftercare component of the program appears not to have been implemented as originally 
envisaged in the Model of Care. If the focus is on acute resolution of immediate health issues, then the 
uneven aftercare implementation is less of a concern. 
 
With only a very small number of non-completions and reportedly comprehensive and high quality care 
provided within IDAT, it is expected that patient outcomes will be positive. However, this process 
evaluation did not assess patient outcomes; the outcome study underway (2016 to 2019) will be an 
independent, comprehensive assessment of the treatment outcomes associated with the NSW IDAT 
program.   
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1 Introduction and context 
The concept of compulsory treatment was founded on the 1960s notion that some people who use 
drugs are motivated for treatment, while others are not [1]. Those who are not motivated for treatment 
may require some lever to facilitate treatment entry. This lever is often referred to as ‘rational 
authority’ and entails a mandatory, but not punitive, requirement to attend treatment.[2] Compulsory 
treatment aims to force treatment commencement among involuntary clients and provide an 
opportunity for therapeutic benefits to take effect [3]. Laws relating to compulsory treatment have 
been established in response to a range of conditions, including ‘mental illness, developmental 
disabilities, sexual and violent offences, some dually diagnosed conditions and A&D use and 
dependence’ [3]. Here we distinguish between 6 main models: diversion programs; court-mandated 
treatment; civil commitment; centre-based compulsory rehabilitation; quasi compulsory treatment; and 
incarceration-based treatment. The model of direct relevance to IDAT is civil commitment, but we 
provide brief details of all six models.   
 
Generally, compulsory treatment (for alcohol use and substance use/dependence) refers to 
interventions where individuals are forced (or coerced) into treatment as a result of a legal order              
(in the context of most developed countries) or administrative sanction (in the context of developing 
countries, particularly East and Southeast Asian countries). In the main, and as will be seen in this brief 
literature review, compulsory treatment models pertain to criminal law (and thus to drug offending or 
drug-related offending). Most research on involuntary treatment has come from this frame of 
reference.  
 
An international review found that as of 2009, 69% of a sample of countries (n=104) had criminal laws 
allowing for compulsory drug treatment [4]. While most often consisting of forced inpatient treatment 
(i.e., individuals are placed under the care and supervision of treatment institutions), compulsory 
treatment can nevertheless be designed as outpatient treatment as well, either using an individualised 
treatment or group-based model that can include psychological assessment, medical consultation and 
behavioural therapy [5, 6]. There is considerable variability in the ways in which compulsory treatment 
is implemented internationally, with substantial differences in the people targeted, levels of legal 
coercion, the point in proceedings at which it is imposed, and whether consent needs to be given [7, 8].  
 
In many developed countries, including the United States and Australia, the focus of compulsory 
treatment is on people who use drugs charged with drug use offences (with the act of using illicit drugs 
an offence itself) while most European countries focus on illicit drug users who have been arrested for 
various crimes. In many countries (e.g., United States, Spain, Italy, the Netherlands), courts can impose 
sentences that include a requirement to enter drug treatment. In some countries (e.g., Britain and 
Holland), offenders might be encouraged to seek treatment as soon as they are arrested. In others (e.g., 
Austria, the Netherlands), the prosecutor may encourage the offender to enter treatment by 
suspending proceedings on the condition that he or she enters treatment. During the sentence, 
compulsory treatment can be applied, as it is in Italy, by releasing offenders from prison on condition 
that they enter drug treatment. In most European countries, entry to treatment depends on the 
consent of the offender, who is given the somewhat constrained choice of either entering treatment or 
serving another punishment (such as imprisonment). However, in Austria, Germany and the 
Netherlands, the courts can also impose sentences that send criminals to a treatment centre, without 
the person’s consent to enter treatment.  
 
By comparison, the approach to compulsory treatment taken in most East and Southeast Asian 
countries (China and Vietnam included) and some regions including Latin America and Eastern Europe is 
much stricter. People who use drugs who have broken the law (by using illicit drugs) can be compelled 
to be detained in a compulsory rehabilitation centre for up to two years without either consent or due 
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process [7, 9]. In most East and Southeast Asian countries, compulsory treatment mostly consists of 
residential, long-term and abstinence-based treatment in facilities that resemble prisons, located in 
remote areas. International observers have expressed concern with respect to evidence that 
compulsory treatment centres in East and Southeast Asia appear to incorporate approaches generally 
unsupported by scientific evidence (such as forced labour work or shaming), and employ harsh physical 
punishment for individuals who relapse into drug use [10, 11]. Therefore, many commentators [12-15] 
criticise this approach and question the legitimacy of the term ‘treatment’ used to describe this 
approach, suggesting that the ‘detention’ should be a more appropriate term.  
 
Differences in compulsory systems make it harder to compare them, but do offer the opportunity to 
examine what types of compulsory treatment are more effective with which type of person. For this 
reason, some scholars distinguish compulsory treatment from coerced treatment, whereby compulsory 
treatment refers to interventions where the individual is forced to enter treatment primarily as a result 
of a legal order, that is, either a civil commitment or an order disposing of a criminal case, without a 
choice. In contrast, coerced treatment refers to people being given the choice between entering 
treatment for their drug using behaviour or facing legal sanction, such as imprisonment [16]. The most 
widely known example of coerced treatment is court-mandated treatment, where a choice is given 
between compulsory drug treatment or prosecution.[17] 
 
Given the complexity in structure and arrangements of compulsory treatment approaches and the 
diverse characteristics of the targeted participants served by each of these approaches, Table 1 provides 
a conceptual schema that facilitates the comparison of the six most commonly discussed compulsory 
treatment approaches with the aim to provide a conceptual framework for distinction. They are: a) 
diversion programs; b) court-mandated treatment; c) civil commitment; d) centre-based compulsory 
rehabilitation; e) quasi-compulsory treatment; and f). incarceration-based treatment. It can be seen that 
the majority of compulsory treatment approaches are covered under some form of criminal law and 
pertain to offending (with the exception of civil commitment). Seven features are described in Table 1 
for the treatment approaches: 1) the nature of offence committed (drug offence or drug-related 
offence); 2) freedom of choice (choice between compulsory treatment or prosecution); 3) treatment 
duration; 4) treatment setting (community-based versus institution-based); 5) freedom of movement 
during treatment; 6) types of treatment services provided; and 7) the scale and development of the 
approach. It should be recognised that any descriptive typology is likely to miss the complexity of the 
individual experience of treatment, which depends on much more than the legal and clinical protocols 
in place [8]. As such, treatment options presented in Table 1 are not mutually exclusive. For example, 
the legislative status varies from country to country [1]. In Australia, although possession and use of 
illicit substances, and public drunkenness, are criminal offences, alcohol and drug dependence itself is 
not a crime, nor is it subject to criminal justice system intervention unless associated with an offence. 
Similarly, in the U.S., alcohol and drug dependent persons are not viewed as offenders, although 
criminal conduct such as the possession and sale of illicit substances can be prosecuted [1]. In addition, 
in the literature, the term ‘offender’ refers to both ‘drug offender’ and ‘drug-related offender’. Drug 
offenders are people who use drugs, possess drugs or traffic drugs, and drug-related offenders are 
people who commit a criminal behaviour to support their drug use [18]. The text in this section of the 
report will follow this convention. The following sections will provide brief descriptions for each of these 
approaches. It is important to note that most of the approaches described below focus on illicit drug 
use/dependence. Measures for mandating treatment for alcohol-dependent people (non-offenders) are 
somewhat embedded in civil commitment approach. 
 
Diversion possibilities exist throughout criminal justice proceedings for offenders to be diverted into 
treatment and can apply to both ‘drug offenders’ and to ‘drug-related offenders’. People are given a 
choice between compulsory treatment and prosecution. Diversion can occur at the early stages of 
criminal proceedings (i.e. pre-arrest or pre-trial) or later stages (i.e., post-sentence). Depending on the 
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severity of the committed offence, referral could involve offenders being diverted into treatment as an 
alternative to being processed any further [7] or given a warning/education session [18]. Diversion 
could be offered through multiple avenues: police diversion, court diversion or specialist drug court 
diversion. Alternatively, offenders may be required to complete a treatment program before sanctions 
are lifted or may be mandated to seek treatment in lieu of incarceration or as a condition of probation 
[19]. The goal of diversion programs is to re-direct drug-related offenders away from the judicial process 
with the aim to provide treatment, reduce imprisonment rate and save public resources [20, 21]. 
Diversion programs across countries and across states within one country vary within the justice system 
(police versus court based), eligibility criteria, drugs targeted, diversionary discretion, referral 
procedures, interventions and penalties for non-compliance [22]. If the choice of compulsory treatment 
is made, the treatment duration can be from one session to three months or one year, depending on 
the types of referral [18].  
 
Court-mandated treatment (a.k.a. drug court) is one type of diversion and is defined by the New South 
Wales Standing Committee on Social Issues [23] as ‘the treatment of an offender, required by a court 
order’. It usually occurs where the offender’s drug dependence has contributed to the offending 
criminal behaviour. In its simplest form, a drug court uses the power and authority of a magistrate to 
keep a drug-related offender in treatment, providing rewards for successes and sanctions for failures 
[24]. Depending on the structure of the drug court, successful completion may be accompanied with 
dropping the charges that brought the person before the court (pre-plea/ diversionary court) or 
expunging the drug-related offence from the record (post-plea court) [24]. Drug courts were introduced 
in the US in the late 1980s [25] and by the turn of the 21st century had become the contemporary 
compulsory treatment model employed in many Western countries [7]. There is suggestive evidence 
from quasi-experimental study designs that drug courts reduce recidivism in the short term of one to 
three years [26-29]. However, the effects on recidivism (assuming them to be causal) are modest [30].  
 
Civil commitment is one type of compulsory treatment imposed on people who are severely dependent 
on alcohol or drugs such that their substance dependence impairs their decision-making capability. Civil 
commitment allows them no choice in the matter. For example, New Zealand’s Alcoholism and Drug 
Addiction Act 1966 provides for compulsory detention and treatment of people who use illicit drugs and 
people who are severely dependent on alcohol for up to two years and is used to commit approximately 
200 people per year [23]. The New Zealand Act is under review and is about to be replaced by an Act 
very similar to the NSW Act except that the initial period of detention is 56 days rather than 28 days2. In 
the United States, civil commitment does exist but it cannot be readily distinguished from offence-based 
detention, the key criterion being that they are either unwilling or unable to control their alcohol or 
substance abuse, or to obtain services on their own [31]. In Europe (except Sweden), although once a 
popular strategy, civil commitment is no longer heavily relied upon due to human rights concerns [32, 
33].  
 
Centre-based compulsory rehabilitation in East and Southeast Asian settings is presented separately 
from civil commitment in the context of developed countries because the concept of ‘treatment’ in 
Asian countries is different from developed countries. By the definition of “choice” (treatment for drug 
offenders with no freedom of choice), the compulsory treatment approach that has been widely used in 
East and Southeast Asia in the last two decades falls into this category even though the governments of 
East and Southeast Asia do not use this language. The language used is ‘centre-based compulsory 
rehabilitation’ or ‘re-educational centers approach’. Specifically in countries such as China, Vietnam, 
Thailand, Malaysia, Cambodia, Myanmar and the Philippines, it is still the most dominant approach in 
dealing with people who use illicit drugs [10] who are processed through an administrative order for 
illicit drug use behaviors, rather than a legal order through the criminal justice system designed for 
drug-related offenders as is the case in most developed countries. The ‘rehabilitation’ strategies in 
 
2 Personal communication provided by Dr Leon Nixon, IDAT Program Director at Bloomfield Hospital.  
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compulsory centers focus mainly on moral teaching, basic health care services, ‘cold turkey’ 
detoxification, forced labour work (in the belief that labour work will directly aid in drug dependency 
treatment, for example, by sweating out toxins) [10]. Although an accurate estimate of the total 
number of people detained in compulsory centers throughout East and Southeast Asia is difficult to 
determine, it has been reported that in 2013 more than 550,000 people were detained in over 1,000 
centers in the above-listed eight countries [12, 34]. None of the other forms of compulsory treatment 
currently exists in East and Southeast Asia, except for Malaysia where a court-ordered mechanism has 
been used occasionally for people who are confirmed as people who use drugs by the police [35].  
 
Quasi-compulsory treatment (QCT) is a term typically used in European literature, and is defined as ‘the 
treatment of drug-dependent offenders that is motivated, ordered, or supervised by the criminal justice 
system and takes place outside regular prisons’ [8].  QTC is in essence the European version of the 
American drug court system [36] even though the QCT arrangements in each country differ [37]. In most 
contexts, the offender’s consent to enter treatment is required and the offender is given a choice of 
either going into treatment or imprisonment for the committed offence. Quasi-compulsory treatment 
may be applied at any stage of the criminal justice system [8] and therefore has a broader meaning and 
includes all types of coercive treatment that are mandated through the criminal justice system. In 
Europe, QCT is applied in a variety of ways. England uses sentences which enable courts to order an 
offender to enter treatment for a specified period as an alternative to some other sentence, usually 
imprisonment. In Austria, Germany and Switzerland, legal arrangements are in place that can broadly be 
described as ‘therapy instead of punishment’, with the possibility to suspend prosecution or sentence 
on the condition that the offender enters treatment. In Italy, prison sentences of no more than 4 years, 
or the last 4 years of a longer prison sentence, can be replaced by a period in judicially supervised drug 
treatment but require the informed consent of the offender. This is in contrast to the Dutch SOV 
system, in which offenders may be placed in treatment institutions without their consent. European 
arrangements for QCT differ from the drug courts established in many states of the U.S., in that they are 
not limited to drug offenders and are often used for persistent offenders, who would be excluded from 
several of the American drug court systems [37].  
 
Given the uniqueness of QCT, evidence of effectiveness can only be sought from studies that evaluate 
the effectiveness of compulsory treatment programs specifically defined as QCT in Europe. In general, 
studies – predominantly from English-speaking countries – tend to agree that QCT can be effective in 
reducing substance use and crime, and that it can improve health and social integration. They suggest 
that QCT is at least as effective as voluntary treatment [38-40] and that legal compulsion can improve 
retention in treatment. In contrast, literature from other countries (e.g. Germany and the Netherlands) 
tends to be more pessimistic about the effectiveness of QCT [8]. The challenge is QCT arrangements 
among countries differ in the stage at which people are encouraged to begin treatment, the level of 
compulsion used, and the types of crimes that are of focus [36, 41]. These methodological and political 
differences among various countries might explain the limited international comparisons of QCT 
arrangements [37]. In order to overcome this challenge, a European multimethod, multicentre study 
was conducted in 2009 [37]. The study was able to confirm that QCT was at least as effective as 
voluntary treatment, with higher reduction of substance use found for inpatient-treated participants 
compared to outpatient-treated participants. For reduction of crime and retention rate, study results 
were similar between QCT and voluntary groups, after controlling for various factors. 
 
Incarceration-based treatment in developed countries (presented in the last column) is one modality of 
compulsory treatment provided in in-patient settings (versus out-patient, community-based settings) 
and is generally nested within a broader criminal justice-oriented response to drug-related harms. The 
reason incarceration-based treatment in developed countries is presented in a separate column is 
because ‘boot-camp’ is one of the four treatment sub-types and has characteristics that resemble those 
of the compulsory treatment approach in East and Southeast Asia. As such, empirical research on ‘boot-
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camp’ approaches could be generalized to compulsory treatment in East and Southeast Asian settings if 
all other intervention features are also similar.  
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Table 1: Conceptual schema facilitating the comparison of compulsory and/or coerced treatment approaches 
Types 
 
Diversion  Drug Court  Civil commitment in 














Both drug offence 
and drug-related 
offence [18] 
Medium to high risk 
criminal offence: drug 
possession, property 
offences, driving while 
under influence, felony 
[42] 
No offence required. 
Intervention is based 
on evidence of self-
harm [7] 
Drug offence; 
intervention is based 
on positive urine 
screen [43] 






offences such as 
robbery, felony where 
sanctions have to be 





A choice is given 
between treatment 
and prosecution  
A choice is given 
between treatment and 
prosecution 
No choice No choice A choice is given 
between treatment 
and prosecution 
A choice is given, most 
of the time in exchange 
for an early release 
Treatment 
duration  
Can be 1 session, or 
range from 3 
months to one 
year, depending on 
types of referral 
[18] 
Most drug courts require 
a minimum program 
length of one year [45] 
14 days to 6 months 
(12 months in some 
extreme 
circumstances) [46]                                                      
Approximately 2 
years 
Average 15 months, 
with minimum of 12 
months [44] 
Duration of sentencing 
for criminal behaviors 
committed as decided 





treatment facilities  
Can be inpatient or 
outpatient settings 
depending on choice of 
individual and 
assessment by clinical 






based in remote 
areas) 
 
Can be inpatient or 
outpatient settings 
depending on choice 
of individual and 
assessment by 




Yes (but with 
requirement of 
scheduled 
reporting for urine 
testing) 
Yes (but with 
requirement of 
scheduled reporting for 
urine testing).  
To a limited extent 
[46] 
No  Yes (but with 
requirement of 
scheduled reporting 







that are available in 
Drug dependence 
treatment services that 




Moral teaching, law 
education, labor 
work, structured daily 
Drug dependence 
treatment services 
that are available in 
Four sub-types:  
1) Therapeutic 
communities;  





Diversion  Drug Court  Civil commitment in 









treatment in developed 
countries  
provided  the community, 
mostly outpatient 
services the option 
of choice 
community, mostly 







activities, basic health 
care 
the community, with 





3) counseling; 12-step 
programs 





Large scale. In December 
2011, there were 2,400 
drug courts in the US 
(Huddleston and 
Marlowe, 2011). In 
Australia, as of 2007 
drug courts had been 
established in all but two 
jurisdictions with 9 








[12]. In 2004, China 
had 583 centers for 
300,000 people [49] 
and Vietnam had 121 
centers for 60,000 
people [50].  
Large scale in 
Europe. In England, 
since 2001 annual 
average 8,500 entries 
to compulsory 
treatment imposed 
by court [36] 
Large scale, popular 
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Definition in the context of the NSW Drug and Alcohol Treatment Act 2007  
 
According to the categories and definitions above, the Drug and Alcohol Treatment (IDAT) Program 
under the NSW Drug and Alcohol Treatment Act 2007 is a form of civil commitment. The 
terminology used in the NSW Act is “involuntary (detention and) treatment” instead of the term 
“civil commitment”. Therefore, for the remainder of this section, the term “involuntary treatment” 
and “civil commitment” might be used interchangeably.  
 
The effectiveness of drug and alcohol involuntary treatment 
 
In the context of the NSW Drug and Alcohol Treatment Act 2007, the literature review in this report 
focuses on the evidence of effectiveness of alcohol and other drug (AOD) involuntary treatment (civil 
commitment). In addition, as explained previously, the legislative basis and the legal framework in 
mandating people who are drug or alcohol dependent are different between developed countries 
and developing countries (in South East Asia and Latin America). Therefore, the review of the 
literature in this report only focus on studies conducted in developed countries on involuntary 
treatment (or civil commitment) for drug and alcohol dependent people who are not necessarily 
involved with the criminal justice system. 
 
Wild and colleagues [40] completed a systematic review and considered compulsory treatment for 
substance dependence broadly. The authors reported on 18 quantitative comparative and 
longitudinal studies. Eight related to legal mandates (mainly involving drug-related offenders being 
mandated or coerced to treatment through the criminal justice system), five were formal mandates 
(via coercion outside the criminal justice system, e.g., via the employer, welfare system), three were 
informal mandates (family, group persuasion), and two were mixed mandates (employers, informal 
family, court mandated). None of these studies was relevant for the context of the NSW Act, 
primarily because they related to coercion of drug-related offenders identified through the criminal 
justice system. With respect to the body of research that exists, Wild et al. (2002) reported that 
mandated treatment generally demonstrated better outcomes compared to non-compulsory 
treatment in terms of treatment process (uptake of treatment following referral). Results indicated 
more equivocal results for retention rates with 6/11 studies reviewed by Wild et al. (2002) reporting 
higher participation for clients receiving compulsory treatment than those receiving non-compulsory 
treatment. In terms of illicit drug use outcomes, two of eight studies found superior outcomes for 
clients receiving compulsory treatment compared with voluntary treatment, whilst the other six 
studies reported no difference in benefit. Wild et al. (2002) also noted that most empirical research 
had employed non-equivalent comparison groups at baseline, with those receiving mandatory 
treatment more likely to be drug-related offenders. They argued that such population differences 
could bias results at outcome. 
 
A  review of Australian legislation, key informant interviews, and reference group consultation was 
included in a discussion document by Pritchard and colleagues [7]. Three reviews were identified: 
two systematic reviews of studies of coercion for drug-related offenders [8, 51], and a narrative 
review by [40] (discussed in previous paragraph). Commenting specifically on research relating to 
civil commitment of drug-offenders, Pritchard et al.’s review concluded that long term effectiveness 
has not been evaluated, with only some, mainly anecdotal, evidence suggesting that civil 
commitment for short periods can be effective in minimising harm.  That is, to provide short term 
involuntary care in life threatening circumstances is justified. While alcohol and drug dependence is 
generally viewed as a chronic condition, acute emergency situations do occur, and if civil 
commitment is one mechanism to prevent deaths and minimise harm, then it can be considered to 
play a useful role. Nevertheless, the authors of the review suggested that there may be other 
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mechanisms that are as effective, or more so, as compared with compulsory treatment but this has 
not been robustly investigated.  
 
The UK National Institute for Health and Clinical Excellence (NICE) review [52] undertaken by the 
National Collaborating Centre for Mental Health was a guideline on drug misuse. A sub-topic within 
this review related specifically to residential/inpatient legally coerced treatment interventions across 
the spectrum of compulsory treatment. The authors reported on evidence from a single systematic 
review [40] (discussed in previous paragraph). The NICE review argued that any negative outcomes 
for legally mandated treatments could be due to the nature of the difficulties of those entering 
mandated treatment when compared with those in voluntary treatment, rather than the 
compulsory nature of their referral/treatment per se. 
 
The New Zealand Ministry of Health commissioned a review of the Alcohol and Drug Addiction Act 
(ADA) 1966 by Broadstock et al. (2008) with the goal to inform decision making on interventions for 
alcohol and drug dependent non-offenders. The authors reported on evidence from four reviews:  
[7, 40, 52] and [1]. Broadstock et al. (2008) concluded that the area of compulsory treatment for 
people who are mandated purely on the basis of their alcohol use or illicit drug use has attracted 
very little research attention and that based on the results from their review, there is no reliable 
evidence pertaining to the effectiveness of compulsory residential treatment for this population 
compared with any other treatment approach.  
 
The data resulting from the four most current literature reviews outlined above were surprisingly 
sparse, compared to the current magnitude of AOD compulsory treatment for offenders in many 
countries, including the United States, Australia, New Zealand, and Sweden. Reviews of the field 
have consistently reported the lack of research on AOD involuntary treatment in non-offender 
population, and conclusions have often been drawn from expert opinions, stakeholder interviews, 
case studies, and largely anecdotal reports. It is therefore not possible to draw conclusions from the 
current evidence base about whether AOD involuntary treatment in non-offender populations is 
likely to be more or less effective than non-mandatory treatment modalities for people with 
substance dependence.  
 
What other jurisdictions are doing?  
 
In Australia, civil commitment legislation for substance dependence exists in New South Wales, 
Victoria and Tasmania, while the Northern Territory has involuntary treatment orders for alcohol 
and volatile substance dependence. Other states and territories of Australia do not have specific 
equivalent legislation, but it is under active consideration in Western Australia. The specific 
legislations are listed below: 
 
Victoria  Severe Substance Dependence Treatment Act 2010 (Vic)  
New South Wales  Drug and Alcohol Treatment Act 2007 (NSW)  
Tasmania  Alcohol and Drug Dependency Act 1968 (Tas)  
Northern Territory  Alcohol Mandatory Treatment Act 2013 (NT) (AMT Act)  
 
Table 2 below summarises these comparisons by the following categories: 1) objects of the 
legislation; 2) criteria for detention and treatment; 3) time for detention and treatment; and 4) 
human rights safeguard measures. 
 
 





The current Victorian legislation on involuntary treatment is the Severe Substance Dependence 
Treatment Act 2010 (SSDT), which came into effect on 1 March 2011. The main provisions of the 
SSDT are that it grants adults with the power to lodge an application for a detention and treatment 
order, which if granted, enables a person to be detained and treated to enable medically assisted 
withdrawal from severe substance dependence, for up to 14 days. All persons subject to a detention 
or treatment order under the SSDT have access to legal representation and advocacy support 
through the Public Advocate and Victorian Legal Aid. There are also provisions for a discharge and 
case management plan (s36). This is to be developed in conjunction with the person on the 
detention and treatment order. However, the focus on service upon discharge is very limited. 
 
An application for a detention and treatment order must contain a medical recommendation by a 
prescribed registered medical practitioner and they must consult and seek a second opinion from a 
senior clinician at a drug and alcohol treatment centre. Once the assessment has been completed a 
person can lodge an application with the Magistrates Court. The person subject to the detention and 
treatment order will then be granted the right to obtain legal representation. A hearing must be held 
within 72 hours of the filing of the application, and the person who is subject to the application has 
the right to appeal.  
 
Once a court order is made, the person is given a priority listing on the waiting list to access a 
treatment service. The legislation provides that a person can only be placed on a detention and 
treatment order for a maximum of fourteen days. This differs somewhat from the previous Act                
(the Alcoholics and Drug Dependent Persons Act 1968 - ADDPA), which allowed the court to make a 
treatment order for a maximum of seven days, with a provision for the treatment centre to apply for 
an additional seven day extension.  
 
The SSDT Act also differs from the ADDPA in that it introduces a set of guidelines which affect the 
operation of treatment centres and provides for greater involvement of a person throughout all 
stages of their treatment. As part of the SSDT provisions, a person entering a treatment facility is 
given the right to nominate a person to act to protect their interests. This nominated person may act 
as an advocate and provide support and assistance to the person receiving treatment for their 
dependence. The Office of the Public Advocate also plays an important role in the administration of 
this legislation. Acting as an independent voice, the public advocate visits and supports the person 
subject to the detention and treatment order with the aim of assisting them in exercising their rights 
(Severe Substance Dependence Treatment Act 2010 and Parliament of Victoria, Severe Substance 
Dependent Treatment Bill 2009, Second Reading Speech 2010). 
 
Northern Territory  
 
The Alcohol Mandatory Treatment Act 2013 (NT) (AMT Act) commenced on 1 July 2013. It is stated in 
the legislation that the Act is a health based legislative framework for the mandated assessment, 
treatment and aftercare of people who chronically misuse alcohol and who are either unlikely or 
unable to voluntarily access treatment option. The Act also aims to stabilise and improve the health 
and social functioning of people, restore their capacity to make decisions about their alcohol use and 
personal welfare, and improve their access to ongoing treatment.  
 
Clients in the system are clinically assessed and an independent Tribunal then decides their best 
treatment option. Income management orders can also be applied. An individual treatment plan is 
developed for each person, with components varying according to the needs of the person and the 
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kind of programs and approaches offered by different agencies. An aftercare plan is negotiated at 
the end of treatment to support reintegration. 
 
The AMT system is aimed at people who are chronically drinking and publicly intoxicated. The Police 
Administration Act 1981 (NT) provides that, where a person is apprehended by police 3 times for 
public intoxication over 2 months, they must be referred by a senior assessment clinician (SAC) in 
accordance with the AMT Act. Under the AMT Act, the SAC – who is not required to be a medical 
doctor – must assess the individual within 96 hours and then request a mental health assessment or 
make an application to the Alcohol Mandatory Treatment Tribunal. The tribunal is not required to 
follow the SAC’s assessment report recommendations, but can make a mandatory treatment order 
in relation to the person if they meet the same criteria used by the SAC [53]. The AMT treatment 
period does not exceed 3 months. It is important to note that the AMT system is the only system in 
Australia that sets income management orders and allows a treatment service to charge persons 
under AMT for consumables. Some commentators regard the AMT as a criminal justice rather than 
health or medical response per se (triggered by the process of arrest) and speculate that one effect 




The current Tasmanian Alcohol and Drug Dependency Act 1968 (the ADDA) makes provision with 
respect to the treatment and control of persons suffering from alcohol or drug dependency. The 
main aim of the ADDA was to provide for a separate legislative regime for the treatment of 
alcoholism partly because of the absence of a serious drug problem in Tasmania in the 1960s. Until 
the ADDA’s development, alcohol dependent people who were unresponsive to social pressures and 
who required hospitalisation were sent to mental hospitals under an involuntary order pursuant to 
the Mental Health Act 1963. At the time, the consensus of opinion appeared to be against alcohol 
and drug dependency being coupled with mental illness and a suggestion was made that a separate 
Act should be introduced to cover these cases [54].  
 
Under the ADDA, an involuntary application must be made with the support or recommendation of a 
practitioner, and a person may be detained for up to fourteen days after admission on the basis of 
an application that is made with such support or on recommendation. The detention may be 
extended for up to six months if the “appropriate medical officer” (the superintendent of the 
treatment centre or a medical practitioner directed by the superintendent to examine the patient) 
issues a certificate to that effect. A person’s detention may also be extended for subsequent six 
month periods if the medical officer deems this to be necessary and in the interest of the patient’s 
health or safety or the protection of others. A person who is being detained, or his or her relative, 
may apply to the Alcohol and Drug Dependency Tribunal (the Tribunal) for the person’s discharge 
from the treatment centre. Other than that, there are limited provisions to protect the patients’ 
human rights and legal rights. A discussion paper for the review of the Tasmanian Alcohol and Drug 
Dependency Act 1968 on behalf of the Tasmanian Department of Health and Human Services states 
that “The ADDA is deficient in its adherence to international human rights principles in a range of 
respects. In particular the ADDA does not require a person’s detention to be provided in the least 
restrictive manner; it does not clearly establish what a detained person’s rights are and there is a 
lack of oversight around detention decisions.”[54] 
 
 
3 Personal communication provided by Dr Leon Nixon, IDAT Program Director at Bloomfield Hospital.  
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Published results on the NSW IDAT program 
 
At the point of undertaking this process evaluation, no formal evaluation of the NSW IDAT had been 
conducted. Indeed, this is the purpose of this process evaluation and the subsequent outcome 
evaluation. However, practitioners within the NSW IDAT program have reported data on a sample of 
IDAT patients[55].  Specifically, they found that at six-month follow-up relapse to previous levels of 
drinking occurred in 11 patients (27.5%); five (12.5%) were lost to follow-up; 13 (32.5%) were 
abstinent and seven (17.5%) continued to drink alcohol but at a reduced amount and frequency. 
Death was reported for four patients (10%), two from acute gastrointestinal haemorrhage, one from 
accidental overdose and one from traumatic injury when intoxicated. This work was based on a 
small sample (n=40 patients), and without a comparison group. The process evaluation reported 
herein does not address patient outcomes, but the associated outcome study (due for completion in 
2019) will provide data on patient outcomes. 




Table 2: Objects of the legislation, criteria for detention, time limit and human rights safeguards  
 Objects Criteria Time limit Human rights safeguards 
NSW To provide for the involuntary treatment of 
persons with a severe substance dependence 
with the aim of protecting their health and safety  
To facilitate a comprehensive assessment of 
those persons in relation to their dependency.  
To facilitate the stabilisation of those persons 
through medical treatment, including, for 
example, medically assisted withdrawal  
To give those persons the opportunity to engage 
in voluntary treatment and restore their capacity 
to make decisions about their substance use and 
personal welfare (s3(1))  
A person may have a dependency certificate issued 
against them if:  
the person has a severe substance dependence; 
and  
care, treatment or control is necessary to protect 
the person from serious harm; and  
the person is likely to benefit from treatment for 
his or her substance dependence but has refused 
treatment; and  
no other appropriate and less restrictive means for 
dealing with the person are reasonably available. 
(s9(3))  
 
28 days with 
possible 
extension to up 
to 3 months  
(s14(a)).  
 
A person must not be detained in a 
treatment centre under this Act 
unless an accredited medical 
practitioner has issued a dependency 
certificate in relation to the person 
(s7)  
 
Victoria To provide for the detention and treatment of 
persons with a severe substance dependence 
where this is necessary as a matter of urgency to 
save the person's life or prevent serious damage 
to the person's health (s1(a)).  
To enhance the capacity of those persons to 
make decisions about their substance use and 
personal health, welfare and safety (s1(b)).  
person must be 18 years old (s8(1)); and  
have a severe substance dependence; and  
because of the person's severe substance 
dependence, immediate treatment is necessary as 
a matter of urgency to save the person's life or 
prevent serious damage to the person's health; 
and  
the treatment can only be provided to the person 
through the admission and detention of the person 
in a treatment centre; and  
there is no less restrictive means reasonably 
available to ensure the person receives the 
treatment. (s8(2))  
14 days  
(s20(3)).  
 
All of the objects of the Act must be 
performed so that detention and 
treatment is a last resort; and  
human rights and any interference 
with the dignity and self-respect of a 
person who is the subject of any 
actions authorised under this Act are 
kept to the minimum necessary. (s4)  
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Tasmania (Tasmania Act does not contain an 
objects/principles section)  
An admission application may be made in respect 
of a patient on the grounds -  
(a) that he/she is suffering from alcohol 
dependency or drug dependency to a degree that 
warrants his detention in a treatment centre for 
medical treatment; and  
(b) that it is necessary in the interests of his health 
or safety or for the protection of other persons 
that he be so detained. (s24)  
Period of detention in place of safety:  
Where a person has been conveyed to a place of 
safety under this Part he/she may, during the 
period of 72 hours following that conveyance, be 
detained in any place of safety, and during that 
period may be  
conveyed from one place of safety to another by a 
police officer or a welfare officer. (s60)  
6 months from 




A discussion paper for the review of 
the Tasmanian Alcohol and Drug 
Dependency Act 1968 on behalf of 
the Tasmanian Department of Health 
and Human Services states that “The 
ADDA is deficient in its adherence to 
international human rights principles 
in a range of respects. In particular 
the ADDA does not require a 
person’s detention to be provided in 
the least restrictive manner; it does 
not clearly establish what a detained 
person’s rights are and there is a lack 




The objects of this Act are to assist and protect 
from harm misusers of alcohol, and other 
persons, by providing for the mandatory 
assessment, treatment and management of 
those misusers with the aim of (s3):  
stabilising and improving their health; and  
improving their social functioning through 
appropriate therapeutic and other life and work 
skills interventions; and  
restoring their capacity to make decisions about 
their alcohol use and personal welfare; and  
improving their access to ongoing treatment to 
reduce the risk of relapse 
The following are the criteria for a mandatory 
treatment order in relation to a person:  
(a) the person is an adult;  
(b) the person is misusing alcohol;  
(c) as a result of the person's alcohol misuse, the 
person has lost the capacity to make appropriate 
decisions about his or her alcohol use or personal 
welfare;  
(d) the person's alcohol misuse is a risk to the 
health, safety or welfare of the person or others 
(including children and other dependants);  
(e) the person would benefit from a mandatory 
treatment order;  






Not specified  
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(f) there are no less restrictive interventions 
reasonably available for dealing with the risk 
mentioned in paragraph (d).  
(s10)  
 






1.1 Aims of the process evaluation 
In February 2016 the NSW Ministry of Health engaged the Drug Policy Modelling Program (DPMP) at 
the National Drug and Alcohol Research Centre (NDARC) to conduct an evaluation of the IDAT 
program. The evaluation has three components: a process evaluation, an outcome evaluation and 
cost assessment. This report is the output of the process evaluation. 
 
The evaluation team for the process evaluation was Dr Thu Vuong, Prof Alison Ritter and Dr Marian 
Shanahan. An Advisory Committee convened twice during the process evaluation and included the 
following representatives: 
 
• Debbie Kaplan/Tanya Merinda - Manager, Alcohol and Other Drugs, Ministry of Health 
• Adrian Dunlop - Chief Addiction Medicine Specialist, Ministry of Health 
• Larry Pierce - CEO, Network of Alcohol and Drug Agencies (NADA) 
• David Rogers - District Manager, Drug and Alcohol Services, Mid North Coast Local Health District 
(MNCLHD) 
• Andrew Taylor - Clinical Nurse Consultant, Drug and Alcohol, Hunter New England LHD (HNELHD)  
• Gaylene Bawden - Involuntary Treatment Liaison Officer (ITLO), Mid North Coast Local Health 
District (MNCLHD) 
• Anthony Jackson - Operations Manager, Drug and Alcohol, South Eastern Sydney Local Health 
District (SESLHS). 
 
The process evaluation aimed to provide descriptive information about the program operations, its 
reach, patient progression though the model of care, and the feasibility and appropriateness of the 
model of care. In providing this description, it also aimed to evaluate whether the NSW Drug and 
Alcohol Treatment Act 2007 is being implemented according to how it was originally conceived, and 
the extent to which the implementation of the IDAT program is consistent with the Model of Care 
and the legislative basis for the program.  
 
The questions that the process evaluation sought to address included: 
- What is the profile of referred patients? What proportion of people referred is admitted? 
What are the differences in profile of admitted and non-admitted patients? What is the 
profile of people who have been referred who opt for voluntary admission? 
- What is the profile of patients accepted for treatment, in terms of age, gender, residential 
location, circumstances precipitating referral, primary substance abused, severity of 
substance abuse, co-morbidities? (What is the profile of those referred, but not admitted?) 
- To what extent do IDAT transport funds enable access to the service? What is the profile of 
people referred utilising IDAT associated transport funds? 
- Tracking implementation: progression through model of care  
- What is the length of stay (range, median, mean); and other characteristics of patients 
discharged < 14 days, <28 days, at 28 days?  
- What is the pattern of medical services utilised during detention? 
- What is the profile of patients known to make the transition to community care services? 
What is the pattern of community services utilised?  
- Is the program reaching an appropriate target group? That is, is it the case that the program 
is used by patients with serious health risks [to patients themselves or others], severe 
substance dependence and after rejection of voluntary treatment?  
- Do the key stakeholders consider each of the key program elements feasible and 
appropriate in terms of achieving the objectives of the program?  






- What are the perspectives of patients and their carers regarding the value of IDAT? Is it 
acceptable? Do they perceive that it reduces harm? 
 
What specific issues or changes do key stakeholders propose, in order to improve the feasibility, 
appropriateness or effectiveness of the model of care? 
1.2 Report outline  
The next chapter provides the methodology for the process evaluation. This is then followed by two 
descriptive chapters: the first describing the Act, and the next describing the Model of Care 
documentation.  
 
The fifth chapter provides the analysis of the IDAT database, a quantitative review of the 
throughput, patient characteristics and other quantitative data analysis derived from the formal 
administrative record. 
 
The sixth and final chapter uses the qualitative data collected through the stakeholder interviews to 
analyse the operations of the program. In the first instance, the Act itself was examined in light of 
the stakeholder views. This is then followed by analysis of the program operations though the 
stakeholders’ perceptions, including the processes for program entry, the treatment provided, the 
aftercare and then a series of issues such as transportation, brokerage fund and so on. 
 







Ethics approvals for the conduct of the process evaluation were obtained. 
• Full NEAF application approved by the Northern Sydney LHD HREC on 14 July 2016, approval 
number HREC/16/HAWKE/159. 
• UNSW HREC for non-LHD data collection: approved on 7 September 2016, approval number 
HC16633. 
Site-specific application (SSA) for five LHDs: 
• Illawarra Shoalhaven LHD approved on 16 August 2016, approval number DT16/86213; 
• Western NSW LHD (Bloomfield Hospital) approved on 18 August 2016, approval number  
SSA/16/GWAHS/117; 
• Hunter New England LHD approved on 19 August 2016, approval number not applicable; 
• South Eastern Sydney LHD approved on 30 August 2016, approval number 16/G/271; 
• Northern Sydney LHD (Royal North Shore Hospital) approved on 26 September 2016, 
approval number SSA/16/HAWKE/300. 
 
Data sources 
Data for this process evaluation were collected from the following sources: 1) the IDAT program 
database; 2) in-depth interviews with patients; 3) in-depth interviews with stakeholders;                               
4) observations of weekly staff meetings at the two IDAT Treatment Centres; and 5) documentary 
review (including legislative documents, and records by the Official Visitors, namely the Official 
Visitor Book – Official Visitor Review), and review of a limited number of patient files. 
 
The IDAT database 
The IDAT database was developed by the Ministry of Health for the purpose of facilitating ongoing 
internal quality improvement and evaluation of the IDAT program. The IDAT database includes 17 
different data tables. Seven data tables refer to administrative data obtained during the assessment 
and treatment phase (including referral, admission and discharge, and Magistrate review). Ten other 
data tables refer to outcome data for different time-points (at assessment, admission, at discharge, 
1 month, 3 month and 6 month post discharge). The outcome measures aim to allow for both 
tracking and evaluation of outcomes. By program design, the core outcome tools are required to be 
administered at 5 time-points across the delivery of the IDAT program for an average patient (at 
admission, prior to discharge, 1 month, 3 months and 6 months after discharge).  
 
For the process evaluation, a complete copy of the IDAT database was made available to the 
evaluators, covering the period from program commencement (31 May 2012) to 24 June 2016                   
(4 years).  
 
Review of documents  
The purpose of the documentary review was to ensure that the evaluators were familiar with all 
aspects of the program as documented, such that comparisons can be made between the 
documents (the Act vs the Model of Care) and the actual practice. Actual practice was collected 
through the database, and interviews with stakeholders and with patients. The following documents 
were reviewed:  
• Drug and Alcohol Treatment Act 2007: under which the IDAT program was established.  
• The Model of Care for IDAT program. 
• Case conference reports (for selected patients). 
• Complete patient files (for selected patients). 
• Report of the Official Visitors.   
 






Interviews with IDAT patients 
In-depth interviews with IDAT patients aimed to ask about the patients’ experience and perceptions 
about their alcohol and drug use, their experience with the process of being admitted to IDAT, their 
treatment and care received while in IDAT, perceptions of the strengths and weaknesses of the IDAT 
treatment program, and any issues of ethics and rights, and expectations versus the reality of the 
program. A total of 12 in-depth qualitative interviews were conducted.  
 
In-depth interviews with stakeholders 
In-depth interviews with stakeholders focused on the features, strengths and challenges they 
experience through their engagement with the implementation of the IDAT program.  The main 
stakeholders involved in aspects of IDAT program implementation were identified as:  
- NSW Ministry of Health 
- Involuntary Treatment Liaison Officers (ITLOs) from 5 LHDs referring to IDAT units  
- Accredited Medical Practitioners  
- Mental Health, Drug and Alcohol Directors from each of the 2 sites 
- Medical Directors from each of the 2 IDAT units 
- Staff members from each of the 2 IDAT units 
- Aftercare providers/community care coordinators (including NGOs) 
- Magistrates from each of the 2 sites 
- Official Visitors from each of the 2 sites 
 
A detailed semi-structured interview schedule (which was tailored to the role of the stakeholder 
interviewed) was prepared that covered a range of topics including perceptions of the program 
overall (strengths and weaknesses); degree of consistency between documentation and practice; 
ethical and issues concerned with rights; referral processes and other procedural operations; the 
ways in which IDAT community brokerage and transport funds are used; and issues concerned with 
efficient program operation, smooth transition for patients, their carers and perceptions of 
appropriateness of the program (fit between patient group and services offered). A copy of the 
stakeholder interview schedule is attached at Appendix A.  
 
A total of 37 stakeholders were interviewed and written submissions were received from two 
stakeholders between September 2016 and November 2016. The list of the names of the 
stakeholders who were interviewed is not provided here to avoid any breach of confidentiality. The 
pool of interviewees, however, covered all the above categories of stakeholder. Notes were taken 




Across the five different types of data collected for the process evaluation, a number of quantitative 
and qualitative data analytic tools were deployed. For the quantitative data, descriptive statistics 
were used along with simple tests of associations to analyse the IDAT database. The qualitative data 
(in-depth interviews with stakeholders) were analysed according to standard qualitative data 
techniques. Specifically, the recorded interviews were reviewed and transcribed where required. 
The text was analysed against pre-determined content (for example with reference to the transport 
fund: all comments pertaining to the transport fund were collected, then summarised and analysed 
for the main messages). Analysis of the diversity or congruence of views was also undertaken.  
 
 






3 The NSW Drug and Alcohol Treatment Act 2007 
Background to and setting of the Act  
In New South Wales (NSW) involuntary treatment had previously been provided under the 
Inebriates Act 1912. However, a review of that Act, recommended at the 2003 Summit on Alcohol 
Abuse and subsequently conducted in 2004 by the Parliament of New South Wales Standing 
Committee on Social Issues, concluded that the Inebriates Act was “fundamentally flawed” and 
recommended that it be “immediately repealed”[56]. As a result of this review, the Drug and Alcohol 
Treatment Act 2007 replaced the Inebriates Act 1912 and provides the legislative basis for the 
involuntary detention, treatment and stabilisation regime for persons with severe substance 
dependence, with the stated aim of protecting the health and safety of such persons, while also 
aiming to address all human rights aspects that were the subject of criticism of the previous 
legislation. Under the new legislation, the Involuntary Drug and Alcohol Treatment Program (the 
IDAT program) was developed to “provide short term care, with an involuntary supervised 
withdrawal component, to protect the health and safety of people with severe substance 
dependence who have experienced, or are at risk of, serious harm and whose decision making 
capacity is considered to be compromised due to their substance use”[56]. 
 
Purpose and objectives of the Act 
The objects of the NSW Drug and Alcohol Treatment Act 2007 are: 
a) to provide for the involuntary treatment of persons with a severe substance dependence with 
the aim of protecting their health and safety, and  
b) to facilitate a comprehensive assessment of those persons in relation to their dependency, 
and  
c) to facilitate the stabilisation of those persons through medical treatment, including, for 
example, medically assisted withdrawal, and 
d) to give those persons the opportunity to engage in voluntary treatment and restore their 
capacity to make decisions about their substance use and personal welfare. 
 
In addition, the “Act must be interpreted, and every function conferred or imposed by this Act must 
be performed or exercised, so that, as far as practicable: 
 
a) involuntary detention and treatment of those persons is a consideration of last resort, and  
b) the interests of those persons is paramount in decisions made under this Act, and 
c) those persons will receive the best possible treatment in the least restrictive environment 
that will enable treatment to be effectively given, and 
d) any interference with the rights, dignity and self-respect of those persons will be kept to the 
minimum necessary.”  
 
Eligibility criteria for a Dependency Certificate  
The criteria for the issue of the dependency certificate are:  
• the person has a severe substance dependence, and  
• care, treatment or control of the person is necessary to protect the person from serious 
harm, and  
• the person is likely to benefit from treatment for his or her substance dependence but has 
refused treatment, and  
• no other appropriate and less restrictive means for dealing with the person are reasonably 
available.  
Safeguards to ensure patients’ civil and human rights are addressed under the Act 
The Act contains provisions to ensure that: 






• involuntary detention is a last resort 
• the interests of the person are paramount 
• the person will receive the best possible treatment in the least restrictive environment 
• any interference with the rights, dignity and self-respect of the person is kept to a minimum. 
 
The Act also contains provisions to ensure that a person and their primary carer are provided with 
clear information about their legal rights and their rights of appeal. All Dependency Certificates must 
be reviewed by a Magistrate as soon as possible after issuing. 
 
Independent Official Visitors have been appointed to inspect the Treatment Centres regularly, to act 
as an advocate on behalf of patients if required, and to provide reports to the Minister for Health. 
 
How the Act works  
Under the NSW Drug and Alcohol Treatment Act 2007 (hereinafter referred to as ‘the Act’), the 
decision to detain a person in the first instance is a clinical one, made by a medical practitioner. The 
person may be detained and treated initially under a Dependency Certificate without the need to 
wait for a formal application to and order by, a court. The process is that a medical practitioner may 
request an accredited medical practitioner (AMP, who are specific to the context of the Act) to 
assess a person for detention and treatment under the Act. After assessing the person, the AMP may 
issue a 'Dependency Certificate', stating the person may be detained for treatment under the Act for 
the period stated in the certificate.  
 
Importantly, under section 9(5) of the Act, if a dependency certificate is issued, ‘the person may be 
detained in accordance with the certificate for treatment under this Act'. Therefore the certificate 
gives the authority to detain. The AMP may have regard to any serious harm that may occur to 
children in the care of the person or dependents of the person.  
 
The maximum period for which a dependency certificate may be issued is 28 days, although this is 
subject to reduction or extension for up to three months, by the Magistrates Court on the review. 
The extension for up to three months is on application by an AMP for up to three months from the 
day of first admission if the practitioner is satisfied that: 
• the dependent person is suffering from drug or alcohol related brain injury; and  
• additional time is needed to carry out treatment and to plan the person’s discharge; and  
• the practitioner presents, with the application, a proposed treatment plan to be followed 
during the additional time granted.  
 
There is provision for 'transport officers' to take dependent persons to or from a treatment centre, 
powers of search and apprehension, and for police assistance to take dependent persons to and 
from a treatment centre. 
 
Under the Act, there is also no requirement for a Court or Tribunal to authorise initial detention or 
treatment. These are clinical decisions, but the Magistrates’ Court is responsible for reviewing the 
issue of dependency certificates and extending them. A person aggrieved by an order or 
determination of a Magistrate under Part 4 may appeal against the order or determination to the 
Civil and Administrative Tribunal under Part 4 of the NSW Act. 
 
An AMP must, as soon as practicable (within 7 days) after the certificate is issued, bring the person 
before a Magistrate for a review of the issuing of a certificate. The review by the Magistrates Court is 
compulsory. At the Magistrates Court hearing, the Magistrate must consider relevant information in 
deciding whether a person meets the criteria in section 9 of the Act, including the clinical reports 
and recommendations of the AMP who has examined the person, any proposed further treatment 






for the person, the likelihood the treatment will be of benefit to them, the person's views, and any 
cultural factors relating to the person that may be relevant to the determination. It is mandatory 
that the patients are represented by a legal representative. The Magistrates Court decision may be 
appealed to the Civil and Administrative Tribunal.  
 
There are various human rights protections built into the NSW Drug and Alcohol Treatment Act, for 
instance in relation to the information to be given to the dependent person and their carer. The Act 
provides for Official Visitors, whose role is that of a general inspector and advocate for client issues 
in the system as a whole. 
 






4 Model of Care document 
The objects of the Act form the basis for the Model of Care for the implementation of the IDAT 
Program. Specifically, the Model of Care provides a resource for managers, clinicians and other key 
stakeholders involved in supporting and delivering the Program. The Model of Care describes the 
principles, objectives, aims and underpinning approach for the Program and broadly defines the way 
in which the Program is delivered, to facilitate consistent implementation and assist clinicians and 
other stakeholders to interpret legislation as it relates to the Program [56]. The Model of Care 
contains specific protocols regarding the medical management and psychosocial interventions 
during treatment. 
 
The IDAT program has two components: the involuntary inpatient treatment (28 days and up to 3 
months) and voluntary community-based aftercare component (6 months). The Model of Care 
involves 7 stages of a patient journey and outlines activities to be undertaken, timeframes for 
activities and roles and responsibilities of staff and the identified patient and their primary carer. The 
seven stages are used here to describe the Model of Care documentation.   
 
Referral and Screening 
Referrals to an Accredited Medical Practitioner (AMP) for assessment for a dependency certificate 
can only be received from Medical Practitioners, such as, but not limited to, general practitioners, 
emergency doctors and psychiatrists. Once the AMP at the Treatment Centre has received a referral 
from a Medical Practitioners, a determination will be made as to whether there is sufficient 
information (a local comprehensive assessment) for the AMP to assess the identified patient for a 
Dependency Certificate. If not, further screening and a comprehensive assessment at the local level 
will be requested of the Medical Practitioners and local Involuntary Treatment Liaison Officer (ITLO). 
Contact details of local ITLOs will be provided to the Medical Practitioners for liaison regarding 
further drug and alcohol screening and assessment needs. 
 
An ITLO conducts screening, triage and assessment to a standard of, and in liaison with, the Medical 
Practitioners, Treatment Centre and AMPs to determine if a person should be recommended for 
referral for assessment by an AMP for a Dependency Certificate. An ITLO is a qualified professional 
either doctors or nurses who are trained for IDAT assessment, has at least five years’ experience of 
providing direct drug and alcohol patient care and the skills to screen persons who may be eligible 
for a Dependency Certificate under the Drug and Alcohol Treatment Act (2007). Across NSW, there 
are more than 100 ITLOs who have been appointed and trained by the Ministry of Health. It is not 
necessary for the screening assessment to involve contact with the patient, although this may occur 
if the patient is already a patient of the ITLO, medical practitioner or the AMP. The referral 
application involves 3 forms to be filled out: 1) Form 1 by an ITLO to request a medical practitioner 
for a referral; 2) Form 2 by the medical practitioner; and 3) Form 3 is a Comprehensive Assessment 
by the ITLO. It is important to note that an aftercare plan is required to be included in the 
Comprehensive Assessment. As such, the ITLO has a critical task in working with the referring team 
and/or the community drug and alcohol worker to develop the aftercare plan. If the identified 




The Model of Care states that “Dependency Certificates should only be issued if the patient meets all 
eligibility criteria and if there is a bed available immediately at the inpatient unit”. If a bed is 
available, upon receiving the complete referral application, the AMP in consultation with his/her 
IDAT team will conduct an assessment to identify the level of dependency and immediate risk to the 






patient, to establish the level of need an individual may have and what interventions are required to 
address these needs. This comprehensive assessment builds on the screening and triage assessment 
of the ITLO, which might include the following information: 
 
- current and previous history of drug and alcohol use and impact on functioning and capacity; 
- current and previous treatment history, including history of withdrawal and previous 
complications; 
- current overview and history of physical and mental health; 
- psychosocial issues that need to be addressed, e.g. homelessness; 
- involvement in the criminal justice system and details of bail or community sentencing 
conditions and pending court dates. This is noting that the patient should be accepted onto 
the program if charges are pending, except in cases of significant violence or sexual offences 
(i.e. behaviours that put staff and other patients at risk of harm by the patient); 
- risk of harm to self and to others, including children living with the patient; 
- other risk factors, such as pregnancy; 
- willingness of the patient to engage in treatment voluntarily; 
- availability of less restrictive treatment options that can be accessed; 
- identification of key significant others, e.g. family, carer, guardian; 
- identification of community care coordinator (to coordinate care post discharge from the 
inpatient phase of the Program); 
- identification of a GP; 
- identification of transportation needs should the patient be issued a dependency certificate 
and does not reside near the IDAT inpatient unit.  
 
If the patient is assessed as eligible for the IDAT Program, the ITLO and the referring team will be 
informed of the outcome of the eligibility of the patient.  
 
The AMP will issue a Dependency Certificate if they are also satisfied that:  
- the patient is not willing to undertake voluntary treatment, and  
- involuntary care will not introduce new serious harms or exacerbate existing harms to the 
patient, and  
- involuntary care is highly likely to result in reduced, safer substance use or abstinence over 
an extended period following discharge, or  
- involuntary care is highly likely to facilitate engagement with ongoing care following 
discharge, and  
- involuntary care has a good prospect of significantly ameliorating harm to the patient and 
improving their quality of life, and  
- there is a bed available immediately at the inpatient unit.  
 
This means that the Dependency Certificate will only be issued if: 1) there is a bed available 
immediately at the inpatient unit; and 2) the patient meets all eligibility criteria. If a bed is not 
immediately available, the patient will be placed on the waiting list. If a patient is not considered 
suitable for a Dependency Certificate assessment the reasons for this decision are explained to the 
referrer and ITLO, and alternative treatment/intervention options are suggested. 
 
If it is not possible to access a patient for assessment of suitability for a Dependency 
Certificate (e.g. if the patient refuses to come into a clinic and won’t let anyone in their house), 
Section 10 of the Act can be used. An application is made to a Magistrate to legally authorise the 
AMP to visit and assess the person in relation to issuing a Dependency Certificate. The order may 
also authorise another person to assist the AMP in conducting the assessment, e.g. a police officer. 
 







If the patient meets all the eligibility criteria for involuntary treatment and a bed is available, a face 
to face (or video-conference) meeting between the patient, the referring team member and the 
AMP is to be arranged, to take place as soon as possible. This is the final assessment of the patient 
for the AMP to determine whether the patient should be issued a Dependency Certificate for 
detention and treatment under the Act.  
 
If a Dependency Certificate is issued, the Act provides for the patient to be immediately detained in 
order to be transported to the inpatient unit. 
 
Immediately following the issue of a Dependency Certificate, the following steps should be 
undertaken:  
- provision of advice to patient (and family members, carer or guardian, if appropriate) of 
their right to appeal; 
- identification in writing of the primary carer(s); 
- identification of transport options and arrangement of transport to the Unit.  
 
The patient will be received at the unit by a member of the clinical team, as per the local unit 
procedures. All paperwork and administration tasks will be completed and a medical record will be 
requested, or commenced, for patients who do not have a medical record number in the LHD in 
which the Program is located. Information gathered during the referral, screening and assessment 
for the Dependency Certificate should also be included in the medical file, as should the Dependency 
Certificate and any documentation pertaining to court orders.  
 
A court hearing by the Magistrate should occur within 7 days of admission. 
 
Orientation should take place as soon as the patient is admitted to the unit, unless the patient’s 
mental or physical state prevents them from engaging in the induction activities. 
 
The purpose of orientation is to:  
- admit and orient the patient to the unit; 
- provide the patient and their nominated primary carer with information about the unit, 
including expectations regarding behaviour; 
- provide information to the patient and their nominated primary carer about their rights in 
relation to the program, including the process for reviewing and extensions of the 
Dependency Certificate and their right to appeal.  
 
Identification of a primary carer: The Act stipulates that a patient may nominate a person to be their 
primary carer under the Act. The primary carer should be informed of the patient’s admission to the 
program, and, where possible and appropriate, involved in the development of the care plan, 
particularly the community-based component of this plan. The primary carer may be a family 
member, carer, friend or another professional who is known to the patient. This may include the 
patient’s Public Guardian, if applicable and appropriate. The Act stipulates that the primary carer 
must be notified within 24 hours after a Dependency Certificate has been issued. If the patient is 
unable to nominate a primary carer on admission, they will be asked again at an appropriate time, 
but within 24 hours. 
 
Withdrawal 
This stage provides a medically supervised withdrawal for admitted patients before further medical 
and psychosocial interventions and support can be provided to address other aspects and 
consequences of substance misuse. The aim of withdrawal is to initiate abstinence and attain patient 






safety while frequently monitoring the individual and providing appropriate care when necessary. 
Planning and coordinating post-withdrawal care is an integral part of the treatment process, 
including throughout withdrawal. This stage involves a number of aspects, including assessment for 
withdrawal to inform the development of a withdrawal management plan, supervised withdrawal 
(including psychosocial and pharmacological interventions) and monitoring. 
 
Post withdrawal Treatment 
During this stage, ongoing intensive support and interventions are provided to address the patient’s 
bio-psychosocial needs and to assist them to move towards improved substance misuse, health 
(physical and mental) and social functioning outcomes. This involves further and on-going 
assessment, continued development and review of the care plan and the provision of a range of 
structured medical, psychological and other interventions and supports, delivered by a                          
multi-disciplinary team. A key principle of care post withdrawal is the involvement and engagement 
of the patient (and their primary carer if appropriate) in all aspects of care planning and review.  
 
With regard to assessment of cognitive impairment, further assessment will be undertaken to 
consider capacity, neurological, bio-psychosocial and physical functioning to inform a comprehensive 
care plan (global care plan). Due to the extensive history of substance misuse of the client group and 
the likely impact on functioning and capacity it is not appropriate to undertake these types of 
assessment prior to withdrawal as the validity of the assessment outcomes will be limited. 
 
A range of structured interventions will be provided by Program staff during the post withdrawal 
inpatient stage, as indicated by the global care plan, to reinforce changes in behaviour and to 
support the patient and equip them with skills to make healthier lifestyle choices. These might 
include: 
- structured psychosocial interventions, including cognitive behavioural therapy (CBT), coping 
skills training, contingency management;  
- counselling, e.g. trauma or grief counselling; 
- living and life skills, including cooking, cleaning and budgeting, in preparation for                            
re-integration into the community;  
- relapse prevention and active practice of relapse prevention skills during therapy; 
- advice, information and education about substance misuse  
 
All structured interventions should be underpinned by motivational and engagement approaches, 
such as motivational interviewing, to encourage the development of insight and to develop more 
effective life skills. 
 
Discharge  
During this stage, the patient is discharged from the inpatient unit and transitioned to the 
community-based stage of the Program. The IDAT outcome tools are required to be completed prior 
to discharge. Discharge may be back to the patient’s community, to another identified and agreed 
community, to a residential rehabilitation setting or to another inpatient setting, for example, if the 
patient requires admission to an acute health or mental health unit for further treatment. Discharge 
is underpinned by a discharge plan, which is commenced at admission to the inpatient unit, to 
ensure there is a continuum of care between the inpatient and community based components of the 
Program.  
 
The discharge plan should be coordinated by the inpatient case manager, IDAT transfer of care 
coordinator and community care coordinator in consultation with the multi-disciplinary care team. 
Discharge planning must include liaison with community-based providers, such as residential 
treatment facilities and specialist community services, to negotiate access to services post discharge. 






A discharge summary should be developed and made available to the community care coordinator 
and other professionals who will be involved in the patient’s on-going care. This should include an 
overview of the patient’s treatment as an inpatient and should provide details of current 
medications and any areas of ongoing concern. 
 
As part of discharge planning, primary case coordination responsibility transfers from the inpatient 
case manager to the IDAT Transfer of Care Coordinator (based in the IDAT Unit) and the Community 
Care Coordinator. Either the Transfer of Care Coordinator or the Community Care Coordinator are 
identified as the main case coordinator and this will be determined on a case by case basis and take 
into account factors such as patient’s area of residence and treatment support needs. Ideally, this 
should be marked by a formal discharge case conference, involving the patient, and should be 
documented in the discharge plan and summary.  
 
The IDAT transfer of care coordinator and where possible the community care coordinator should 
assist the inpatient team in physically supporting the patient (and family) at discharge, in managing 
anxiety associated with discharge and in implementing and monitoring the community-based care. 
 
Community based Program 
The community based component of the Program provides support and interventions to encourage 
continued healthy lifestyle choices, to continue to work towards goals and to address and manage 
the risks of relapse after the patient has been discharged from the inpatient phase of the Program. 
This stage responds to the need for long term, comprehensive and holistic supports to achieve 
sustained behaviour, psychosocial, health and wellbeing outcomes.  
 
While this post discharge community-based component of the Model of Care is a crucial phase of 
comprehensive treatment, it is important to note that this is not an involuntary component and 
therefore relies on the patient's willingness to engage. 
 
This component of the Program provides support and interventions for up to six months; the first 
few weeks involve intensive case management and support and the remaining support involves a 
stepped down approach. Over this time, support decreases in intensity and frequency as the patient 
builds links and relationships with alternative community based treatment and support providers. It 
is acknowledged that some patients may require longer term management with no stepped down 
approach. 
 
The IDAT transfer of care coordinator and the community care coordinator are responsible for the 
development, implementation and review of the global care plan in the community. They are also 
responsible for the completion and recording of the outcome tools at three time intervals across the 
community care component of the Program. How responsibility is distributed is to be negotiated 
between the transfer of care coordinator and community care coordinator on a case by case basis.  
 
Treatment and support needs that are identified including housing, health care and community and 
vocational pursuits may require brokerage funding.  
 
It is important that the care coordinators support the patient in the community to work towards a 
goal of successfully exiting the Program. This is important to encourage the patient to be 
independent of the Program and to continue to improve their quality of life. It is also essential from 
a resource perspective to maintain the capacity of the Program to work with other patients.  
 






For many patients, some form of on-going support may always be required, as a result of limited 
functioning and capacity. It is important that these patients are supported to access appropriate 
mainstream services.  
 
To work towards successful exit, there should be a planned step down of the intensity and frequency 
of support by the care coordinators. This should be undertaken in consultation with the patient and 
their family / carers and should occur at a pace that is acceptable to the patient. It is essential that 
appropriate links and relationships with other community based services, including specialist and 
mainstream services, are in place before the step down occurs to prevent the risk of disengagement 
and relapse. 






5 Quantitative analysis: IDAT database and 
administrative records 
The IDAT Program commenced in New South Wales in 2012 with two gazetted treatment units. One 
treatment unit has 4 IDAT beds, is located in Sydney as part of an existing voluntary detoxification 
unit at Herbert Street Clinic (HSC), Royal North Shore Hospital, Northern Sydney LHD. The other 
treatment unit has 8 IDAT beds, is located in Orange, as part of the Bloomfield (BF) hospital in 
Western NSW LHD. The choice of location aimed to ensure that both metropolitan and rural regions 
were covered.  
 
This chapter draws on the IDAT database that was developed to monitor the administrative aspects, 
the patient throughput and the outcome of the IDAT program. The IDAT database was obtained 
from the IDAT Data Manager on 25 July 2016 in order to analyse: 
• The numbers of patients and the patient flow 
• The lengths of stay 
• The waiting periods (time between referral and admission) 
• The patient characteristics 
• Comparisons between those admitted and non-admitted on demographic characteristics 
• The outcome data at 1, 3 and 6 months  
 
The IDAT database is a relational database, with 17 different data tables. Seven data tables refer to 
administrative data obtained during the assessment and treatment phase (including referral, 
admission and discharge, and Magistrate review). Ten other data tables refer to outcome data for 
different time-points (at assessment, admission, at discharge, 1 month, 3 month and 6 month post 
discharge). It is a complex arrangement for simple data analysis, with multiple entries for the same 
individual patient depending on the number of admissions for the same patient, the number of 
responses to one data field, the number of time-points for which data for a single patient is 
available, and different linking mechanisms across data tables (some need to be linked by ID, some 
need to be linked by MRN, some need to be linked by InterviewID, and some need to be linked by 
more than one of these 3 identifiers in a certain order). There are also substantial missing data. This 
section of the process evaluation report provides our analysis of the available data. At the end of this 
chapter there is discussion of the challenges and issues associated with the data, database and 
recording of outcomes.  
5.1 IDAT patient flows and admission rates 
There are more records than unique patients in the IDAT database as a patient can be referred, 
assessed or admitted to the program more than once. The IDAT database provides a total of 640 
valid records, each representing a patient episode for the period from 31 May 2012 to 24 June 2016 
(4 years) for both IDAT treatment units. A total of 529 unique patients are identified from these 640 
records, with 80 patients (15.12%) having two records (referred twice) and 31 patients (6%) having 
three records (referred three times).  
 
For some analyses, it is appropriate to use the N=640 (such as for admission rates, length of stay). 
For other analyses, it is more appropriate to use the unique patients (such as analyses of 
demographic characteristics). We specify whether the N=640 (episodes) or the n=529 (unique 
patients) are used throughout the below.  
 
 








Figure 1 shows the flow of admission to IDAT (N=640). 
 
 
Figure 1: IDAT patient flows  
 
 
 640 patient episodes 
referred   
(327 HSC, 313 BF) 
438 patient episodes 
assessed as eligible  
(223 HSC, 214 BF) 
 
202 patient episodes 
assessed as non-eligible  
(104 HSC, 98 BF) 
 
342 patient 
episodes admitted                        
(132 HSC, 210 BF) 
 
   
96 patient episodes               
not admitted 
(91 HSC, 5 BF) 
                        
Reasons: 
+ 75 due to ‘other treatment 
options are available’                                
(72 HSC, 3 BF) 
+ 17 due to ‘unlikely to benefit 
from treatment’ (17 HSC,                  
0 BF) 
+ 2 missing values (1 HSC, 2 BF) 
+ 1 Pending assessment by 
AMP (1 HSC) 
Reasons:  
+ 3 no severe substance dependence                    
(1 HSC, 2 BF) 
+ 58 other treatment options are available                      
(41 HSC, 17 BF) 
+ 54 unlikely to benefit from treatment                               
(45 HSC, 9 BF) 
+ 87 missing values because:  
- 30 ‘pre-referred only not 
assessed/referred’ (10 HSC, 20 BF) 
- 7 assessed as ineligible upon 
assessment by AMP (all HSC) 
       - 50 actual missing values (all BF) 
 
Exit status: 
+ 192 discharged at end of treatment 
period (61 HSC, 131 BF) 
+ 50 discharged after initial extension 
period (17 HSC, 33 BF) 
+ 31 discharged after further 
extension period (20 HSC, 11 BF) 
+ 38 discharged early by AMP  
   (22 HSC, 16 BF) 
+ 18 discharged early (Magistrate not 
granted) (2 HSC, 16 BF) 
+ 5 absconded (2 HSC, 3 BF) 
+ 8 missing values on ‘exit status’                  
(all with HSC) 
*Note: Dependency certificates of 324 
patient episodes (95% of 342) were 
granted by the Magistrate.  
 
Note: The Exit status given in Figure 1 was as recorded in the database. These do not match the data in Table 8 (Section 
5.4: Length of Stay) due to discrepancies between data fields. See detailed explanation at the beginning of Section 5.4.  
 
 
Figure 1 describes the flow of all 640 patients who have been referred to the IDAT program from the 
commencement of the program to 24 June 2016, with an almost equal number of referrals to each 
of the two IDAT program units. Of the total of 640 patients, 202 were assessed as ineligible. Of the 
438 referrals assessed as eligible, 96 referrals resulted in the patients not being admitted into 
treatment with most of these (91) at Herbert Street Clinic. It is assumed that this is due to the bed 
availability and wait time – resulting in a second subsequent assessment at which time patients who 
were originally deemed eligible had now received alternate options (note: other treatment options 
were found for 75 of the 96 patient who were eligible but not admitted).  
 






Of the 342 referrals that resulted in the patient being admitted into treatment, 63% (217) completed 
a full treatment episode and were discharged at the end of the treatment period, 3% (12) were 
discharged after an initial extension period (i.e. Dependency Certificate was extended), 3% (9) were 
discharged after a subsequent, second extension period, 19% (66) were discharged early by the 
AMP, 5% (16) were discharged early because the Dependency Certificate was not confirmed by the 
Magistrate (15 cases were with Bloomfield), 1.5% (5) absconded and the exit status of 5% (18) was  
unclear.  
 
A Dependency Certificate was issued for 324 episodes of care over the four year period (95% of the 
admitted patient episodes).  
 
Table 3: Number of episodes referred and admitted: 2012-2016 (N=640) 
  Year 1  
(31 May 
2012 - 31 
May 2013) 
Year 2 
(1 June 2013 
- 31 May 
2014) 
Year 3 
(1 June 2014 
- 31 May 
2015) 
Year 4 
(1 June 2015 – 





HSC 76 89 78 84 327 
BF 37 95 84 97 313 
Total 
referred 




% of referred 
episodes) 
HSC 39 (51.32%) 36 (40.45%) 30 (38.46%) 27 (32.14%) 132 (40.37%) 




65 (57.52%) 97 (52.72%) 90 (55.56%) 91 (50.28%) 342 (53.44%) 
Note:  
1. Seven (7) referrals with records “pending assessment by AMP” (all from HSC) are included in the table but 
counted as “referred episodes”. 
2. HSC referrals: The 327 referrals represent 269 unique patients as some patients are referred to the program 
more than once. Of the 269 unique patients, 49 of these patients were referred to the program a second time, 
and 9 of the 269 unique patients were referred to the program a third time (269*1) + (49*1) + (9*1) =327. A total 
of 18.22% (49/269*100) of referrals are second referrals and 3.35% (9/269*100) are third referrals to the 
program. As such, overall 21.56% (18.22+3.35) of first referrals results in a subsequent referral to the program. 
3. BF referrals: The 313 referrals represent 260 unique patients as some patients are referred to the program more 
than once. Of the 260 unique patients, 31 of these patients were referred to the program a second time, and 22 
of the 260 unique patients were referred to the program a third time (260*1) + (31*1) + (22*1) = 313. A total of 
11.92% (31/260*100) of referrals are second referrals and 8.5% (22/260*100) are third referrals to the program. 
As such, overall 20.42% (11.92+8.50) of first referrals results in a subsequent referral to the program. 
4. The table does not show separate data for episodes or unique patients a) assessed as eligible for admission, b) 
assessed as ineligible for admission or c) eligible, but not admitted to the program. 
5. HSC admissions: A total of 95 unique patients were admitted, and 29 of the 95 unique patients were re-admitted. 
6. BF admissions: A total of 159 unique patients were admitted, and 30 of the 159 unique patients were                          
re-admitted. 
7. HSC + BF admissions: A total of 254 unique patents were admitted to both treatment units (159+95). The number 
of unique patients who were re-admitted (once or twice) to both treatment units was 59 (30+29). These numbers 
are used for data in Table 15. 
 
 
The data in Table 3 (pertaining to all referrals, and as per Figure 1), reveal a number of features: 
• In the first year, referral numbers were low, as would be expected with a new program 
establishment. By year 2 however, the rate of referral seemed to have stabilised (at 184 for 
year 2, 162 for year 3 and 181 for year 4).  






• The admission rates were slightly higher in year 1 (57% of all referrals), but have since 
stabilised to an average of 53%. This means that half of all referrals to IDAT do not result in 
an admission. 
• On average there is an almost equivalent referral rate to the two units – HSC receiving a 
total of 327 referrals over the period, and BF receiving a total of 313 referrals. 
• On the surface the admission rate for HSC (40%) is lower than the admission rate for BF 
(67%) but this is due simply to the number of available beds – 4 beds at HSC and 8 beds at 
BF. 
 
5.2 Waiting time: IDAT database analysis 
The waiting time was calculated by subtracting the admission date from the referral date4. Table 4 
shows that the median waiting time for admitted patients was 15.5 days; at HSC (19 days) it is longer 
than BF (14 days)5. The proportion of patients admitted on the day of referral was 9.8%. While the 
proportion of patients who are admitted on the day of referral and within 7 days of referrals are 
similar for the two treatment units, it appears that a higher proportion of patients at BF are 
admitted within 28 days compared to HSC.  
 
Table 4: Waiting time from referral date to admission date (in days): unique patients, first admission 
only 
 Total  HSC (n=95) BF (n=159) 
Mean/(SD) 27.42 (35.93) 31.49 (42.52) 24.98 (31.23) 
Median/(range) 15.50 (0-265) 19.00 (0-265) 14.00 (0-185) 
% of patients admitted on the day referral was 
received  
9.8 10.5 9.4 
% of patients admitted within 2-7 days from date 
of referral  
24.8  23.2  25.8  
% of patients admitted within 8-28 days from date 
of referral 
35.1  31.6  37.1  
% of patients admitted within 29-42 days from 
date of referral 
11.0  11.5  10.7  
% of patients admitted within > 42 days from date 
of referral 
19.3 23.2 17.0 
 
Almost 20% of patients attending IDAT waited more than 42 days before their admission. But 25% 
were admitted within 2 to 7 days after referral and 9.8% were admitted on the day referral was 
made. 
 
4 Waiting time was calculated based on the data of unique patients; because it is likely that patients who are 
re-referred to IDAT might have a different wait time. 
5 Median statistics are reported because the data are highly skewed, as evidenced by histograms. 






Figure 2: Days in waiting time for unique patients admitted to HSC for first admission only (n=95) 
 
 
Figure 3: Days in waiting time for unique patients admitted to BF for first admission only (n=159) 
 
   






5.3 Referring LHDs and referral sources 
The LHDs which referred patients to the IDAT program is given in Table 5.  
 




patients for both units 
(n=513)  
Unique referred 
patients for HSC 
(n=259) 
Unique referred 
patients for BF 
(n=254) 
Number    %  Number   %  Number   %  
1. CCLHD (Central Coast) 17 3.31 9 3.47 8 3.15 
2. FWLHD (Far West) 2 0.39 0 -- 2 0.79 
3. HNELHD (Hunter New 
England) 26 5.07 6 2.32 20 7.87 
4. ISLHD (Illawarra Shoalhaven) 43 8.38 25 9.65 18 7.09 
5. MLHD (Murrumbidgee) 27 5.26 2 0.77 25 9.84 
6. MNCLHD (Mid North Coast) 25 4.87 10 3.86 15 5.91 
7. NBMLHD (Nepean Blue 
Mountains) 10 1.95 4 1.54 6 2.36 
8. NNSWLHD (Northern NSW) 23 4.48 2 0.77 21 8.27 
9. NSLHD (Northern Sydney) 105 20.47 97 37.45 8 3.15 
10. SESLHD (South Eastern 
Sydney) 54 10.53 45 17.37 9 3.54 
11. SNSWLHD (Southern NSW) 26 5.07 6 2.32 20 7.87 
12. St Vincent’s 21 4.09 17 6.56 4 1.57 
13. SWSLHD (South Western 
Sydney) 33 6.43 17 6.56 16 6.30 
14. SYDLHD (Sydney) 27 5.26 14 5.41 13 5.12 
15. WNSWLHD (Western NSW) 67 13.06 1 0.39 66 25.98 
16. WSLHD (Western Sydney) 7 1.36 4 1.54 3 1.18 
Total  513 100.00 259 100.00 254 100.00 
Note: Missing value = 16 (10 with HSC). Therefore, the denominator is the valid data. 
 
As can be seen from above table, the most common referring LHD was NSLHD (20.47% of unique 
patients), followed by Western NSW (13.06%). Unsurprisingly, these are the two LHDs with the 
actual IDAT inpatient units. The spread of the referrals differs between the two IDAT units: HSC has 
37.45% of its referrals from its home LHD, whereas BF has 25.98% of its IDAT referrals from its home 
LHD (suggesting a wider spread for BF than HSC). Some LHDs are referring very few patients, notably 
Far West (0.4%), Nepean Blue Mountains (1.9%) and Western Sydney (1.3%). While geographical 
distance (and population size) might be possible explanations for such a low referral rate from Far 
West LHD, the possible explanation for a low referral rates from NBMLHD and WSLHD is not clear. 






Table 6 provides the details of the referring LHD for only those patients admitted to IDAT (n=254). 
Again, given the location of the IDAT units and the referral rates (Table 5), Northern Sydney (17.7%) 
and Western NSW (15.4%) had the highest rate of admitted patients. Likely due to larger number of 
beds, the treatment unit in BF admitted patients from both rural LHDs and metropolitan LHDs, and 
had at least one admitted patient from every LHD. HSC on the other hand did not admit any patients 
from four LHDs: FWLHD, NBMLHD, WNSWLHD and Northern NSW LHD.  
 
Table 6: Admitted patients - referring LHDs (n=254, unique admitted patients) 
LHD 
Unique admitted 
patients for both 
units (n=254) 
Unique admitted 
patients for HSC 
(n=95) 
Unique admitted 
patients for BF 
(n=159) 
Number % Number % Number % 
1.  CCLHD (Central Coast) 8 3.1 1 1.1 7 4.4 
2. FWLHD (Far West) 2 0.8 -- -- 2 1.3 
3. HNELHD (Hunter New England) 14 5.5 2 2.1 12 7.5 
4. ISLHD (Illawarra Shoalhaven) 8 3.1 7 7.4 1 0.6 
5. MLHD (Murrumbidgee) 15 5.9 1 1.1 14 8.8 
6. MNCLHD (Mid North Coast) 10 3.9 1 1.1 9 5.7 
7. NBMLHD (Nepean Blue 
Mountains) 
6 2.4 -- -- 5 3.1 
8. NNSWLHD (Northern NSW) 18 7.1 -- -- 18 11.3 
9. NSLHD (Northern Sydney) 45 17.7 41 42.1 5 3.1 
10. SESLHD (South Eastern Sydney) 22 8.7 17 17.9 5 3.1 
11. SNSWLHD (Southern NSW) 17 6.7 3 3.2 14 8.8 
12. St Vincent’s 12 4.7 8 8.4 4 2.5 
13. SWSLHD (South Western Sydney) 19 7.5 8 8.4 11 6.9 
14. SYDLHD (Sydney) 15 5.9 5 5.3 10 6.3 
15. WNSWLHD (Western NSW) 39 15.4 -- -  39 24.5 
16. WSLHD (Western Sydney) 4 1.6 1 1.1 3 1.9 
Note: no missing data. 
5.4 Lengths of stay 
Data were complete for LOS for the full sample of admitted patient episodes (N=342, see figure 1). 
Two approaches to LOS calculations were used: firstly a continuous variable calculated by 
subtracting ‘ExitDate’ from ‘AdmissionDate’; secondly a categorical variable classified according to 
exit/discharge status. 
 
LOS continuous variable 
The mean LOS (across both units) was 35.24 days (SD=22.80). The median LOS (across both units) 
was: 27.00 days (Interquartile Range=24-49 and range from 0-138 days) (Table 7) and the modal LOS 
(across both units) was 27.00 days (Figure 4). In comparing the two units, the mean length of stay for 
patient episodes at HSC was 38.12 days (median at HSC 28 days, range 0-138),whereas the mean 
LOS at BF was 33.43 days (median at BF 27, range 1 to 87). This suggests little difference between 
the two units in terms of average lengths of stay (see Figure 5 and Figure 6 below).  
 






Table 7: Summary of Length of Stay Statistics  
Statistics  Both units HSC BF 
Mean (SD) 35.24 (22.80) 38.12 (27.15) 33.47 (18.43) 
Median (range) 27.00 (0-138) 28 (0-138) 27 (1-87) 
 
 

























LOS: categorical variable 
 
The Exit/Discharge status list includes the following: 
Description Days 
Discharged at end treatment period 28 
Discharged early (Magistrate not granted) <28 
Discharged after initial extension period 56 
Discharged after further extension period 84 
Discharged early (by AMP) Various 
Absconded  Various 
 
Approximately 20% of the recorded exit/discharge status did not correspond with the date derived 
LOS. This issue was discussed with the IDAT Data Manager for advice, who confirmed the issue and 
suggested this was evidence of poor quality data entry for the ‘exitstatus’ field. It was also suggested 
that the dates entered are more likely to be correct than the exit status.  We reconciled the two 
different data sources by cross-checking the data fields ‘DCissueDate’, ‘InitialDCendDate”, and 
‘ExtendedToDate’, with the ExitStatus to eventually have a completely corresponding LOS and 
ExitStatus.  
 
The Act specifies up to 28 days as the LOS, although an extension can be applied for. 
For the purpose of analysing LOS categorically, we used the reconciled ‘exitstatus’ data, which were 
recoded into three mutually exclusive categories:  
1) Discharged early (Magistrate not granted), or discharged early by AMP, or absconded with 
length of stay ranging from 0-21 days; 
2) Discharged at end of treatment period with length of stay ranging from 22-42 days;  
3) Discharged after the Dependency Certificate (DC) extension period with length of stay 
ranging from 43-90 days.  
 
Table 8: Length of stay: categorical data (episodes) 
LOS categories % of patient 
episodes: Total 
% of patient 
episodes: HSC 
% of patient 
episodes: BF 
Discharged early (0-21 days)  19.6% = 67 of 342   22.0% = 29 of 132 18.1% = 38 of 210 
Discharged at end of treatment (226-42 days)  52.3% = 179 of 342  46.2% = 61 of 132 56.2% = 118 of 210 
Discharged after DC extension (43-90 days7)  28.1% = 96 of 3428 31.8% = 42 of 132 25.7% = 54 of 210 
 
Table 8 shows that the most common period of program retention is between 22 and 42 days 
(52.3%). The next most common category is an extension to the DC, received by 28.1% of IDAT 
patients. A relatively small proportion (19.6%) was discharged in under 21 days. 
 
 
6 The cut-off of 22 days is driven by the reality that there is a strong level of consistency across the data of two 
treatment units in that LOS of 22+ days corresponds highly with the recorded ExitStatus of ‘Discharged at end 
of treatment’, and that can occur at less than 28 days. 
7 A small proportion of patient episodes have LOS longer than 90 days, probably due to waiting for availability 
of aftercare services to be discharged to (i.e. residential rehab or housing) 
8 Three HSC patient episodes had LOS of 138 day, 115 days and 108 days. Checking of other data fields suggest 
that this might not be due to data entry error. These three patient episodes are included in group 3 
(discharged after DC extension period). 






5.5 Bed occupancy rates 
The bed occupancy rate is a measure of utilisation of the available bed capacity. It indicates the 
percentage of beds occupied by patients in a defined period of time. For this analysis we used the 
period of 4 years. It is computed using the following formula9: 
BOR= (Total number of inpatient days x 100)/(Total number of bed days during the 4-year period) 
Where, 
- Total number of inpatient days = the total number of inpatient days of all admitted patients, 
including readmitted patients in 4-year period; 
- Total number of bed days = number of beds × 1,460 days; 
 
For HSC, with 4 beds and 5,032 inpatient days (number of episodes x LOS), the bed occupancy rate 
was 86.2%. 
  
For BF, with 8 beds and 7,020 inpatient days, the bed occupancy rate was 60.1%.  
 
An ideal bed occupancy rate is around 90%10. Everything else equal, programs that have a longer LOS 
can usually achieve a higher bed occupancy rate because the turnover is slower. There was not a 
significant difference between the average LOS at BF compared to HSC.  
 
The bed occupancy rate should also take into consideration patient complexity. It appears that BF 
admits more patients with acute physical health and mental health issues (see Table 14 and text 
underneath Table 14), which may partly account for the lower bed occupancy rate because more 
staff time would be needed to care for an individual patient. But it is more likely to be driven by 
staffing levels on any one shift. For example, if there is not enough staff time to provide quality 
standard of care to eight (maximum number of patients in BF) complex patients in any given week at 
BF, new patients may not be admitted. Therefore, even though a bed is available and there are 
patients on the waiting list, a new patient might not be admitted due to concern that a standard 
level of care might not be provided. In addition, bed occupancy rate is strongly driven by limitations 
in local referring services who often cannot find patients by the time admission can be offered.  
5.6 Patient profiles: admitted patients (n=254) 
The remainder of this section concentrates on describing the patient profiles for those patients 
admitted to IDAT over the course of the four years. The referral sources for the admitted inpatients 
(n=254) are given in Table 9. 
 
 
9 Usman, G., Memon, K. N., & Shaikh, S. (2015). Bed occupancy rate and length of stay of patients in Medical 
and allied wards of a tertiary care hospital. Journal of Ayub Medical College Abbottabad, 27(2), 367-370. 
10 Op cit 






Table 9: Referral Sources, admitted patients (n=254, unique patients) 
Referral sources Total 
(n=254) 
HSC 
Admitted patients (n=95); 
missing = 1 
BF 
Admitted patients 
(n=159); missing = 0 
Frequency % Frequency % Frequency % 
Family and child protection 
service 
0 - - - - - 
Family member/friend 3 1.2 1 1.1 2 1.3 
General practitioner 15 5.9 6 6.3 9 5.7 
Medical officer/specialist 76 29.9 23 24.2 53 33.3 
Non-residential alcohol and 
other drug treatment 
agency 
66 26 45 47.4 21 13.2 
Non-residential community 
health centre 
6 2.4 4 4.2 2 1.3 
Non-residential community 
mental health centre 
4 1.6 1 1.1 3 1.9 
Other hospital 59 23.2 4 4.2 55 34.6 
Other non-health service 
agency 
0 - - - - - 
Other residential 
community care unit 
3 1.2 3 3.2 - - 
Psychiatric hospital 5 1.9 1 1.1 4 2.5 
Residential alcohol and 
other drug treatment 
agency 
13 5.1 5 5.3 8 5.0 
Residential community 
mental health care unit 
2 .8 - - 2 1.3 
Self 1 .4 1 1.1 - - 
Notes:  
*Numbers may not sum to 100% due to rounding  
** There was a question about the possibility of self-referral. It is possible. During November 2016, a patient at 
HSC referred herself from the detox voluntary unit to IDAT and got admitted to IDAT. 
 
The majority of admitted patients were referred from a medical officer/specialist (29.9%) followed 
by a non-residential AOD treatment agency (26%), and then “other hospital” (23.2%). Very few 
admitted patients were referred by a family member or friend (1.2%), non-residential community 
MH centre (1.6%), community health centre (2.4%) or psychiatric hospital (1.9%). Indeed, if the 
referral sources for admitted patients are categorised into: 1) a general health service (including GP, 
hospital, and medical officer/specialist; 2) an AOD service; and 3) a MH service, the corresponding 
referral percentages are: 59% (5.9+23.2+29.9); 31% (26+5.1); and 4.3% (1.6+1.9+0.8). Clearly general 
medical is the highest referrer for admitted patients (see later, discussion of extent to which ITLOs 
are already managing these patients). There are key differences between the two facilities in terms 
of referral sources: 1) BF gets 34.6% of their referrals from “other hospitals” versus 4.2% for HSC;              
2) HSC gets 47.4% of theirs from “non-residential alcohol and other drug treatment agency” 
compared to 13.2% at BF. We appreciate this is the official data. There might be many cascading 
pressures from multiple sources prior to the point of formal referrals. 
 
Table 10 provided the demographic characteristics of the admitted patients to the IDAT program, as 
recorded in the IDAT database. The average age was 44 years, with 56% being male, and 6.7% were 
of ATSI origin. The majority were on some form of government support/pension (65%). 60% had 
attained year 11 or above, and about half had been married or in a de facto relationship. Alcohol 






was the principal drug of concern for the vast majority (83%), but more than half also had poly 
substance use.  
 
The data analysis suggests that patients admitted to the two treatment units have similar profiles 
pertaining to most demographic characteristics (Table 10). However, patients admitted to BF seem 
to be more likely to be homeless and to have ‘other supported housing’ and less likely to have 
‘privately owned or rented house/flat’ compared to patients admitted to HSC. There is evidence that 
a higher proportion of patients admitted to BF were poly substance users (for both two substances 
and three substances) even though both groups had similar rate of alcohol as the primary drug of 
concern. There is also evidence to suggest that a higher proportion of patients admitted to HSC ever 
injected drugs compared to patients admitted to BF, although this interpretation should be done in 
the context of the high level of missing data for this variable for HSC patients.  
 
Table 10: Demographic profile of IDAT admitted patients (n=254, unique patients) 





two groups  
(tests and                    
p-values) 
Age (mean)  44.56 43.23 45.35 t=1.52; p=0.22 
Gender (male %)  55.90 54.70 56.60 X2=0.08; p=0.77 
ATSI origin (%)  6.70 3.20 8.80 X2=3.04; p=0.08 
Living alone (%)  49.20 46.30 50.90 X2=0.51; p=0.48 
Type of accommodation (%) (missing values = 2, 
all in HSC patients) 
       Privately owned or  rented house/flat 
       Homeless/no usual residence 



















Marital status (ever married or in de facto 
relationship) (%) (missing values = 12, of which 
11 in HSC patients + 7 recorded as ‘not 










Principal income (%) (missing value = zero) 
No income 
Employed (full-time or part-time) 



















categorical test on 
this variable is not 
meaningful because 
of small % of two 
categories 
Education (year 11 or higher including TAFE, 
trade or tertiary) (%) (missing values = 35, of 
which 15 in HSC patients, 20 in BF patients + 48 
recorded as ‘inadequately described’, of which 42 
are in HSC patients) 
60.2 71.1 57.1 X2=2.39; p=0.12 
 
Alcohol as principal substance of concern 
(%)(missing values = 1 BF patient) 
83.40 78.90 
 
86.10 X2=2.18; p=0.14 
Poly substance use (2 substances or more) (%) 
(missing value = zero) 
69.70 30.50 93.10 X2=110.16; p<0.001* 
Poly substance use (3 substances or more) (%)  
(missing value = zero) 
43.70 16.80 59.70 X2=44.49; p<0.001* 
Ever injected drugs (%) (missing values = 51, of 




43.10 25.00 X2=6.03; p=0.01* 
 
Note: for some variables, missing data are high, result may be unreliable. 






Table 11 below presents data for the admitted patients with reference to the primary substance of 
concern (the data source for primary substance of concern is drawn from data sheet DD-3). Across 
the IDAT program, the primary substance of concern for most admitted patients is alcohol (83.40%), 
followed by meth/amphetamines (9.09%), benzodiazepines (2.77%), heroin (1.98%) and cannabis 
(1.58%).  
 
Table 11: Principal drug of concern among admitted patients  
Principal drug of 
concern 
Total HSC (n=95) BF (n=159, missing=1) 
 
cases % Cases % cases % 
Alcohol 211 83.40 75 78.95 136 86.08 
Meth/amphetamine 23 9.09 13 13.68 10 6.33 
Benzodiazepine 7 2.77 3 3.16 4 2.53 
Cannabis 4 1.58 2 2.11 2 1.27 
Heroin 5 1.98 1 1.05 4 2.53 
Methadone 1 0.40 1 1.05 0 0.00 
Morphine 2 0.79 0 0.00 2 1.27 
Total 253 100.00 95 100.00 158 100.00 
 
The two data sources that provide data on severity of substance abuse are the Severity of 
Dependence Scales (SDS) and the Australian Treatment Outcome Profile (ATOP). Table 12 presents 
at admission data on severity of abuse of the principal drug of concern based on the SDS for 
admitted patients. Table 11 shows that the mean SDS scores for patients admitted to both 
treatment units are high and nearly identical (8.95 for HSC and 8.33 for BF) and the majority of the 
admitted patients (89% for HSC and 91.3% for BF) had a SDS score of 3 or above, which meets the 
criteria for dependence of alcohol and other substances.11  
 
Table 13, at admission data on severity of alcohol dependence based on the ATOP for the admitted 
patients, shows that patients admitted to HSC had a lower mean unit per day of alcohol on a typical 
day of alcohol use during the 4 weeks prior to admission (mean UPD=11.74), compared to patients 
admitted to BF (mean UPD=22.18). Data on the number of days in month (DIM) that alcohol use was 
self-reported during the 4 weeks prior to IDAT admission confirmed the difference in heavy use, with 
a mean of 11.78 DIM for HSC patients compared to a mean of 15.95 DIM for BF patients.  
 
 
11 References for cutoff points of SDS scores:  
Lawrinson, P., Copeland, J., Gerber, S., & Gilmour, S. (2007). Determining a cut-off on the Severity of Dependence Scale 
(SDS) for alcohol dependence. Addictive behaviors, 32(7), 1474-1479.);  
Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995). The Severity of Dependence Scale 
(SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. 
Addiction, 90(5), 607-614. 
 






Table 12: Severity dependence scale (SDS) scores on principal drug of concern at admission: for 
admitted patients 















Patients with SDS score >3= 91.3% 
Notes:  List-wise descriptive statistics were used. An SDS score of 3 or above has been determined as optimal for 
characterising dependence for alcohol and other substances (see footnote).  
 
Table 13: Severity of alcohol use scores at admission based on ATOP: for those reporting alcohol 
consumption  






































*UPD = unit per day; DIM = days in month.  
** The means and medians DIM were low because most patients were spending some time in a hospital prior to being 
admitted to IDAT. 
 
Some description of the types of presenting issues for the IDAT patients can be ascertained from the 
details of the case management issues (as recorded in sheet DD-5) that were identified as part of the 
assessment. Table 14 provides the number of issues identified for the admitted group (n=204, 
missing data for 50 patients). 
 
The majority of the admitted patients (94% of 204 for which data were available) had at least one of 
the following case management issues: ‘Physical health/medical’, ‘Risk behaviour management’, 
‘Psychiatric/Mental Health’, ‘Family, parenting and relationships’, and ‘Housing’. 78% of the 
admitted patients (159 out of 204) had two case management issues, 57% (116) had three case 
management issues, 25% (51) had four case management issues and 11% (23) had five recorded 
case management issues. 
 






Table 14: Case management issues for admitted patients  











Education/training/literacy 12 2 10 
Employment 35 6 29 
Family, parenting and relationships 46 8 38 
Housing 45 18 27 
Physical health/medical 149 32 117 
Psychiatric/Mental Health 86 14 72 
Risk behaviour management 134 26 108 
Financial  27 4 23 
Note: A proportion of patients have more than one case management issues. Therefore, the data in Table 14 sum to more 
than the number of patients. 
 
As can be seen in the above table, the most commonly presenting issue is physical health, followed 
by risk behaviours and psychiatric/mental health. The extent of physical health can be estimated 
from the above: for HSC, 69.56% (24/4612) admitted patients have serious physical health conditions 
and for BF, 74.05% (117/158) admitted patients have serious physical health conditions. The extent 
of mental health co-morbidity can be estimated from the above: for HSC, 30.43% (14/4613) admitted 
patients have mental health co-morbidity and for BF, 45.57% (72/158) admitted patients have 
mental health co-morbidity. 
5.7 Re-admissions 
As noted earlier (see Table 3) there were 59 patients admitted for a second IDAT and a third episode 
of care over the period under analysis. When this group (n=59) are compared with those patients 
having a single admission to IDAT over the four year period under review (Table 15), we observe that 
those people admitted more than once are more likely to be younger, female, alcohol as the 
principal drug of concern, and with higher severity of dependence scores. At the same time, they are 
also less likely to be homeless, and to have fewer physical health (and mental health) problems. 
Missing data prevents confident statistical analyses of these differences.  
 
 
12 Using 46 as the denominator given missing value=49 (out of 95). 
13 Using 46 as the denominator given missing value=49 (out of 95). 






Table 15: Comparison of those patients who were readmitted (n=59) with those with a single 
admission (n=195) 






45.18 (11.51) 42.47 (12.59) 
Gender (Male) (%) 
 
56.90 52.50 
Homelessness (%) (missing values = 50, of which 34 in single 
admission patients) 
23.10 15.30 
Psychiatric/mental health problem (%) (missing values = 50, 
of which 34 in single admission patients) 
44.70 32.60 
Physical health problems (%) (missing values = 51, of which 
35 in single admission patients) 
75.00 67.40 









SDS scores (Mean/SD) (missing values = 38, of which 29 in 
single admission patients) 
8.23 (3.88) 9.64 (4.05) 
ATOP for alcohol (missing values = 28, of which 19 in single 
admission patients) 
UPD Alcohol (mean/SD) 
DIM Alcohol (mean/SD) 
UPD Amphetamine/ Methamphetamine (mean/SD) 













SF12 (missing values = 31, of which 23 in single admission 
patients) 
PCS (Physical Composite Score) (mean/SD) 







MOCA (mean/SD) (missing values = 59, of which 36 in single 
admission patients) 
23.53 (4.79) 23.97 (3.58) 
ACE-R (mean/SD) (missing values = 159, of which 128 in 
single admission patients) 
82.99 (15.42) 80.93 (10.60) 
MMSE (mean/SD) (missing values = 181, of which 114 in 
single admission patients) 
26.06 (6.42) 26.44 (3.44) 
 
5.8 Relationship between early discharge, end of treatment period 
discharge (28 days) and DC extension 
In addition to the above analysis of the readmissions to IDAT, we also sought to ascertain whether 
those admitted IDAT patients who were discharged early, and those who stayed for 28 days were 
different to those patients who had an extension of the Dependency Certificate. The available 
demographic and drug use data are limited for such a comparison, and the level of missing data is 
also a concern for reliable interpretation of the results. The findings are given in Table 16.  
 






Table 16: Profile description of three groups (group 1=33 admitted patients discharged early; group 
2=143 admitted patients discharged at end of 28 days; and group 3 = 78 admitted patients 
discharged after DC extension period) 





end of 28 days 
(n=143) 





41.55 (12.39) 45.01 (11.47) 44.99 (12.12) 
Sex (male) (%) 
 
63.60 59.40 46.20 
Homelessness (%) (missing values = 8  for group 1, 26 for 
group 2 and 16 for group 3) 
 
24.00 22.20 35.50 
Physical health problems (%) (missing values = 8  for 
group 1, 27 for group 2 and 16 for group 3) 
 
72.00 71.60 77.40 
Mental health problems (%) (missing values = 8  for group 
1, 27 for group 2 and 16 for group 3) 
 
52.00 44.40 33.90 












SDS scores (Mean/SD) (missing values = 13 for group 1, 
17 for group 2 and 8 for group 3) 
8.70 (3.73) 8.65 (4.02) 8.36 (3.96) 
ATOP (missing values = 13 for group 1, 11 for group 2 and 
4 for group 3) 
UPD Alcohol (mean/SD) 
DIM Alcohol (mean/SD) 
UPD Amphetamine/Methamphetamine (mean/SD) 



















SF12 (missing values = 12 for group 1, 12 for group 2 and 
7 for group 3) 
PCS (Physical Composite Score) (mean/SD) 













MOCA (mean/SD) (missing values = 16 for group 1, 35 for 
group 2 and 8 for group 3) 
22.94 (3.88) 24.27 (4.58) 22.77 (4.65) 
ACE-R (mean/SD) (missing values = 26 for group 1, 90 for 
group 2 and 43 for group 3) 
 
80.57 (12.31) 82.47 (15.69) 82.60 (12.22) 
MMSE (mean/SD) (missing values = 26 for group 1, 100 
for group 2 and 55 for group 3) 
 
26.43 (4.65) 26.26 (5.09) 26.00 (6.75) 
Note: the denominators are the number of cases with valid data. 
 
There appears to be some gender differences, with women more likely to have a DC extension than 
males (who in turn were more likely to be discharged early). Unsurprisingly a DC extension14 was 
associated with a higher proportion of patients who were homeless (this confirms that one of the 
challenges is discharge planning for those who do not have accommodation). In addition, a DC 
extension is associated with greater physical problems, but fewer mental health problems. 
 
14 The legal basis for a Dependency Certificate extension is alcohol-related or drug-related brain injury (see 
“How the Act works’ section on page 34. 






Methamphetamine as the principal drug of concern appears to be more commonly associated with a 
DC extension.    
5.9 Differences between eligible and ineligible patients  
A series of analyses were undertaken to compare the unique eligible patients (n=341) with those 
patients assessed but found to be ineligible (n=188). Table 17 provides the results.  
 
In the first instance, the amount of missing data should be noted. The variables for which missing 
data were extensive (and hence the statistical test may not be reliable) are: living alone, type of 
accommodation, marital status, and educational attainment and ever injected drugs. Across these 
variables, most of the missing values occur for ineligible patients because it is suspected that the 
IDAT units prioritise collecting and entering data for the admitted patients. Excluding these variables, 
the results suggest that eligible and ineligible patients have different profile. Specifically, eligible 
patients tend to be slightly older, less likely to be of Aboriginal origin, more likely to live alone, more 
likely to have alcohol as their primary drug of concern, and more likely to use poly drugs. The data 
analysis suggests that the ineligible patients are more likely to have injected drugs. The preliminary 
finding regarding Aboriginal people being less likely to be admitted (statistically significant difference 
between eligible and ineligible patients) is worthy of further investigation. 
 
Table 17: Comparison of profile of eligible and ineligible unique patients (total=529) 







two groups  
(tests and p-values) 
Age (mean) (missing values = 9, all in ineligible 
patients) 
44.48 (12.17) 42.20 (12.61) t=2.00; p=0.046* 
Gender (male %) (missing values = 8, of which 7 in 
ineligible patients) 
56.2 63.00 X2=2.26; p=0.13 
ATSI origin (%) (missing values = 12, of which 8 in 
ineligible patients) 
6.80 13.30 X2=6.01; p=0.01* 
Living alone (%) (missing values = 115, of which 100 
in ineligible patients) 
47.00 32.1 X2=5.75; p=0.02* 
Type of accommodation (%) (missing values = 133, 
of which 123 in ineligible patients) 
       Privately owned or  rented house/flat 
       Homeless/no usual residence 














Marital status (ever married or in de facto 
relationship) (%) (missing values = 156, of which 123 






Principal income (%) (missing values = 123, of which 
114 in ineligible patients) 
No income 
Employed (full-time or part-time) 















test on this variable is 
not meaningful 
because of small % of 
two categories 
Education (year 11 or higher including TAFE, trade 
or tertiary) (%) (missing values = 327, of which 176 







Statistical test was not 
conducted for this 
variable due to 
substantial level of 
data missingness  
Alcohol as principal substance of concern (%) 














Poly substance use (≥2 substances) (%) (missing 







Poly substance use (3 substances or more) (%) 








Ever injected drugs (%) (missing values = 262, of 










Analyses to examine program entry bias 
One of the issues raised by stakeholders has been to query the extent to which certain patient 
groups may be less likely to be admitted to IDAT. One example given to the evaluators was 
homelessness (also discussed elsewhere) where perceptions have varied about whether 
homelessness would be a reason not to admit a patient. It is difficult to obtain hard data to examine 
this question but it is possible to review the extent to which admitted patients differed from those 
referred to the program on the identified case management issues. For example if 80 referred 
patients had homelessness issues, but only 40 admitted patients had homelessness issues, it would 
suggest some operation of selection procedures. While the data are not ideal for this purpose, we 
have done some indicative analyses, see Table 18.  
 
For the majority of case management issues, between 90% and 100% of patients with those case 
management issues identified at the referral stage, ended up admitted to the program. But for 
housing issues, 71% of those with housing as an identified issue were admitted. For psychiatric and 
mental health problems, 65% of those referred with these issues were admitted. 
 
Comparisons between the two units can be made (see Table 18). HSC appeared to admit a lower 
proportion of people presenting with employment (75% of those referred) and family, parenting and 
relationship issues (62% of those referred) than BF. On physical health, HSC also admitted a smaller 
proportion than were referred (78%). For mental health issues, consistent with stakeholder 
perceptions, BF admits a greater proportion of referred patients with mental health problems                
(70% of those referred) than HSC (47% of those referred). There also appears to be a difference in 
terms of risk behaviours, with BF admitting a greater proportion who present with this issue at 
referral (99%) than HSC (65%). The higher admission rate of patients with psychiatric/mental health 
conditions is consistent with comments made by a number of ITLOs and aftercare providers that               
“BF is a bit more welcoming in accepting mental health patients”. It is expected that BF would admit 
a higher proportion of patients with risk behaviour management compared to HSC because BF is a 
more secure unit. 
 
It should be noted that these data (derived from the case management issues at assessment) are not 
ideal for this kind of analyses, but do provide an overall picture which lends support to the notion 
that BF tends to admit more complex patients than HSC. 






Table 18: Comparison of referred and admitted patients on case management issues 
 Case management 
issues  
Total HSC BF 




















12 12 100% 2 2 100% 10 10 100% 
Employment 37 35 95% 8 6 75% 29 29 100% 
Family, parenting 
and relationships 
51 46 90% 13 8 62% 38 38 100% 
Housing 63 45 71% 26 18 69% 37 27 73% 
Physical 
health/medical 
159 149 94% 41 32 78% 118 117 99% 
Psychiatric/ Mental 
Health 
133 86 65% 30 14 47% 103 72 70% 
Risk behaviour 
management 
149 134 90% 40 26 65% 109 108 99% 
Financial  30 27 90% 7 4 57% 23 23 100% 
 






5.10 Data issues 
The original expectations for IDAT included comprehensive data collection such that ongoing 
performance monitoring and evaluation of the program could be facilitated. This expectation has 
not been met. As noted in the analysis of the IDAT database, there are substantial missing data. 
 
IDAT is subject to the Minimum Dataset Requirement guidelines for NSW, which lists the required 
fields. These required data fields include: basic patient identification, admission and discharge dates, 
demographic details, and some substance use details (substance type, method of use, case 
management issues).    
 
We were advised that “The IDAT database allows for collection of one of the standard datasets for 
Drug and Alcohol (NSW D&A Minimum Data Set – although only Herbert St utilised this from the 
IDAT database. Bloomfield obtained their MDS from CHIME)”.  
A number of issues were identified in relation to data pertaining to the IDAT program. These were: 
• Data collection and the use of paper-based forms; 
• Missing data and outcome data;  
• Database. 
These various issues largely surround two key aspects: responsibility and resources. The 
responsibility for data collection and entry is not clear, and relatedly, the resources are reportedly 
insufficient.  
 
Data collection via paper-based forms 
At present, the assessment for entry into IDAT is all paper-based. There are two forms to be 
completed by the ITLOs (Forms 1 and 3) and one by a Medical Practitioner (Form 2). This is in 
contrast to the shift to electronic records throughout Health. The ITLOs found the paper-based 
system “laborious”. It was not clear to them why existing online/electronic hospital forms could not 
be used (with the use of some kind of download of the relevant fields for IDAT). The complexity of 
the electronic records in NSW is noted, for example not all hospitals have EMR and it is beyond the 
scope of this evaluation to assess each of the electronic record systems that are available and assess 
suitability for IDAT. But this is an important task if ongoing data about the IDAT program 
performance is required. 
 
As we understand it, two of NSW Health’s source data systems or applications are Community 
Health Information Management Enterprise (CHIME) and CERNER. During the study period from 31 
May 2012 to 24 June 2016 (the period that the data from the IDAT database was available for), 
Bloomfield used CHIME to collect all National Minimum Data Set (NMDS) items, and Herbert St Clinic 
used MATISSE, an interim collection system, developed by the Ministry of Health, to collect all NMDS  
items. In the second half of 2016 both Bloomfield and Herbert St migrated to the CERNER CHOC 
state wide build. In 2017, NMDS items can be extracted from CERNER-CHOC and CHIME-CHOC. 
 
Community Health and Outpatient Care (CHOC) is a program which helps build data and 
documentation into the two source systems, i.e. CERNER and CHIME. CHOC facilitates community 
collected data into CHIME EMR, and into CERNER EMR. CHOC has been implemented across eight 
community health clinical services. E.g. Drug and Alcohol, Mental Health, Aboriginal Health. 
 
IDAT inpatient data at Bloomfield is collected in iPM-PAS, and in CERNER – PAS at Herbert St Clinic.  
This inpatient data is included in the Admitted Patient Data Collection (APDC). 
 
 






Missing data and outcome data 
Missing data are extensive for the admissions and treatment period as well as for the 1, 3 and 6 
month outcome data. Addressing the referred and admitted patient episodes first, there are three 
‘groups’ of patients (based on episode data): those assessed as ineligible (n=202); those assessed as 
eligible but not admitted (n=96) and those patients admitted to the program (n=342) (See Figure 1). 
 
There are missing data across these three groups. The ineligible group (n=202) has the highest 
amount of missing data, with 50 of the 202 (25%) missing the reasons why the person was 
determined to be ineligible. For the patients deemed eligible (both admitted and non-admitted 
patient episodes), the full assessment should technically be available, including demographic, drug 
use and health data from the initial assessment (Forms 1, 2 and 3).   
 
For admitted patients (based on first admission only), there was no missing data for length of stay 
(calculated as it is from date of admission to date of discharge, n=254). Discharge status was also 
available for almost all patients (there were 8 missing data points for exit status).  
 
The follow-up data (at 1, 3 and 6 months) was designed to include the following: 
• Principal drug of concern (DUC) 
• Severity of Dependence Scale (SDS) 
• ATOP 
• SF12 
• Mini Mental State Exam (MMSE) 
• Addenbrooke’s Cognitive Examination- Revised (ACE-R) 
• Montreal Cognitive Assessment (MOCA) 
• AOD treatment engagement (last 4 weeks) 
• Engagement with other health providers (last 4 weeks) 
• Contact with police (last 4 weeks) 
• Guardianship order (last 4 weeks) 
 
This would have provided a comprehensive suite of outcome data points at 1, 3 and 6 months post 
the IDAT inpatient admission. The intention, as we understand it, was that these were paper-based 
forms, which were to be completed by the aftercare provider and/or ITLO if the ITLO was providing 
ongoing care. A package was to be sent to the aftercare provider for completion, the package then 
completed with the patient and returned to the IDAT unit, where the IDAT unit team then entered 
the data into a database and forwarded it to the IDAT data custodian. 
 
In the Model of Care (page 60), it is stated that “Existing health data systems should be used to 
capture and provide required data and information. This is specified in a core set of data items, 
which provides the base level of information required for reporting, planning, performance 
monitoring, evaluation and accountability. Specific data sets and reporting arrangements will need 
to be negotiated with community-based services delivering community-based interventions to 
discharged patients.” The outcome data collection (at 1, 3 and 6 months) is currently done by the 
Outreach Team of each of the treatment units by contacting patients over the phone (for BF) and 
over the phone and face-to-face for HSC.   
 
Substantially, these mechanisms have failed, as indicated by the proportion of patients who were 
contacted at 1, 3 and 6 months post inpatient admission (Table 19). 
 






Table 19: Extent of follow-up outcome data (1, 3 and 6 months post discharge) 
 Total % HSC % BF %  
1-month post discharge 28.7% 41.5% 20.9% 
3-month post discharge 21.0% 40.9% 8.3% 
6-month post discharge 18.1% 36.8% 6.0% 
Note: % calculated from the total admitted patients who had reached the 1, 3 and 6 months post-discharge time-points at 
time of process evaluation. 
 
As can be seen, only 29% of all admitted patients have data for the 1 month follow-up. This drops to 
21% at 3 months, and 18% at 6 months. For HSC, 40% of the admitted patients were contacted at 1 
and 3 months (with lower number at 6 months). For BF, the percentage of patients who were 
successfully contacted at 1, 3 and 6 months was very small (by 6 months, only 6% had been 
contacted). There is little point analysing these data for any outcome indications, because the 
sample is not representative (indeed, it is highly likely to over-represent the success of the program). 
 
In addition to the lack of contact with the majority of patients at 1, 3 and 6 months, even for those 
patients who were contacted, the full suite of outcome measures noted above were not available. 
For example, the ATOP had the highest completion rate amongst those (the minority) contacted at 
1, 3 and 6 months, but other outcome tools such as the ACE-R and police or guardianship orders 
were largely missing.  
 
The reported reasons for the failure to collect and enter follow-up data include: 
- The package of forms not being sent to the aftercare provider; 
- The aftercare provider failing to complete the forms; 
- The aftercare provider failing to return the forms; and 
- The data not entered once the forms returned. 
The likely higher completion rate for HSC (although still below 50% of patients) is likely explained 
because the IDAT team are also the aftercare providers for those patients in the Northern Sydney 
LHD, whereas for BF, they are not aftercare providers for many patients in Western NSW LHD. 
 
In addition, stakeholders advised that resources were limited and a priority was given to existing 
patient care, rather than data entry for past patients. That the system is reliant on paper-based 
completion of forms and time-consuming data entry, with many points of possible failure, as noted 
above, it is perhaps unsurprising that this aspect of the IDAT program has failed. 
 
There is a further consideration here in relation to the overall aims of the IDAT: given that the Act 
(see later section) and some stakeholders see the primary purpose to be assessment, stabilisation 
and protection, rather than AOD treatment per se, the outcome measurement should match the 
program goals. Is there an expectation that there will be differences six month post-IDAT on 
substance use measures (as implied by the collection of ATOP for example)? The IDAT may be being 
held to account for outcomes which they are not resourced for, nor ones which are regarded as the 
primary purpose of the program.  
 
Database 
The relational (MS Access) database is very difficult to interrogate, and is not amenable to analysis. 
Substantial recoding and data cleaning were required in order to establish a database for the 
process evaluation work which represented both episodes and unique patients. Linked to all the 
above, a key question is what are reasonable requirements for data from such a program? What is 
the minimum dataset that would be required to monitor the program? 






5.11 Staffing levels 
The Ministry of Health supplied the evaluators with the allocated staffing profile for each of the two 
IDAT units. This allocated staffing profile has not changed since the inception of the program, and is 
given as part of Table 20 (left column). 
 
The process by which these staffing profiles were determined is not known to the evaluation team. 
As can be seen above, there are differences between the two programs in terms of the profile and 
numbers of FTE (noting that BF has 8 beds, and HSC 4 beds). 
 
The current staffing profile was somewhat difficult to determine for each of the units. This is partly 
because of the complex local LHD processes that occur to determine a daily staffing profile. As we 
understand it, there are three separate decision-makers involved in the local LHD staffing profile for 
IDAT: for the allied health staff, the profile (and availability) is determined by the hospital Allied 
Health Director; for the medical staff it is determined by the hospital Clinical Director, and for the 
nursing staff it is determined by the hospital Director Nursing.  
“If we separate our funding entirely so we are the actual employer of the nurses rather than 
being part of the hospital overall …. That would be the only way we get around that one 
(shortage of nurses and well-trained nurses being pulled away).” (IDAT team member) 
 
The extent to which the hospital prioritises the staffing rosters for IDAT over and above all the other 
hospital wards is not known.  
 
An additional factor was a regular pool of staff for IDAT:  
“If we had the staff we are supposed to have and had some system of back-up for when 
people are on leave or sick and are able to maintain and nurture a cadre of nurses who want 
to be nurses and who want to be here and enjoy being mixed medical and psychiatric nurses, 
then our staffing level would work.” (IDAT team member) 
 
Based on a number of assumptions and calculations, the current staffing profile for the two units is 
provided as part of Table 20 (right column). The nursing staff profile in the below table was derived 
from the following calculations: 
Nurse hours for BF:  
Weekday: 2 nurses on shift of 8 hours + NUM   
Weekend: 6 patients or more 3 nurses, less than 6 patients 2 nurses on duty   
With the assumption that there are always 6 patients or more, the nursing hours per week will be as 
below:   
= (2 nurses * 3 shifts * 8 hours * 5 days) + (3 nurses * 3 shift * 8 hours * 2 days)   
= 384 hours   
= 9.6 FTEs (each FTE is 40 hours working a week). 
 
Nurse hours for HSC:  
From 0700 hrs - 1330hrs: 4 nurses on the floor all the time for both patients groups    
From 1300hrs - 2200hrs: 3-4 nurses on the floor all the time for both patients groups    
From 2130 hrs - 0730hrs: 2 nurses on the floor all the time for both patients groups    
With the assumption that because IDAT patients are much more medically unwell, 2 nurses are 
always on floor for IDAT patients on weekdays, and 1.3 nurses are on the floor for IDAT patients on 
weekend, the nursing hours per week will be as below:   
= (2 nurses * 3 shifts * 8 hours * 5 days) + (1.3 nurses * 3 shifts * 8 hours * 2 days)   
= 302.4 hours   
= 7.56 FTEs (each FTE is 40 hours working a week). 






Analysis of the staffing levels needs to take into account the number of beds and the patient profile 
of each treatment unit: analysis of the IDAT database suggests that a higher proportion of patients 
admitted to BF are homeless, have serious physical health conditions, and have mental health issues 
compared to patients admitted to HSC (see Table 14). In addition, connecting IDAT patients to 
community-based services for BF patients is believed to be more challenging given rural and regional 
areas are not as well-resourced as metropolitan areas. Finally, at HSC the unit is both for IDAT 
patients and voluntary detoxification patients, and as such staffing levels are not necessarily clearly 
split between the two patient groups on the same unit (efficiencies of scale). In addition, the HSC 
team need to provide aftercare outreach (visiting patients in their homes) for patients returning to 
NSLHD area. This involves time and workload not only for the two members of the outreach team 
but also for the Director and the CNC in terms of clinical follow-ups. 
 
Table 20 summarises the Ministry of Health allocations and the current profile across both units. The 
current staffing level for BF is 16.3, lower than the allocated FTEs by 1.6. The current staffing level 
for HSC is 16.2, higher than the allocated FTEs by 2.6.  
 
Table 20: Ministry of Health IDAT staffing profile compared to current operational staffing profile 
Bloomfield 
FTE allocated 
by the MOH Current FTE  
Aboriginal Worker (Q1) 0.5 Senior D&A Outreach Worker  1.0 
Diversional Therapist (X4) 0.5 Occupational Therapist  0.5 
Psychologist (Y1) 0.5 Psychologist  0.5 
Social Worker  (S1) 0.5 Social Worker  1.0 
Nurse Unit Manager (NUM) 1.0 Nurse Unit Manager  1.0 
Enrolled Nurse 3.8 Enrolled Nurse 
9.6 Registered Nurse (NR) 7.0 Registered Nurse 
Clinical Nurse Consultant (CNC) 0.5 n/a  
Ward Clerk / Admin (WA) 0.5 Admin Assistant  0.5 
Career Medical Officer (MC) 0.5 Medical Officer  1.0 
Staff Specialist (MH) 0.5 Addictions Specialist/Director  0.5 
Information Worker (WG) 0.1 Pharmacist  0.5 
Social Worker  (S1) 2.0 Dietitian  0.2 
Total FTE 17.9  16.3 
Herbert St Clinic  
FTE allocated 
by the MOH Current FTE  
Nurse Unit Manager (NUM) 1.0 Nurse Unit Manager (NUM) 0.5 
Staff Specialist (MH) 0.5 Consultant Psychiatrist 0.2 
Registrar (R1) 0.6 Resident Medical Officer  0.3 
Social Worker  (S1) 0.5 Intern 0.3 
Occupational Therapist (X5) 0.5 Psychiatry Registrar 0.4 
Clinical Psychologist (Y1) 0.5 Clinical Nurse Consultant  1.0 
Administrative Officer (WA) 0.5 Administrative Officer 0.5 
Registered Nurse (NR) 5.0 Registered Nurse  7.6 
Registered Nurse (NR) 2.5 Outreach staff/nurses  2.0 
Social Worker  (S1) 0.5 Social Worker  1.0 
Occupational Therapist (X5) 0.5 Occupational Therapist  1.0 
Clinical Psychologist (Y1) 0.5 Clinical Psychologist  1.0 
Staff Specialist (MH) 0.5 Consultant Psychiatrist/IDAT Director  0.4 
Total FTE 13.6  16.2 
Note: the exact role description and sequence of role description as listed in the document provided by the 
Ministry of Health were used for this table (for example, there are two rows for Registered Nurse for HSC).  
 






The evaluation team noted that there are many demands on staff time over and above the provision 
of central IDAT program functions. These includes: 
• Responding to enquiries from other health professionals, families and others15; 
• Much time spent on administrative work given the complexity of patients, absconding 
patients, requests for extensions, activities (i.e. taking individuals walking in ground or to 
town) for those cognitively unable to participate in treatment program/group activities. Staff 
often need to take patients to town to purchase clothing, especially the homeless who arrive 
in one set of clothes only; 
• Guardianship applications (for patients with mental health issues). 
 
It is not clear whether there is an appropriate benchmark to use for the IDAT staffing profile. 
Possibly the staffing profile of an acute, secure mental health unit may be used as a proxy to 
benchmark, but the IDAT program also involves the provision of more usual AOD treatment - 
whereas acute secure mental health facilities are much more focussed on stabilisation and 
assessment. (This again points to one of the tensions for IDAT between assessment, stabilisation and 
protection versus AOD treatment functions). The observations above also make clear that the IDAT 
staffing profile could not be based on a AOD treatment service per se, for example, an AOD 
treatment service is highly unlikely to be commencing guardianship orders, or managing the level of 
physical health and mental health complexity. 
 
Management at the HSC IDAT program stated that the current staffing levels were good for the 
inpatient care component. For aftercare and data collection/entry, they indicated a need for more 
staff.   
 
For Bloomfield, there was consensus in the team that the current staffing levels for allied health and 
administrative support is not sufficient, resulting in the cancellation of group activities at times and 
lack of one-on-one counselling. The lower bed occupancy rate at BF would also suggest a problem 
with staffing levels. 
 
A further concern at BF was the movement of nursing staff. The evaluators were told that nursing 
staff who are IDAT-trained are often “pulled away to do other things” and replaced by nurses that 
are not IDAT trained.  
 
In the stakeholder interviews with BF team members, the evaluators were provided with 
recommendations for changes to the BF staffing profile for IDAT. This included: 
• Psychologist position: changing from part-time to full-time; 
• Occupational Therapist position: changing from part-time to full-time; 
• Administrative Assistant:  changing from part-time to full-time (given the amount of admin 
work + data entry is higher with higher number of patients); 
• Allied Health Assistant: a new position to assist the workload of the allied health staff. 
 
One stakeholder also explained the reasons for the discrepancy between actual staffing level and the 
MOH allocated staffing level:  
“Because unfortunately we are part of a major hospital that has a nursing problem and they see 
our nurses just as a part of a larger pool of nurses and we have a major difficulty in Orange in 
actually getting enough nurses all round. And part of it is that they rely very heavily on agencies’ 
nurses and agencies’ nurses usually had heard that IDAT is a very interesting place to work and 
 
15 It was noted that ADIS was envisaged to be the point of contact for such queries but a stakeholder noted 
that ADIS was unable to respond to a specific query. A centralised single point of contact was recommended 
by ITLO stakeholders. 






say that “I want to work in IDAT”. So our staff therefore are pulled to work somewhere else 
where most people don’t want to go to. That is what happens. It is a hospital issue, where the 
hospital is always way below nursing level.” (IDAT provider) 
 
“We have challenges due to staff shortage with nursing staff and the OT role and psychologist. 
We’ve also been missing an Allied Health Assistant for a long time. This means that our patients, 
due to nurses being short of staff don’t get to access other things on campus that other mental 
health patient do, such as ceramics, women’s group, men’s group, escorted walking, cycling….” 
(Allied Health team member)  
 






6 Qualitative analysis of program  
The qualitative analysis was undertaken in light of the quantitative data from the database analysis 
(see previous chapter), documents of relevance to the program and its operation, and the 
stakeholder interviews.  
6.1 Analysis of the Act governing the IDAT program 
In the first instance, it is noted that the NSW Drug and Alcohol Treatment Act 2007 is currently 
regarded as model legislation[57], providing the best balance between deprivation and liberty and 
the level of care that the targeted patient population require. Other jurisdictions, such as Western 
Australia, are actively aiming to achieve a similar program modelled on the NSW legislation.  
 
As noted above, there are four eligibility criteria in order to determine a person’s suitability for 
involuntary detention under the Act. All four must be met with each person. Stakeholders noted that 
the eligibility criteria were subject to individual interpretation – which was regarded as both a 
strength (capacity for individual tailoring) and a potential weakness (insufficient clarity). Here we 
examine each of the four in turn.  
 
a). Severe substance dependence: A person has a ‘severe substance dependence’ in accordance 
with the Act if the person: 
• has a tolerance to a substance; and 
• shows withdrawal symptoms when the person stops using, or reduces the level of use of, 
the substance; and 
• has lost the capacity to make decisions about his or her substance use and personal welfare 
due primarily to his or her dependence on the substance. 
 
The requirement that the person ‘has lost the capacity to make decisions about his or her substance 
use and personal welfare due primarily to his or her dependence on the substance’ is of practical 
importance for the comprehensive assessment by the ITLOs and the referring team and 
determination if a patient is eligible for IDAT (by the AMP and subsequently the magistrates). It is 
notable that the NSW and Victorian legislation makes reference to decision making and capacity, a 
construct that is absent from other such civil commitment legislation. This approach is similar to 
capacity/mental health legislation that is currently in place in the United Kingdom.[58] (page 16). 
 
Neither the DSM-IV nor the ICD-10’s diagnostic guidelines for dependence syndrome are referred to. 
The equivalent legislation in other Australian jurisdictions (Victoria, Tasmania) or other countries 
(New Zealand, Sweden) are also not currently using the DSM-IV or the ICD-10’s diagnostic guidelines 
as the criteria for severe substance dependence [57]. This might be due to the nature of the IDAT 
program and the context of involuntary treatment in that: 1) 50% of the time the ITLOs do not see 
the patient for an assessment; and 2) with the possible lack of insight and impaired cognitive 
capability, patients who might be eligible for IDAT would not necessarily be providing responses to 
the DSM-IV or the ICD-10 diagnostic questions in a way that they could be categorised as severely 
dependent on alcohol/drugs. In other word, the DSM-IV or the ICD-10’s diagnostic might be more 
appropriate for patients who seek help (i.e. in voluntary treatment context). The third criterion (lost 
capacity to make decisions) is similar to the Victoria Severe Substance Dependence Treatment Act’s 
requirement that the person be ‘incapable of making decisions about his or her substance use and 
personal health, welfare and safety due primarily to the person's dependence on the substance’.  
 






b). Potential for harm to self or others: The potential for harm to self or others is part of the current 
criteria for a Dependency Certificate. This criterion makes clear that a central purpose of the Act and 
involuntary detention is for the purposes of protecting a person from serious harm to themselves or 
to others. This assessment is conducted at different time-points as a way of undertaking checks and 
balances: prior to program entry by the referring team/ITLO; part of the assessment for issuing a 
Dependency Certificate by the AMP; and is reviewed by a Magistrate within 7 days of the 
Dependency Certificate. 
 
c). Benefit from treatment: The Act specifically includes a benefit criterion, which implies that 
deprivation of liberty and decision-making autonomy would not be justified without a real likelihood 
of benefit to the patient. Despite a comprehensive definition of the intended patient group and the 
principles that apply to decisions to detain and treat patients, there is potential confusion about the 
notion of ‘treatment benefit’.  Some stakeholders suggested that this third criterion is too vague 
with regard to how to define “likely to benefit from treatment”. For instance, questions were raised 
whether some people have been too unwell to be likely to benefit. In the meantime, a number of 
other stakeholders thought it good that the criteria are not too proscriptive to allow for some level 
of flexibility in determining the suitability of patients who could be accommodated and treated 
within existing resources.  
 
These considerations, however, reside in a fundamental issue for IDAT, and that is the definition of 
“treatment”. Here there is an important distinction between protection, stabilisation and 
assessment compared to treatment. The objects of the Act appear more concerned with the former: 
protecting an individual, stabilisation of the physical and mental state, comprehensive assessment 
and voluntary treatment engagement post program, versus the implication in the eligibility criteria 
that alcohol and other drug treatment is provided. Stakeholders appear to understand that there is 
tension between the former assessment, stabilisation, protection function and the latter treatment 
function. For example: “the essential role of IDAT is a good multi-disciplinary assessment...rather 
than treatment” (IDAT provider); and the reality that “not much treatment is possible”. (ITLO) 
 
Views are divided on this: for example the Official Visitors in BF noted that patients need more 
treatment interventions, counselling and support: 
“The medical side of it is very good. It is the allied health side of it that needs a lot of work. 
That is why we keep hearing about boredom. …..  There are not allied health staff to run 
these groups consistently because the nursing staff need to attend to the acute duties they 
are doing… And so patients will want more work on relapse prevention and very worthwhile 
topic. They are seeking knowledge, education, and what they can do to prevent relapse… 
There is an opportunity lost for a lot of this stuff.” (Official Visitors)  
 
In addition the Model of Care (the procedural document prepared by the Ministry to accompany the 
Act and which specifies in detail the care elements) makes clear that AOD treatment is a primary 
function of the program. And this is confirmed in some of the stakeholder interviews, who hold the 
same view, as expressed below:  
“We struggle to take people who don’t have an aftercare plan. In fact, we wouldn’t accept 
someone without an aftercare plan because there is no point of admitting them as they can’t 
be followed up as the 6-month requirement for aftercare. And that’s part of the Model of 
Care from the Health Department.” (IDAT provider)  
 
While this may seem a somewhat trivial matter, it actually goes to the heart of a number of themes 
arising from the process evaluation. There is significant pressure on beds (see waiting times section), 
and the provision of treatment (as opposed to protection, stabilisation and assessment) potentially 
increases the length of stay. In addition, the very existence of a delay to admission suggests that the 






immediate protection function may be compromised (someone assessed as in need of protection 
may no longer be in such a situation at the point in time that a bed becomes available). There is also 
some natural inclination for AOD clinicians within IDAT to want to (and be skilled at) providing AOD 
treatment interventions.  
 
There is no ready way to reconcile the tension and ambiguity in the Act about protecting safety, 
stabilisation and assessment versus the provision of AOD treatment. In this context then, the 
assessment of “likely benefit” takes on different meanings. In the context where AOD treatment is 
the key object of the program, then likely to benefit from AOD treatment will be assessed as the 
capacity and willingness to make behavioural changes, and to ensure that the environment to which 
the patient is returning has capacity to support abstinence (or at least reduced use). It is in this 
context that homelessness and cognitive impairment may be regarded by some as an exclusion 
criterion, because someone without cognitive capacity or in precarious accommodation 
circumstances is not likely to benefit from AOD treatment.  
We are now trying to exclude patients with alcoholic dementia and severe cognitive 
impairment because they can’t benefit from treatment. And what they need is placement in 
the community, not an IDAT order. So we are increasingly looking at cognitive test.” (IDAT 
provider) 
 
“If we send people home to a community without a home, we set them up for failure.”  
 
The issue of homelessness provides a useful case in point. The extent to which homelessness 
is seen as an exclusion criteria (because unlikely to benefit) has shifted over time. For 
example: “[it] was very clear that our Model of Care said that we won’t take homeless 
people.”  (IDAT team member)  
 
Compared to: 
“We don’t turn people down because they are homeless. I think it is actually a ‘cop-out’ 
because they are often homeless because their addiction is out of control.” (IDAT team 
member)  
 
The above discussion highlights the differences of opinion on this issue, and the different underlying 
assumptions about the definition of ‘likely to benefit from treatment’, which speak to the 
contradictions in the IDAT paradigm. It is perhaps unsurprising that there is a diversity of opinion 
about this third criterion given the ambiguity inherent in the extent to which “likely to benefit from 
treatment” is understood in the context of AOD treatment and behavioural changes to reduce 
consumption and harm, versus benefiting from being removed from an immediate high risk 
environment where the person is at risk to themselves or to others.  
 
d). No other appropriate options: The fourth eligibility criterion specified in the Act is ‘no other 
appropriate and less restrictive means for dealing with the person are reasonably available.’  
 
None of the stakeholders interviewed raised any concern about this eligibility criterion. Review of 
patient files shows that evidence gathered for this eligible criterion centres around a combination of 
several of the following: 
• Previous failed attempts at use of medications; 
• Multiple prior detoxes in hospitals/forensic hospitals followed by relapse in drinking alcohol; 
• Multiple previous voluntary rehab treatment with poor attendance and outcome; 
• All other appropriate and less restrictive means for dealing with the person have been 
exhausted and the person continues to make an ill-informed decision to use 






alcohol/substances despite the negative consequences (i.e. drug driving charges, ED 
admissions) and continues to refuse any less restrictive care reasonably available to them;  
• Refusal of all other less restrictive interventions but at significant risk of harm to self and 
others when drinking and using meth and required a period of time to allow him to re-focus 
and recover; and/or 
• All other restrictive treatment options have been exhausted. 
 
Some stakeholders stated that the mention of IDAT was useful in the context of patients who had 
failed voluntary treatment or were otherwise non-compliant. As reported by stakeholders, this 
strategy sometimes works well in that the patients engage better in voluntary treatment. However, 
if they continue to disengage and/or resist voluntary and less restrictive treatment options despite 
serious health consequence to self and other, an IDAT referral will be made as a last resort option. 
“In my experience, approximately three quarters of patients will elect for voluntary 
treatment when they are informed that IDAT is being considered for them.  … My preference 
is to mention the possibility of IDAT to patients as soon as possible, as the possible loss of 
freedom is often a motivator to engage in voluntary treatment.  …Some patients are able to 
see that they are struggling to manage their substance use with voluntary treatment, and 
agree that there would be some value in IDAT.  These patients usually ambivalently agree to 
an admission when a bed is available.” (ITLO) 
 
In-depth interviews with patients confirmed that this criterion is very well understood by the 
patients: 
“I’d had numerous relapses on alcohol and I kept ending up in hospital ER, ICU, mental 
health. And hospitals and doctors just got sick of me and referred me to IDAT. The doctor at 
the hospital just told me that I was going to IDAT and at the time I thought that it was a good 
thing. I’ve been to IDAT before and this was my second time. I thought to myself ‘thanks God, 
my relapsing is over.” (Patient) 
 
Specification of “28 days”  
There are divided opinions among the stakeholders on whether 28 days is long enough for IDAT 
patients with a higher proportion believing 28 days is not long enough.  
 
Those stakeholders who regarded 28 days as insufficiently long argued that most of the IDAT 
patients are complex patients and sometimes “the moment the patient steps in the door of the unit, 
the staff already have to spend time on an application for extension of the DC (ITLO)”, putting a lot of 
pressure on staff to spend time on paperwork, hence less time to do clinical work. They think that 
the more appropriate time should be 56 days to prevent time to be wasted on paperwork, and for 
those patients who do not need to stay longer they can be discharged earlier than 56 days. The 56 
days is more meaningful to allow for pre and post assessment of cognitive and neurological 
functioning to assist in determination of the next logical and feasible treatment pathways/strategies 
for patients “…understanding that we cannot even do an adequate neuro-psych assessment or 
cognitive assessment until they are 6 weeks post substance use. And so where are we going to keep 
them in an acute facility for 6 weeks?” (ITLO).  In addition, the unexpected consequence of the 28 
days is that it is only long enough for various assessments to be done, leaving not much time for 
meaningful “treatment” such as CBT, motivational interviewing, and therapeutic group activities16. 
This is the case for the treatment unit in BF (partly due to lack of allied health staff hours, discussed 
in the staffing level section). 
 
 
16 Note: this again links to differing views about the extent to which IDA is AOD treatment or assessment and 
stabilisation only. 






On the other hand, the stakeholders who thought that 28 days was an appropriate length of 
detention under the Act argued that this length of time is sufficient to ensure that resources are 
used responsibly, “to prevent the treatment facility from being a dumping ground for patients that 
are a huge burden on the system. It actually then becomes a treatment facility rather than a holding 
facility”. Two other stakeholders believe that 28 days is actually right because “a lot of patients are 
really engaging during that time. They don’t necessarily need longer. For those who are cognitively 
impaired they definitely need longer time and they can get an extension”.  
 
As noted elsewhere (Section 5.4), the average length of stay in the IDAT program to date is a median 
of 27 days, and a statistical mean of 35 days. This would suggest that most of the patients stayed for 
28 days.  However, one indication that the LOS may be too short is the proportion of patients for 
which an extension of the DC is applied for. The data (see Table 8) revealed that 28.1% of IDAT 
patients received an extension to the original Dependency Certificate.  
 
Other issues 
The Act requires that one of the two Official Visitors has to be a medical doctor, which according to 
stakeholders is challenging because it is very hard to find a medical doctor for this responsibility 
unless they are retired. A stakeholder felt that there is no need for an Official Visitor to be a medical 
doctor: the reason this was a requirement in the D&A Treatment Act is because it mirrored the 
Mental Health Act in this respect. The MH Act has been revised and this requirement is no longer 
active. Consideration could be given to doing the same for the D&A Treatment Act. On the day the 
evaluators conducted the interview with the Official Visitors at BF which occurred on the same day 
with the regular visit to the treatment unit, the medical doctor Official Visitor was not able to attend 
due to family circumstances “so neither of us are a medical doctor. So in a sense we are violating the 
act. But if we are not conducting the visit today because our colleague Official Visitor who is a 
medical doctor is not available, we are also violating the Act. We are violating the Act either way”.  
 
The conditions under which an extension to the Dependency Certificate can be granted under the 
Act are limited to those with acquired brain injury and impaired cognitive function (“drug and/or 
alcohol related brain injury”). This poses challenges, for example in the case of a pregnant woman, 
or those with other complex psycho-social presentations requiring more time. We were unable to 
access data (patient clinical records) to assess whether everyone who received an extension met the 
criteria (but we suspect this has not necessarily been the case). On the surface, it appears a potential 
limitation to the legislation, with drug or alcohol related brain injury being only one of a number of 
potential reasons for seeking an extension to the DC. A comprehensive neuropsychological 
assessment in theory is therefore required for anyone being assessed for an extension (especially 
given the specificity of “drug/alcohol related brain injury”, as opposed to any form of cognitive 
impairment). At the same time, defining clearly the basis for an extension provides protections for 
human rights and a clear rationale for involuntary detention.  
  
6.2 Other relevant legislation  
As part of the process evaluation, we explored whether other existing legislation could be applied to 
the IDAT patient group. There was strong consensus that a program like IDAT needs to be under a 
separate Act from Mental Health because drug and alcohol treatment and mental health are 
different disciplines, with a different focus (noting overlap of patients). 
“Look the reality is it is a completely different patient population and different treatment 
requirement and being under Mental Health Act, their focus is on severely mentally ill 
patients, some of whom have D&A issues. Our focus is on severely drug and alcohol 






dependent patients, a lot of whom have MH issues but not severe. … very different patient 
populations, very different treatment needs, very different model of care.” (IDAT provider) 
 
The Drug and Alcohol Treatment Act can act in concert with the Mental Health Act such that a 
person with both acute mental health and alcohol or drug issues can be managed across the two 
legislative frameworks, as explained by one stakeholder: 
“OK so somebody becomes suicidal or becomes mentally ill and they are being held under the 
D&A Treatment Act, they are taken off the D&A Treatment Act and put under the MH Act. 
And you can’t be under both at one time. So we can actually put the DC on hold and then 
when they are cleared and no longer can be held under a MH Act, they can resume being 
held under the D&A Treatment Act.” (ITLO) 
 
Another highly relevant piece of legislation is the Guardianship Act. A number of IDAT patients 
become subject to a guardianship order as part of their IDAT treatment. Guardianship can become a 
challenge because it takes a lot of time to arrange for guardianship. Once in guardianship, the public 
guardian needs to be informed and they need to agree on the aftercare options before the patient 
can be discharged. We were told that there are a number of situations where the inpatient stay 
needs to be continued due to lengthy negotiations between the treatment team and the public 
guardians. 
 
A field in the IDAT database (data table DD-17) provides data on guardianship, indicating if a patient 
has a guardianship order in place or whether one has been applied for. However, it is not possible to 
know whether the guardianship was in place prior to or commenced during IDAT. In addition, the 
data were recorded for 4 BF patient episodes and 104 HSC patient episodes (with 89 recorded as ‘no 
order in place’). Therefore, it is not possible to assess the magnitude of administrative workload 
required for guardianship application by the IDAT team. 
 
Option for community treatment order (CTO) 
 
The evaluation team was informed that most people subject to a Compulsory Treatment Order 
under the NSW Mental Health Act receive a Community Treatment Order. Under these orders, the 
clinician at the community-based service manages or coordinates care for the person. There is 
intensive community-based support if required - for example there may be daily home visits for 
administration of medication or other matters. For other persons there may be less frequent visits, if 
their condition is stabilising or responding to treatment.  
 
Most of the stakeholders consulted referred to this as a potential option for consideration under the 
Drug and Alcohol Treatment Act, allowing a person to be compulsorily treated in the community 
without the need for detention as an inpatient. They thought this option should be available as an 
alternative and/or an adjunction to detention at the treatment centre.  
“It would make life a lot easier if we had CTO to follow-up afterwards. Also, it makes a lot of 
sense to have outreach for those people who perhaps don’t need to be held under the Act but 
need to go through the same process to get treatment in a less restrictive environment.” 
(ITLO) 
 
“I think a CTO would greatly enhance the scope of involuntary treatment, as it would allow for a 
greater mix of inpatient and outpatient management” (ITLO). Also, it could potentially allow for a 
shorter period of admission for some patients. Once the patient is stabilised through withdrawal, 
medical and psychiatric treatment could be continued in the community. And this then potentially 
could free more beds because in-patient length of stay will be shortened. At the same time many of 
the stakeholders raised concerns over the current lack of infrastructure for a CTO scheme for IDAT in 






NSW. Firstly, in the Mental Health Act, if a patient breaches a CTO, they could be subject to 
readmission to a mental health facility. This is not currently possible within IDAT because of the lack 
of beds across the state. Secondly, mental health services are well-resourced with community teams 
who are responsible to reinforce the CTO while this workforce is lacking for drug and alcohol 
services. A number of stakeholders stated that there is no “case management” for D&A services in 
NSW: “So I think for us, we do it well here because [staff name] and I decided from the beginning 
before we started this program that we needed to have an aftercare component because we knew 
that there would be a significant number of patients from our area being referred in and we knew 
that it would be very difficult to coordinate care in D&A services because there isn’t case 
management” (IDAT provider). Thirdly, even when the first and second factors are resolved, a CTO 
scheme means that it is mandatory for the community AOD worker or team to enforce patients to 
engage in community-based treatment services which are currently not even readily accessible for 
voluntary patients (i.e. long waiting list for residential rehab). This then raises the concern of who is 
more worthy of the limited community-based treatment slots: the voluntary patients or the 
involuntary patients?  
“Well, this is something again you’ll find people on both sides. My personal view is that they 
(CTOs) are useful. Unfortunately, they are useful not for the reasons that people may think. I 
think they are useful because if a person is in psychiatry or in mental health and they are on 
community treatment orders, it means the resources have to be allocated for their care. So in 
an ideal system, those resources would be available anyway, and you wouldn’t need a 
community treatment order. But here, they become the most prioritised patients so they get 
the resources that are needed.” (Drug and Alcohol Clinical Director) 
 
6.3 Human rights and coercion issues 
There are various human rights protections built into the NSW Drug and Alcohol Treatment Act 2007 
with a strong aim to address all human rights aspects that were the subject of criticism of the 
previous legislation (the Inebriates Act 1912). The Act 2007 emphasises that the rights of the patient 
are paramount and that this is a last resort treatment option. The Act also sets out stringent 
eligibility criteria.  Specifically, in setting the eligibility criteria, the Act requires that involuntary 
treatment is only considered as the last resort treatment option after all other less restrictive 
treatment avenues have been exhausted and that involuntary treatment is likely to bring about a 
reasonable prospect of sustainable client benefit, sufficient to justify the infringement on human 
rights associated with detention and involuntary treatment. The Act sets out the process of 
screening, assessment, involuntary detention and treatment, the role of Accredited Medical 
Practitioners (AMPs), assessment criteria and the rights of appeal to ensure that the rights of the 
identified patients are protected throughout the process. The Act also contains provisions to ensure 
that a person and their primary carer are provided with clear information about their legal rights and 
their rights of appeal17. All Dependency Certificates must be reviewed by a Magistrate as soon as 
possible (within 7 days) after issuing. The patients are always represented by a legal representative 
during the review of the Dependency Certificate conducted by the Magistrate. Under the legislation, 
two independent Official Visitors must visit each gazetted inpatient unit at least once per calendar 
month to inspect the centre, to ensure that patients’ rights are protected and they have appropriate 
standard of treatment and care, to act as an advocate on behalf of patients if required, and to report 
identified matters to the Minister for Health for further investigation. Patients and their primary 




17 Although this might not be a realistic option because it is not covered by Legal Aide. 






Overall, all stakeholders interviewed (particularly the Magistrates and the Official Visitors) confirmed 
that the safeguards that are set out in the Act are properly exercised in practice. The stakeholders 
interviewed also stated that interpretation of the legislation through the model of care and 
implementation is more consistent with contemporary values regarding human rights and dignities 
of severely substance dependent people (compared to the old Inebriates Act). 
 
While acknowledging the high standard of treatment and care for patients at IDAT, the Official 
Visitors noted some concerns (through review of the Official Visitor’s Book of the two treatment 
units and interviews with the Official Visitors). For example it was noted by the Official Visitors that 
some patient files do not have a record to indicate that a primary carer has been nominated. In one 
case a patient was discharged and then readmitted right after discharge (ie not what is intended in 
the Act). But the Official Visitor did not feel that it was done to the detriment of the patient. 
 
While the Official Visitors reported to the evaluators that patient rights are protected and the 
medical standard and care is always delivered, they are concerned for the dignity of the patients for 
the following reasons: 
• Due to lack of Allied Health staff, there is concern that patients’ experience (insufficient 
program activity). The Allied Health Assistant position was trialled for a period and the trial 
was successful. The Allied Health Assistant was able to assist in taking the patients out for a 
walk on a daily basis, taking the patients out on escorted leave to Orange town for shopping, 
running group activities, or taking the patients to AA meetings. However, the position was 
discontinued with no reason given. This has resulted in cancellation of group activities (with 
no explanation given to the patients). This issue has been brought up by the Official Visitors 
to the hospital management but it had not been resolved by the time the evaluators 
interviewed the Official Visitors “It was like broken records. We were told that the position 
has been approved and it has been with Finance but we were told that three months ago”. 
• Unlike patients in HSC, who have access to a kitchen to practice their cooking and access to 
food of choice, patients at BF have to “take what they are given” (quote by OV). They do not 
have a menu choice and like other patients in BF hospital they are given “snap frozen food 
from Sydney” and “apples from China”. The flip side is that patients at BF have access to a 
dietitian who sits down and works with them on diet that is best suited to their medical 
condition and their health.  
• Patients at BF are allowed only one cup of tea or coffee during meal time. They are not 
allowed to make tea or coffee themselves because it involves hot water (rules of mental 
health institutions). We were told that this was not for want of trying and that the IDAT 
team attempted to introduce an urn to allow patients to make tea and coffee but this was 
defeated by the nurses’ union via the risk management system. “Food is not necessarily a 
rights issue but it is more related to patients’ perception of dignity”. In addition, all the 
bedrooms and bathrooms are locked during meal time or tea time and patients are not 
allowed to be dismissed until all cutlery is counted (rules of mental health institutions). The 
Official Visitors for HSC stated that complaints about food are very common when they do 
monitoring of mental health facilities but IDAT patients at HSC do not complain about food. 
 
Role of the Magistrates 
 
The hearing process that the Magistrates exercise was different across two treatment units: in HSC, 
the Magistrate always conducted the hearing in person at HSC while the Magistrate in BF did it via 
video link. The Magistrate in HSC believed that conducting the hearing face-to-face would make a 
big difference because “in the hearing process that I am involved in, it is a very difficult and 
traumatic time for the persons involved.” The Magistrate in HSC also believed that the hearing was 
done as “an empowering process” in that “They wanted to be heard. They wanted to have their 






concern voiced in that forum”. And as a result of this empowering process, most of the patients who 
opposed the Dependence Certificate at the beginning of the hearing process eventually agreed that 
treatment at IDAT was done for their benefit and consented to engage in treatment. This suggested 
that the role of the Magistrate was critically important not only on the legal process but also 
important in motivating the engagement of the patient at the beginning of the treatment program.  
The Magistrates who worked with both treatment units confirmed that they had confirmed all the 
DCs or extensions of DC under their review. However, the IDAT database indicated that on 15 
occasions, a Magistrate did not confirm 14 DCs at BF and one DC at HSC. Interviews with IDAT team 
members at one of the IDAT units confirmed that on occasions the DCs were not confirmed by the 
magistrates, primarily on the basis that the patients maintained their opposition to being admitted 
to IDAT. When a DC was not confirmed, the patient was discharged immediately. The evaluation 
team were advised that this had resulted in poor outcomes. By way of example: a patient returned 
to excessive drinking straight away and was transported to the ED the next day due to 
gastrointestinal bleeding. This patient was subsequently readmitted to IDAT and on this second time 
the DC was confirmed by the magistrate. This example provides a specific illustration of the 
challenge of walking the thin line between respecting the patient’s autonomy and applying 
measures to protect them from harms. 
 
In in-depth interviews, all patients were asked about their perceptions of whether their civil and 
human rights were protected throughout the process of referral to IDAT and while in IDAT. All but 
one patient interviewed felt that their rights were respected. All interviewed patients were aware of 
their rights with regard to access to the Official Visitors. All the interviewed patients confirmed that 
the Magistrate review occurred within 7 days from admission. All patients expressed the view that 
coercion into IDAT was justified and worked in their best interests. With regard to experience with 
the Magistrate hearing process, all interviewed patients expressed positive opinions of the 
procedure: 
“My understanding was that the Magistrate hearing was an informal procedure. It was 
very positive. Clearly I wasn’t left confused or feeling in any way… After the initial month, 
the doctor here made it clear they were sort of in support or was leaning towards advising 
or recommending at least another month or two and I was already hoping and anticipating 
in my next opportunity in any type of consultation with the doctor as to my own wish to 
stay for that month or two. So there was no conflict at all within me. So therefore my 
attitude was to ‘OK this is the formality’. I found the Magistrate extraordinarily 
compassionate and very clearly altruistic and seriously wishing the best outcome for all 
concerned... I left feeling quite touched.” (Patient) 
 
In summary, across the above three sections, a number of challenges and inconsistencies reflected 
across the Act, the Model of Care and the program operations have been identified. One of these is 
the difference between acute protection versus AOD treatment. The paradigm which is the basis for 
the Act and the IDAT program is that by involuntarily detaining someone who has refused voluntary 
care, is substance dependent and is at risk of serious harm to themselves or at risk of causing harm 
to any dependents under their care, this has the potential to change the course of the person’s 
addiction. There is not level 1 or 2 evidence for this – so it is an underlying assumption. This 
demonstrates the difference from MH – where involuntarily detention is solely a protective function, 
and once the acute risk of harm has passed, the person is discharged without expectation that it will 
have changed the long-term course of the mental health illness. It is precisely this aspect (changing 
the future course of addiction, prevention of future harm) that underpins the current IDAT program 
– which balances both acute care and AOD treatment. Yet, this also then bumps into the problem of 
waiting time (if one leans towards the acute functions of the Act), and bed availability and resources 
for the AOD treatment component if one leans towards the AOD treatment function. 






6.4 Waiting time: supply and demand 
At the time of the process evaluation, there were 19 patients on the waiting list for BF and 10 
patients on the waiting list for HSC. As noted above, the average wait time prior to admission is 27 
days, with 19% of patients waiting more than 42 days prior to admission. This seems to fly in the 
face of the intention of the Act, which is to provide protection and care for people at acute risk.  
 
Stakeholders expressed significant concerns about the waiting time: 
“It is an outrage; very often the community and family members expect the procedure for 
IDAT admission is similar to a mental health admission. We often have to spend a lot of time 
to explain the difference. It is very hard to have to explain to a desperate family that they 
might have to wait for months for an IDAT bed and the application might be knocked back.” 
(ITLO) 
  
“IDAT [is] for patients whose needs are immediate…. but waiting for 4 weeks, 6 weeks and 
sometimes 2 months for a bed then leaves open a level of risk .” (ITLO/Social Worker)      
 
“It is very worrying that we’ve got people on the waiting list who are very unstable and very 
unsafe.” (IDAT provider) 
 
The evaluators were told that ITLOs are not referring because of the long waiting list: 
“I would normally ring the Unit and talk to them about what their waiting lists are like. Is it 
worthwhile doing the IDAT assessment right now when we know that the patient potentially 
can’t be admitted for 2-3 months?” (ITLO) 
 
The two IDAT units are extremely aware of the waiting time problem, and have a “juggling act on a 
daily basis”. The waiting list is not managed on a “first in best dressed” basis. Rather, it is based on 
the level of acute problems presented. This is similar for both treatment units. On average, meetings 
occur weekly to determine which patient is next on the waiting list (see below ‘patient 
prioritisation’). This process is continuously changing, so a prospective patient initially ranked 1 on 
the list, may be subsequently moved down if a more urgent, acute case joins the list.  
 
ITLOs in the metropolitan LHDs are referring patients to both treatment units at the same time. The 
intake workers of both treatment units need to communicate with each other before they make a 
decision on issuing a DC for a patient. Coordination of prospective IDAT patients across multiple 
services, who may be simultaneously seeking an IDAT admission was noted: 
I am sending an email to all CNCs of Drug Health services, East, West, South and SSWAHS 
that an active application is current for [named patient], in case she starts presenting to 
other services, as this is what she did last admission. (ITLO email) 
 
The complexity of coordinating the assessment, the bed availability and the Dependency Certificate 
signature is highlighted in the following exchange, an example which occurred during the process 
evaluation: 
From an ITLO to an IDAT unit: “I understand beds cannot be held and do not expect them 
to….I have been asked to confirm if I call to verify bed availability when a particular patient is 
an inpatient at [mental health facility], can I access that bed please. … [Temporary AMP] will 
not sign DC unless patient is an inpatient.  
 
What happens while they wait? Sometimes, a patient chooses voluntary treatment during the 
waiting period. At other times, the patient appears to get lost in the system. The evaluators were 
advised that there had been cases of mortality while on the IDAT waiting list – an example where the 






consequence of the wait list was severe. If the prospective patient is acutely unwell, a regular 
hospital admission, or being ‘scheduled’ under the Mental Health Act are possible. However, use of 
the Mental Health Act for patients waiting for IDAT may be resisted by mental health services. 
 
It was not immediately clear to the evaluators who is responsible for managing patients on the IDAT 
waiting list. At what point does the IDAT team take over the clinical governance? It appears that this 
occurs at the point when the Dependency Certificate is issued, so that before then it is the ITLOs or 
referring team. 
“One of the challenges in the referring end is who would take the responsibility in locating 
the patient when a bed is available. Is it the ITLO or the regular D&A worker.” (ITLO) 
 
There are two crucial issues: 
• how to reduce the waiting time; and 
• management of patients while on the waiting list 
 
Waiting times may be reduced through: 
1. changes to the program (eg reduce the LOS, refocus on stabilisation, improve care transfer); 
2. increasing the number of beds; 
3. reducing the inflow (eg. by making the entry criteria more strict); 
4. using alternate mechanism for patients who don’t get in within 7 days (MH Act); 
5. establishing two different types of beds: acute and sub-acute; 
6. increasing BF bed occupancy to 90%.  
 
These are not mutually exclusive. All of them to some extent speak to the issue of the type of 
program that IDAT is – whether it is a stabilisation and assessment program (while the patient 
requires protection from themselves or for others) or whether it is an AOD treatment program. If the 
former becomes the primary focus, it is possible that the LOS would be reduced, thereby freeing up 
more beds (although it is not certain that this would be the case, as it appears that complex social 
and welfare circumstances are a primary reason for extended LOS). Some extended LOS is due to 
lack of voluntary NGO residential rehabilitation services. Consideration of greater investment in the 
voluntary treatment sector, and/or specific residential rehabilitation beds for IDAT patients in 
aftercare (that are separately funded) may be worth pursuing. In theory this would reduce the LOS in 
the IDAT beds and hence reduce the waiting time. Some proportion of patients are definitely ready 
for discharge but are waiting for a place in a voluntary service.  
“So it depends really on whereabouts the patient is discharged to. If they are discharged to 
the Western NSW area you are looking at one or two drug and alcohol workers for a very 
large area. So they are stretched, very stretched to deal with our complex clients we are 
putting back there. Then there are people who might be referred back to the cities and they 
are well-resourced.” (Allied Health IDAT team member) 
 
It is not immediately clear that increasing the number of beds within the existing units is sensible. 
Stakeholders noted both the transportation issues and the geographical equity. For these reasons it 
may be preferable to establish a third IDAT unit in another LHD. However, in the absence of the 
outcome and cost evaluation (pending over the next two years), it would be premature to make this 
decision now.  It would also be wise to consider all aspects of this process evaluation and resolve 
some of the operational matters identified herein, prior to any expansion. 
 
Reducing the entry flow into the program does not seem reasonable in light of the program demand 
(see earlier sections of this report). At present the Act carefully crafts the entry criteria such that 
they are neither under- nor over-inclusive.  
 






The use of alternate mechanisms for people who have to wait more than 7 days is plausible. This 
would mean that anyone not admitted within 7 days of referral must be placed elsewhere. The MH 
Act has the potential to be used here, but would require that admitting rights for AOD AMP’s or 
Addiction Medicine Specialists into MH units, and it assumes bed availability.  
 
A reconfiguration of the beds, drawing a distinction between “acute” IDAT beds (for those physically 
unwell, in withdrawal, during the stabilisation phase) and “sub-acute” IDAT beds for those who still 
require residential care but have now moved to the “AOD treatment” part of the program was one 
idea expressed by stakeholders. This could be the same provider (i.e. HSC and BF) or another 
provider (such as an NGO). Patients who are suitable for step-down, and do not need medical 
observation could be moved to these “sub-acute” beds. Sub-acute beds would be less expensive 
than IDAT beds. However, this would require a legal framework (i.e. a CTO) to keep the patients 
there (because it is still one form of involuntary treatment). 
 
This process evaluation noted the bed occupancy rate at BF (60%). If the Bed Occupancy Rate for BF 
could be raised to 90%, there would be an additional 31 admissions (episodes) per annum (assuming 
an average LOS of 28 days per admission). Their current yearly number of admissions (episodes) is 
approximately 90 (with varying LOS). The reasons for the current bed occupancy rate include the 
limited staffing levels at BF (so these would need to be increased), but also the transport problems, 
where it can take a few days to actually physically arrange for the patient to be transported (while 
the bed is held). A 90% occupancy rate could be achieved if: 1) the staffing levels increase; 2) the 
transportation issues can be resolved; and 3) the issues of locating and getting people to video 
facilities for assessment after a long wait on the waiting list can be improved18.  
 
Admissions currently occur only on weekdays because admission requires the presence of a medical 
doctor. Increasing admissions to occur across 7 days would also increase the bed occupancy rate but 
may not be feasible.    
 
Even in an ideal situation, a period of time between the assessment and admission is likely to occur. 
Clear clinical governance arrangements for these patients is essential, given how high risk they are. 
The options for managing people on the waiting list include that the IDAT teams become actively 
involved in managing patients on the waiting list (with appropriate additional resources); that ITLOs 
take on this function; and/or the referring team is responsible for the patient until such time as the 
Dependency Certificate is issued. None of these are necessarily ideal and each has advantages and 
disadvantages. If IDAT becomes the responsible body, the physical geography becomes problematic 
(especially for BF). But the advantages of the IDAT program taking on this role include the 
opportunity for further assessment, development of rapport, capacity to reprioritise, possibly refer 
to voluntary treatment through this process and entry can be streamlined. If it was an ITLO function 
- these are often not the patient group that would be managed usually, so no real connection. 
However, the advantage of the ITLOs is that it would facilitate the aftercare planning and provide 
some level of continuity post IDAT.  The referring team is best placed to take on this function, but 
when the patient is in an emergency department (ED), for example, it is not clear how this could 
occur.  
 
18 Often by the time assessment by video link can be arranged, the identified patient has “gone to ground” and 
the local police cannot find them or cannot get them to assessment. The referring team/IDAT team often have 
to wait until they re-present to hospital. 






6.5 Program entry 
The processes required for program entry, as befits a compulsory program, can be lengthy. The 
ITLOs spoke of the work involved in gathering the evidence and the data required in order to 
prepare the paperwork. On average, there was a consensus that it takes 8-10 hours to complete one 
referral application for one IDAT patient (min 4 hours, max 3 days).  
 
In some cases it was reportedly difficult to collect enough medical data, but this appeared to depend 
on the individual circumstances of the ITLO. For example, those ITLOs located within hospitals 
appear to have more ready access to the required medical records.  On the other hand, some data 
are sensitive, and difficult to obtain.  
“I have been refused access to information. Actually even with FACS (Family and Community 
Services), so I had to go back through their 16A Form. I actually had to go through four layers 
of people who were involved in it whereas the services who were supporting him (the 
patient) in the community had a copy of this information.” (ITLO) 
  
Another example provided was in relation to an Aboriginal Health Service, which refused access to 
data. Problems with access to assessment data from third parties appeared to be more common in 
the rural/regional areas than in the metropolitan areas. Overall though, of those interviewed for the 
process evaluation, few ITLOs claimed that they had problems collecting data from other agencies. 
 
The paper-based forms were raised as a concern (see also elsewhere, using of electronic medical 
records). According to those interviewed, Forms 1, 2, and 3 are somewhat repetitive. Form 1 is 
supposed to be done by an ITLO to request a MP to do the official referral/assessment. Form 2 is the 
“doctor to doctor” form (from MP to Accredited Medical Partitioner) and Form 3 is the 
Comprehensive Assessment done by ITLO. Currently, only Forms 2 and 3 are used.   
 
An aftercare plan is required as part of the entry process (as specified in the Model of Care). Without 
an aftercare plan (with the name of a designated case manager/care coordinator in the community) 
the IDAT unit will not consider the referral application. Some ITLOs said that they could not find a 
case manager for the patient so they put their name into this field and would “worry about it later”. 
One member of the IDAT team in BF said that there are instances where they contacted the case 
manager for arrangement of aftercare plan for patients but the case manager had moved on. In 
some instances the ITLO are developing an aftercare plan for someone who has not been engaged in 
treatment for many years, and not someone who is engaged with their current AOD treatment 
services. While there is sound logic to the importance of an aftercare plan prior to IDAT entry, there 
are some obvious problems with this requirement as well. Firstly, the Model of Care states that the 
ITLO is to work with the referring team to develop the plan, but the ‘referring team’ may be an ED or 
a general health service. In these cases the identification of a community case manager is extremely 
difficult. Secondly, the aftercare plan prior to admission is not developed in consultation with the 
patient, and the patient may also not be in a fit state to consider options. In any case, the 
development of an aftercare plan without patient input is not regarded as best practice. Thirdly, in 
some cases (not able to be quantified) the ITLO preparing the assessment does not physically see the 
patient highlighting the challenge of generating an aftercare plan in the absence of any direct 
contact with the patent. Finally, patient needs may change substantially during the IDAT admission, 
so pre-admission aftercare planning is somewhat misplaced.  
 
According to some stakeholders, many of these issues around program entry (access to data and 
aftercare planning) arise because the original vision for the IDAT program was that people who are 
eligible for IDAT have been involved in AOD services, and/or are part of the regular or usual case 
load of ITLOs. This does not appear to be the case. In reality most patients have not been engaged in 






AOD treatment and they have been identified because they are in and out of ED multiple times. It is 
difficult to ascertain the proportion of the potential patient group which are already connected with 
the ITLOs. The database notes that 23% of the referrals come from “other hospital” and 30% come 
from a “medical officer/specialist” (see Table 8). The database does not record ED (but it is assumed 
that ED referrals are coded under “medical officer/specialist” as this is most likely). While we cannot 
assume that all these referrals are completely unknown to the ITLOs, it is highly likely that some 
proportion of this 50% is unknown to the ITLOs.  
 
This is reinforced to some extent by the numbers of potential patients who are not physically seen 
by the ITLOs. We could not quantify this proportion. The MOC notes “It is not necessary for the 
screening assessment to involve contact with the patient” which does raise the question of the 
extent to which the ITLO is likely to be able to engage with the patient as part of her/his regular 
caseload.   
 
A key question that the evaluators sought to answer was the extent to which the referred patients 
are already part of an ITLO’s regular client load/patient group. We could not ascertain this from a 
quantitative point of view. Most ITLOs interviewed for the process evaluation said that if IDAT did 
not exist, they or other AOD workers in the community would have to work with the patients (who 
would be eligible for IDAT) at some point in time, but this had consequences for workload. 
“If these patients had nowhere else to go I would still be working with them. That’s true. But I 
would also prioritise my time: what work I did with them and what work I needed to do with 
other patients (who are not potentially eligible for IDAT).” (ITLO)  
{IDAT work] separates you away from the unit in the ward. … If I am doing an ITLO 
application, I will be leaving other patients.” (ITLO) 
 
The Accredited Medical Practitioner must issue the Dependency Certificate, and this requires                 
face-to-face or video conferencing. Stakeholders noted problems with video-conferencing: either 
equipment not available, or not working (when available).  
“…I do not have the ability at this time to coordinate video conferencing for IDAT applicants. 
[Named of organisation] is reportedly an option though likely to be a no [due to] risk 
assessments of external persons accessing the inpatient mental health unit.”  
 
The evaluation team cannot confirm that every patient was seen face-to-face or via video-
conferencing prior to the issuing of the DC. In at least one in-depth interview with a patient, the 
patient could not recall the meeting with the AMP (although given mental state issues likely at the 
time this may not be unusual).  
 
Some ITLOs have to spend a lot of their time educating stakeholders about IDAT, explaining to the 
referring medical doctors, family members and other medical professionals about IDAT. There 
appear to be misconceptions in the broader community that sending someone to IDAT is the same 
as sending someone to a mental health hospital. The two fundamental differences are that: 1) a bed 
for a mental health patient can be made available right away while the wait time for IDAT could be 
months; and 2) the amount of work required by the ITLO to gather the evidence to justify the 
eligibility criteria for IDAT is more demanding compared to that for a mental health patient. 
 
Finally, while 127 ITLOs underwent training in September 2014, according to the IDAT database only 
half (66) are active referrers to the IDAT program, with a total of 414 referrals. This suggests that 
each of the active ITLOs have made 6.27 referrals on average since the inception of the program. 
This is somewhat consistent with the estimate provided by the ITLOs who participated in the 
stakeholder interviews that on average, one ITLO makes 3-4 referrals per year (ranging from 1 to 8).  







Overall, there is significant concern amongst those interviewed for the process evaluation about the 
extensive procedural requirements that must be navigated before a referral can be completed and 
considered for a DC, and delays in treatment associated with those procedural requirements. While 
the imposition of procedural requirements assists to ensure detention and treatment is a 
consideration of last resort and to minimise limitations on a person’s human rights, stakeholders 
favoured streamlining procedural requirements to ensure the administrative work preceding a DC is 
not impeded by unnecessary procedural barriers. 
6.6 Admission 
As noted elsewhere, two critical issues preceding admission are transportation of patients to the 
IDAT sites, and the waiting time prior to admission. These are dealt with separately in other sections 
of this report.  
 
Patient prioritisation 
In the context of demand exceeding supply, the IDAT units must engage in an ongoing, active patient 
prioritisation process. Stakeholders reported that patients were prioritised based on need, the 
extent to which the admission was deemed urgent (that is, the patient was highly likely to be 
harmed if not admitted), the fit between the Unit and the patient, and certain population groups, as 
described in the following:  
“We go through the referrals that have been fully worked up. We come to the intake 
meeting. We look at Section 9 criteria, the aftercare, housing issues, we also look at the 
environment here whether the patient is going to be suitable for this particular environment 
with its limitations (security for patients with absconding risk), whether it is going to be 
problematic or if so should they move to Bloomfield. And then we make a determination of 
whether to accept them in principle or not …. And we also need to make a decision around 
who is actually #1 and #2 on the waiting list and that could be very difficult. Sometimes, it 
could be very clear because there is someone who is the most acutely unwell patient in the 
sense that those who we are very worried are going to die within next week or two if they 
don’t come in here. We would try and prioritise those patients immediately. Pregnant 
women, we prioritise them as well. We also look at issues around “first come, first serve” so 
if someone is on the waiting list for many months, and then they got accepted but then they 
dropped off the waiting list because they went on to voluntary treatment but now they are 
back to the waiting list. We tend to prioritise them if we could because we already accepted 
them previously. Otherwise, it is just a juggling act.” (IDAT team member) 
 
Patient prioritisation also takes into account other factors. As discussed earlier under the Act, there 
is potential ambiguity with reference to the “likely to benefit from treatment” criterion, providing 
the potential for programs to be selective about patient prioritisation. This may result in decisions 
that appear to be prejudicial against those who are homeless, or in other ways deemed less “likely to 
benefit from treatment”. In addition patient prioritisation occurs in the context of the current profile 
of patients on the unit – because of the complex presentations, and need for some stability in the 
unit, the process of prioritising and selecting patients is subject to considerations beyond the 
individual patient presentation (ie the therapeutic milieu at the time). Another example noted 
during the process evaluation was gender – the gender mix of the current inpatient caseload.  
 
Once a bed becomes available, the ITLOs reported to the evaluators that they are given very little 
time to arrange for patient transport and admission, resulting in the possibility that the bed is given 
to another patient. The IDAT units usually wait up to a week for the ITLO to arrange to get the 
patient to an assessment.  







The notion of a centralised intake team, across both programs was raised by stakeholders. One issue 
is that the same patient can be referred to both units simultaneously (see earlier) and this is less 
than ideal. In addition, the operation of differential criteria is perceived to be occurring. A 
centralised intake would maximise the likelihood of the best match between the patient and the 
unit. In addition, a centralised intake system could also attend to the waiting time (ensuring safety of 
patients during this period). However, it is not clear which service could provide a centralised intake 
function. If it was a third party (such as ADIS) the clinical flexibility around patient prioritisation 
would be lost (and the units would not have control over the admission). It could be a designated 
function of one of the two IDAT units, but this would again leave the other unit without control over 
admissions. Therefore, coordination between the two units may be preferable. A protocol could be 
developed such that one unit could advise the other when a referral was received. 
6.7 IDAT inpatient interventions/treatment  
Stakeholders noted that the IDAT program was very comprehensive, not only providing health and 
mental health assessment and treatment, withdrawal and drug and alcohol interventions but also 
many welfare services including guardianship orders, and meeting other social welfare needs of 
patients.  
 
Once the patients are admitted, the first phase is detoxification (which lasts 7-10 days) for those 
patients who have not undergone withdrawal prior to admission (the majority of patients undergo 
detoxification in the treatment units). A comprehensive physical and medical assessment is 
undertaken, with priority given to treatment of any medical conditions. Medical care for the 
consequences of alcohol dependence, such as peripheral neuropathy and liver disease were 
reported as well-managed. There were also a small number of female patients who had been 
pregnant during their admission, requiring significant pre-natal care during their stay. Medical 
treatment is reported to be very good at both sites. The patients also report very positive 
experiences of the medical treatment. No concerns about medication were raised with the 
evaluators. No Serious Adverse Events were noted in the review of the Official Visitors records19.  
“When I first came [to IDAT], my feet were numb and tingling and I hardly walked. I had to sit 
on a wheelchair to have breakfast but now it’s all good just for the four weeks. They are 
much better now, they still have a bit of a tingle feeling but compared to what they were, 
ah… my goodness me…” (Patient) 
 
Once the withdrawal is completed, a cognitive and psycho-social assessment can be undertaken. For 
those cognitively capable, they are asked to participate in group work activities with the aim of 
helping the patients to gain insights into their drug and alcohol use problem and to motivate change. 
The provision of this AOD treatment is undertaken in the context of a highly complex patient load. 
This includes active psychosis, aggressive behaviours, and people who are acutely mentally unwell.  
 
The Model of Care lists a comprehensive drug and alcohol intervention program: 
• structured psychosocial interventions, including cognitive behavioural therapy (CBT), coping 
skills training, contingency management;  
• counselling, e.g. trauma or grief counselling; 
• living and life skills, including cooking, cleaning and budgeting, in preparation for re-
integration into the community;  
• relapse prevention and active practice of relapse prevention skills during therapy; 
• advice, information and education about substance misuse.  
 
19 The BF Official Visitors reports were incomplete. 






As raised elsewhere in this report, the extent to which the IDAT program is regarded as an 
assessment, stabilisation and coordination function post-withdrawal versus a comprehensive AOD 
treatment intervention is unclear. At BF, there is a desire to provide the above array of AOD 
treatment interventions, but there were a number of reasons identified by the stakeholders that 
prevented this occurring: 
• some patients may not benefit from these interventions after 7 days because their cognitive 
functioning is still impaired; 
• for patients willing to participate, sometimes it is not possible to deliver these services due 
to limited staffing levels; 
• the way the facility is designed at BF makes it difficult to deliver 1:1 interventions. There is 
no separate room for counselling (although the bedrooms are single rooms). 
“Sometimes if the Multi-function room is occupied, I will need to do the assessment with the 
patient in their own bedroom and it is difficult because it is very distracting for the patient.” 
(Allied Health staff member) 
 
At HSC it appears that the above AOD treatment interventions are provided, notwithstanding 
adjustments for those patients with cognitive impairment. However, allied health staff turnover (for 
IDAT) was identified as an issue which inhibits the provision of the above treatment interventions. 
The mix of voluntary and involuntary patients at HSC is also very difficult to navigate around and a 
“constant” source of tension in terms of different models of care and access to different levels of 
resources. These issues have been recognised as a “huge challenge” and difficult to resolve despite 
trying many different strategies. 
“And I think the burn-out rate with staff [for IDAT] is relatively high compared with detox. We 
are going to appoint our third Social Worker. And we’ve had two consultant psychiatrists 
who work with IDAT. They moved on. They find that it is a high burn-out area. It is very 
challenging work.” (IDAT team member) 
 
There are ongoing assessment and care planning functions throughout the inpatient stay. 
Preparation for application of extension of the DC is required for those who are more seriously 
cognitive impaired, particularly alcohol-related brain injury. Guardianship orders may also be 
required for some patients. The staff works with the patients on the development of a global care 
plan which comprises 7 elements (substance use, physical health, mental health, socioeconomic, 
psychosocial, legal and other).   
 
At both treatment units, escorted and unescorted leave is available for IDAT patients. Decisions on 
which patients should receive escorted and unescorted leave are made as a strategy to test their 
capability to cope with triggers in real life. 
 
There are examples of patients having absconded from both treatment units. The IDAT database 
indicates absconding associated with 5 patient episodes (See Figure 1: 2 absconding events at HSC 
and 3 at BF). It is not clear whether these 5 absconding events were only related to patients who did 
not complete the inpatient treatment period in IDAT (never returned to the unit) or whether this 
included patients who absconded but then returned or were forced to return by the police and then 
eventually complete inpatient treatment. HSC is a less secure facility than BF. The evaluators were 
told that patients at HSC can abscond by jumping over the fence, by sneaking out through the gate 
when they have a visitor, or by not returning after unescorted leave. For BF, patients can abscond 
when on escorted leave (eg doing grocery shopping with the IDAT program staff in town), or by not 
returning to the unit after unescorted leave.  
 
 






Most stakeholders believe that IDAT is equipped with the infrastructure to manage patients with 
dual diagnosis, either within the treatment unit or in collaboration with the mental 
health/psychiatric ward within the hospitals. However, a number of stakeholders have challenges 
referring patients with dual diagnosis to IDAT.  
“A lot of clients suffer dual diagnosis …. And one thing we have noticed is that they [the IDAT 
units] find it very difficult to take on clients with severe mental illness. …. And psychiatric 
services would not admit those clients. They are not eligible for psychiatric services and we 
believe that we need to treat their drug and alcohol use to make sure we can help them into 
health but we often find those clients falling through the gap.” (NGO aftercare provider) 
6.8 Discharge and aftercare 
While still under inpatient treatment, the IDAT treatment team review and work with the patient on 
the aftercare plan, which is often based on the one developed by the referring team. It is very likely 
that circumstances have changed from the time of referral so the aftercare plan could be changed 
substantially.  
 
The “IDAT transfer of care coordinator” is a position identified in the Model of Care20, but this 
position is not specifically identified in the current IDAT program operations. The IDAT staff at HSC 
work as a team across all patients, and tasks vary for different people all the time. At BF there are 
two staff members with this role (the outreach AOD worker and the social worker). 
 
The Model of Care notes that only a discharge letter back to the ITLO or the referring team is 
required. Interviews with patients confirmed this in practice. In addition to the discharge letter, a 
comprehensive aftercare plan (recovery plan) was also sent back to the referring team for continuity 
of care. 
“My recovery plan is so much better here compared to in other places [rehabs]. Here they make 
sure you have a [recovery] plan and the plan goes to my GP, my mom [primary carer] and my 
drug and alcohol worker.” (Patient) 
 
Yet, the highly valuable assessment work that has been conducted during the inpatient stay with 
IDAT could be better shared with future treating clinicians.  
 
The Model of Care does not specify that a discharge summary be returned to the ITLO except where 
the ITLO happens to be the community care coordinator. This means that the ITLOs feel like they 
have put all this initial effort in, without any knowledge of the subsequent outcome. It would be a 
good practice to send a copy of the discharge summary to every referring ITLO, irrespective of the 
ITLO’s engagement in ongoing care.  
 
In the Model of Care, aftercare is called “community based program”, but the IDAT teams call it 
‘aftercare’. There is a lack of clarity in terminology. For some, ‘aftercare’ is (usually minimal) post-
treatment support; for others aftercare implies the provision of the next stage of treatment21. For 
example, at BF, aftercare is more minimalist akin to assertive follow-up post-treatment and involves 
making a phone call to the patient. At HSC, the program is responsible for aftercare services for 
patients who live in NSLHD because it is their local service. It is easier for this patient group because 
there are a lot more community-based treatment services in Northern Sydney, compared rural 
areas. 
 
20 It is also noted that the position of “IDAT inpatient case manager” is not a position which happens in reality 
in the IDAT program. Rather a team approach is observed in relation to inpatient case management.  
21 This definition and terminology problem is not unique to IDAT 






These definitional issues notwithstanding, the extent to which aftercare services are being taken up 
by IDAT patients (which also speaks to whether IDAT changes the course of the person’s addiction) 
was not able to be fully assessed in the process evaluation. In the IDAT database, there are data 
fields designed to collect data on utilisation of aftercare services by IDAT patients (DD-15 and DD-
16). However, the level of missing data for aftercare data is substantial (see Table 21):22 
 
Table 21: The level of missing data on aftercare services received  
 # of episode 
records available  
# of expected 
records 
HSC:   
1 month  33 132 
3 months 31 132 
6 months  27 132 
BF:   
1 month  5 210 
3 months 0 210 
6 months  0 210 
 
For patient episodes where aftercare data were recorded, the range of AOD services includes:  
• Pharmacotherapies (buprenorphine, methadone, naltrexone, disulfiram); 
• Day program rehabilitation; 
• Inpatient/residential withdrawal; 
• Outpatient consultation; and  
• Residential rehabilitation.  
 
The range of other health services includes: GP, community mental health, ED presentation, hospital 
admission, and outpatient specialist services. 
 
With reference to outreach or assertive follow-up, resources for this function are required: 
Most services do not have assertive outreach model and that is what you need for this 
patient group. You can’t just wait around for them to get on the phone and come in because 
they won’t. You need to get on the phone. You need to give them flexible appointment times 
or sometimes you got to go and meet them at their homes or coffee shops.” (IDAT team 
member) 
 
Aftercare was the component identified by nearly all stakeholders as the most challenging part and 
also the weakness of the IDAT program. This is reportedly due to: 
- Limited human resource capacity within the IDAT team to do community outreach 
(especially for BF); 
- Limited options for linking patients to community-case services; 
- Most of IDAT patients are cognitively impaired and could be eligible for ACAT (Aged Care 
Assessment Team) housing but they are under 65 years of age so the option is limited. 
Although ACAT provides options for young people the ACAT team often refuse to conduct 
ACAT assessment for IDAT patients due to various possible reasons; 
- The need for more community based services; 
- Housing and accommodation issues.  
 
22 Again, there is likely to be a lack of clarity regarding who is responsible for these data – is it the IDAT teams, 
who may have no ongoing contact with the majority of patients post-discharge, or is it the referring team, or is 
it the aftercare provider? If the last option, is there are mechanism in place to obtain these data? 







The following services were identified by the stakeholders in relative order of need/importance: 
1. Stepdown program/Day program; 
2. Housing/accommodation;  
3. Residential rehab; 
4. Assertive outreach; 
5. Counselling/psychiatrist. 
 
There were different opinions about what proportion of IDAT patients want to engage in aftercare: 
some stakeholders felt that only 50% are willing to engage, other stakeholders indicated it was 
higher than 50%. In the absence of clarity about whether this refers to assertive follow-up or the 
provision of ongoing AOD treatment post discharge, it is difficult to assess. In the quotes below, 
there is a mixture of aftercare and assertive follow-up: 
 
Proportion of patients saying yes to engagement in community aftercare: 
“Well they all say yes when they leave but not all of them follow through. They all say yes to 
aftercare because that is an exit, that is the way out of the unit but some of them don’t. 
Probably 10% of them don’t allow us to see them at all. Most of them would allow us to 
come and follow them up to some degree.” (IDAT team member) 
 
Could you please talk about the coordination of aftercare services for IDAT patients 
generally? 
 “So I think for us, we do it well here because [staff member’s name] and I decided from the 
beginning that we needed to have an aftercare component because we knew that there 
would be a significant number of patients from our area being referred in and we knew that 
it would be very difficult to coordinate care in D&A services because there isn’t case 
management. So we put some money in the budget to actually cover aftercare workers and 
to have an aftercare plan. So I think as best as one can, it is hard to follow up these patients, 
they go around they disappear, they decease but a significant number of people do allow us 
to follow them up. So we do pretty well with it because we have an Aftercare Team.” (IDAT 
team member)  
6.9 Brokerage fund 
The Brokerage Fund can be used for a range of services to support and/or facilitate a patient’s 
treatment, psychosocial welfare and recovery in the community. The funds are to be mainly used as 
part of the ‘community based’ voluntary component of the IDAT program, which patients may be 
involved in for 3-6 months after their involuntary treatment period. The funds can also be used as 
part of the involuntary part of the program as required23. Examples that were encountered during 
the process evaluation included: accommodation (eg a hotel room), furniture storage fees, travel 
costs to return home, client fees for residential rehabilitation, fee gaps for private specialists, 
pharmaceuticals that are not subsidised under the Pharmaceutical Benefits Scheme, food, travel 
costs associated with attending aftercare and follow-up appointments with health care providers, 
purchasing furniture to set up a new house, and dental care while in inpatient treatment. On 
average the allocation is $6,000 per patient per episode. 
“The Brokerage Fund is a reasonably untested approach in D&A so we always recognised 
that there could be challenges in implementing the Brokerage Fund. And I know there were 
some issues with accessing and the process of accessing Brokerage Fund earlier on so we did 
develop a Brokerage Guideline which is attached to the Model of Care to help guide the 
 
23 Page 2 of the Brokerage Funding Guideline. 






issues around what the money can be used for and also a mechanism to justify access to that 
money. Because obviously when money goes to a district, there is not so much quarantine 
any more as it used to be so we want to make sure that it is clear that this fund can be used 
for whatever is in the guideline.” (NSW Ministry of Health) 
 
Some administrative difficulties local to the hospital accounts arrangements were noted. For 
example, at BF signatures are required from five successive levels of management, which sometimes 
takes 6-8 days. For HSC, it seems less challenging to get approval to use the brokerage fund. A 
concern with the administrative aspects of the Brokerage Fund is the extent to which it is controlled 
by the hospital administration compared to the local IDAT program. It was alleged that IDAT 
Brokerage Funds may have been “misused” by a hospital, but no evidence to assess the veracity of 
this claim was provided to the evaluators.  
 
Stakeholders reflected on the use of the brokerage funds, which provide opportunities to support a 
number of different aspects of clients/patients recovery. But this also gave us a window into a 
broader but more subtle issue raised in stakeholders’ interviews – philosophical differences between 
staff members pertaining to how brokerage should be reasonably used; setting boundaries with 
patients; and the therapeutic alliance and philosophical approach to behavioural interventions.   
 
On the reasonable use of brokerage funds, some stakeholders felt that the use of the brokerage 
funds may encourage or facilitate a sense that the patients are dependent on the program, and may 
hinder opportunities for patients to become independent. For example, prior to admission to IDAT a 
patient had supported housing in the LHD where he was referred from. However, upon discharge, 
the brokerage fund was used to provide him one month of hotel accommodation while finding 
another housing option because the previous supported housing option was assessed as not 
conducive to successful recovery because a lot of drug dealing was occurring in this place. The issue 
here is that some staff believed that funds were not being spent sensibly and that in this situation 
the patient should go back to where he had come from. We were told that funds are limited, and 
should be spent on things that are clearly justifiable. It was also argued that it is unrealistic to expect 
that public supported housing is a perfect environment with no drug dealing and using.  
 
On the issue of boundary, some team members believed that a clear boundary is critical in a 
therapeutic relationship and that high levels of interpersonal engagement were either unnecessary 
for the therapeutic endeavour, and/or potentially counter-productive for future autonomy. “I would 
never eat with the patients at the BBQ. The only time I would have a meaningful conversation with 
the patients is when we are in a therapeutic session” (Psychologist). Other staff clearly felt very 
comfortable conversing with clients in informal settings.  
 
On the issue of therapeutic alliance, the development of a strong therapeutic alliance between 
patient and staff underpins rehabilitation efforts but can be perceived by some staff to jeopardise 
future independence and autonomy. This appeared to represent cultural differences between staff: 
some of the view that strong therapeutic alliances and high levels of interpersonal engagement 
between patients and staff were to be encouraged as part of the rehabilitative effort; with other 
staff of the view that high levels of interpersonal engagement were either unnecessary for the 
therapeutic endeavour, and/or potentially counter-productive for future autonomy.  
 
These differences in cultures are often found in healthcare programs that work over longer periods 
of time with a patient group, and where the patient group also displays features of dependence. 
Indeed, a transfer of the substance dependence onto the clinical program dependence is not 
uncommon. There are no right or wrong answers here – balancing the intensity of the therapeutic 
alliance with the need to facilitate autonomy in the medium to long term is a key challenge for all 






clinicians working in programs such as IDAT. In light of this, it is critical that these issues are 
discussed and managed adequately in such a way that staff members accept their differences rather 
than perceive these as conflicts, which in turn can have negative impact on staff morale and 
subsequently high staff turnover. “I have never worked with such a fractured team like this in my 
career” (IDAT team member). This potentially might have negative impacts on patient care.  
6.10 Transport fund and transport 
According to the Ministry of Health, a specific IDAT transport fund is allocated to each LHD with an 
annual allocation of $19,000 per LHD, irrespective of distance from the IDAT units or patient referral 
numbers. It is clear that a flat rate allocation to each LHD is inequitable when the pattern of referring 
LHDs is examined (see section 5.3, Table 5). 
 
Many ITLOs claimed that they were not aware that a transport fund is available for each LHD for 
transporting patients into IDAT treatment centres. One said that he found out about the fund by 
accident. Some are aware that the fund exists and did some investigation but were told by their LHD 
manager that it was not available and was already used for something else. 
 
As noted by one stakeholder to the evaluation: 
“There is confusion about paying for transport.  If the patient is admitted from community or 
from an outpatient clinic, I have been told that the Drug & Alcohol Service is responsible for 
the hundreds/thousands of dollars this trip costs.  If it is done from a hospital, I have been 
told by Nurse Managers that they are unhappy because the cost will come out of their 
budget.  Also, air ambulances cost much more than road transport, which often increases 
administrative anxiety about admissions.” (ITLO) 
 
Despite obvious best intentions, transport of patients to the IDAT units is a major issue. Even when 
the transport fund is used, there are other important clinical and practical constraints. Geographical 
distance is one example: the need to transport some patients from the metropolitan area to BF was 
noted. It is difficult to manage to get a patient under IDAT order into an airplane or in some towns, 
there are only two policemen in the whole town so they cannot leave town for one IDAT patient. 
 
In addition, patient transport has very strict guidelines, including these noted by SESLHD: 
• Transporting patients by air ambulance if the distance is greater than 250km.  All SESLHD 
facilities are at least 260km (to BF unit in Orange), and unless a great deal of negotiations 
takes place, patients are collected from a facility & driven to Bankstown airport then flown 
to Orange where IDAT clinicians take them to the facility.  For patients who are highly 
anxious, resistant or in withdrawal, a plane journey creates a number of risks and can be 
very distressing for the patients. 
• Patient transport services will not drive all the way to Orange.  The Patient Transport 
department SESLHD uses will only go as far as the Blue Mountains, and another ambulance 
service is required to meet them there and take over the journey.  If this ambulance is called 
away on an urgent matter, the patient transport service is potentially left waiting in 
Katoomba with an involuntary patient for several hours.  This jeopardises the admission, and 
places the patient at risk of absconding in an area they are not familiar with. 
6.11  Families and primary carers 
The critical role of a primary carer (potentially a family member) is identified in the IDAT Act. The Act 
stipulates that a patient may nominate a person to be their primary carer under the Act. The primary 
carer should be informed of the patient’s admission to the program, when they are on leave, if they 






do not return to the IDAT unit after leave, when their Dependency Certificate is extended, or when 
they are discharged and, where possible and appropriate, involved in the development of the care 
plan, particularly the community-based component of this plan. The Act also contains provisions to 
ensure that a person and their primary carer are provided with clear information about their legal 
rights and their rights of appeal. Specifically, the Act stipulates that the primary carer must be 
notified within 24 hours after a Dependency Certificate has been issued24. If the patient is unable to 
nominate a primary carer on admission, they will be asked again at an appropriate time, but within 
24 hours. 
 
The evaluators could not determine what proportion of the IDAT patients had a primary carer 
identified, but the data lent themselves to suggesting that for a number of IDAT patients, a primary 
carer was not nominated.  
“I don’t remember being asked to fill out a form to nominate a primary carer. I am in frequent 
contact with my mom and I tell her about how things are going when I am here.” (Patient) 
 
The Official Visitors (based on data from the Official Visitors’ Book and from in-depth interviews) 
observed the lack of primary carers being noted in patients’ files. The evaluators were provided with 
patients’ files for the last five admissions at HSC (but not BF). Out of those five cases, four had a 
primary carer nominated and one as noted “refused to nominate a primary carer”. Twelve patients 
participated in the in-depth interviews, of whom only four identified that they were asked to provide 
name and contact details of a primary carer. The other eight patients were confident that they were 
never asked to provide these details. One of the eight patients said that she was in regular contact 
with her family while in IDAT but that was because she initiated the contact. Cross-checking with 
patients’ files was possible for one of the eight patients. The file indicated that the primary carer 
form for this patient was completed.  
 
It is likely that in many circumstances, the paperwork/formalities were completed when the patients 
were still physically and/or mentally unstable, rendering their ability to recall these events impaired. 
In other circumstances, the patients could not complete the primary carer nomination form for a 
range of practical reasons. For example, one patient did not remember the phone number of her 
nominated primary carer (her mother) and was unable to gain access to her mobile phone to 
retrieve it25.  
 
The evaluators observed that the IDAT patient group appeared to have few connections with family. 
The IDAT database noted that 50% of the IDAT patients lived alone. Visits from family and loved ones 
while in the IDAT unit did occur but infrequently, made more difficult for many BF patients by the 
distance from their home community.  
“You have to remember that my son is living in Campbelltown. He can’t come to see me. But we 
are in frequent contact over the phone.” (Patient) 
  
Of the 12 patients interviewed, five reported close connections with family members and/or loved 
ones, including children, partners and parents. The other seven did not readily identify family 
support (by way of example, one had experienced the recent death of his partner; another had 
children all living overseas).  
 
24 Section 17 of the Act: “An accredited medical practitioner must, not later than 24 hours after the dependency certificate 
has been issued, take all reasonably practicable steps to notify the primary carer of the dependent person that the person 
has been detained.” 
25 Mobile phones of all IDAT patients were kept in a safe in the nurse station. The patients can retrieve access to their 
phones if justified and if a nursing staff is available.   






6.12   Strengths and weaknesses 
All the stakeholders interviewed for the process evaluation were invited to comment on the 
strengths and weaknesses of the IDAT program.  
 
The balance between involuntarily detention, human rights, and health care is a significant strength 
of IDAT. As intended by the legislators, the program is not simply a short-term detention program 
focussed solely on protecting an individual from harm, but rather it provides the opportunity to 
change harmful alcohol and other drug behaviours into the future. Achieving this balance between 
protection and AOD treatment is challenging and gives rise to some contradictions within the 
program. Nonetheless, it remains a significant strength, as perceived by stakeholders and other 
jurisdictions who are seeking to emulate this model.  
“It allows patients who don’t want to engage in treatment, aren’t engaged in treatment, it 
allows them a place and a space where they can recover enough to make informed decision 
about whether they want to engage or not.” (Drug and Alcohol Clinical Director) 
 
At the same time, the capacity and opportunity to provide “active” alcohol and other drug treatment 
may be limited, especially in the context of significant pressure on beds, plus the perforce 
deprivation of liberty. 
 
While some stakeholders felt that the program was well-resourced (from a budget allocation point 
of view, and relative to other AOD treatment services), other stakeholders noted the lack of 
resources as one of the weaknesses. This lack of resources was due to the cumbersome 
administrative process within hospital administration rather than a lack of budget. The complexity of 
staffing in a unit that is part of a larger LHD system (with priorities other than IDAT) was noted. In a 
similar context, the required administrative processes (hospital bureaucracy) in order to spend the 
brokerage funds were identified as a weakness.  
 
Stakeholders noted good checks and balances in the process of deprivation of liberty, and these 
clinical and legal processes occur independently from any political oversight. 
 
From the clinical perspective, the medical treatment and the comprehensive assessment and care 
that are provided is a strength. The fact that it offers the patients the opportunity to engage in a 
very comprehensive treatment program which addresses multiple issues: medical, psychiatric, 
addictions, social, with a multi-disciplinary team which includes a comprehensive aftercare plan.  
“People are brought to a stage of clarity where they can see that they need more help. These 
people would not engage voluntarily by definition and if they did go to voluntary treatment 
they did not stay very long and they never get to that state of clarity to understand there is 
hope and another way of dealing with things and support to be able to do that. So the length 
of time is critical.” (IDAT provider) 
 
The aftercare planning and provision was, however, identified as a weakness by a number of 
stakeholders. The lack of a Community Treatment Order option was noted, along with the lack of 
resources for voluntary AOD treatment in the community. There is no step-down program. “There’s 
a whole raft of aftercare gaps”.  
 
In relation to the length of the program (28 days as specified in the Act), on the one hand this is 
perceived as a strength in terms of a relatively short time for the deprivation of liberty (with the 
option to cease earlier than 28 days) but it is regarded by some stakeholders as insufficient time to 
achieve the comprehensive assessment, stabilisation and care planning for a substantial proportion 
of patients.  






Another strength of the program is the dedicated team of people (IDAT Team), the commitment of 
staff, the skills and general belief in what they are doing.  
 
The administratively cumbersome referral process was identified as a weakness, along with the lack 
of discharge information being returned to all ITLO/referring teams irrespective of the continuing 
care plan. The process by which a patient is assessed and gains access is hampered by the fact that 
there are only two IDAT sites, one of which is in a rural area and has specific challenges in relation to 
patient transport.  If there were more IDAT sites (which includes the option of IDAT beds in existing 
drug withdrawal facilities rather than stand-alone new units), patient access and smooth entry 
processes may be achieved.  
 
The largest weakness, identified by almost every single stakeholder, was access to beds. The 
significant waiting times for patient entry is perceived to be a substantial issue for the program, 
especially in the context where these waiting patients are highly vulnerable and have been assessed 
as being at risk to themselves or others, and requiring protection.  
  
There were some weaknesses specific to IDAT site raised by stakeholders. In BF, the environment is 
considered too restrictive (according to some stakeholders), with operations mirroring a secure 
mental health unit that may not be most suited to, or in the best interests of some IDAT patients. At 
BF, counselling rooms and space for therapeutic activities is lacking (despite a modern facility). At 
HSC, the unit itself is very old and tired, it looks run-down and uncared for and does not provide the 
kind of respectful physical environment that should be provided for this (or any) AOD program.  
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8 Appendices  
Appendix A: Stakeholders interview schedule 
 
Roles of stakeholders 
 
Remarks  
 MINISTRY OF HEALTH   
Manager, Clinical Policy, Alcohol and Other Drugs 
Centre for Population Health 
 
 WESTERN NSW LHD  
Clinical Director, Mental Health, Drug and Alcohol  
IDAT Director   
Acting Nurse Unit Manager  
Magistrate  
Two Official Visitors   
Social Worker  
Psychologist   
Occupational Therapist   
Outreach Worker/Drug and Alcohol Worker   
Aftercare provider (Lyndon Rehabilitation)  NGO 
 NORTHERN SYDNEY LHD   
Director of Mental Health, Drug and Alcohol   
Director of Drug and Alcohol Services   
IDAT Clinical Director   
Nurse Unit Manager  
Clinical Nurse Consultant   
Intake Worker  
Assertive Outreach Worker 1  
Assertive Outreach Worker 2  
Occupational Therapist   
Clinical Psychologist   
Clinical Psychiatrist   
Two Official Visitors   
Magistrate   
Aftercare provider 2 (New Horizons) Non-governmental 
Aftercare provider 3 (Homeless Health) Non-governmental 
 ITLOs  
ITLO 1 (based in Orange) Western NSW LHD 
ITLO 2  (based in Cowra) 
ITLO 3 (Based in Dubbo) 
ITLO 4  Hunter New England LHD 
ITLO 5  Illawarra Shoalhaven LHD 
ITLO 6 
ITLO 7  South Eastern Sydney 
LHD ITLO 8  
ITLO 9  
Two written submissions from ITLOs based at Langton Centre in SESLHD  
 
